≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Secondary parkinsonism, excluding more controls

Endpoint Browser PheWeb

PD2ND_EXMORE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — G21
  • Hospital discharge: ICD-9 — 3321
  • Cause of death: ICD-10 — G21
  • Cause of death: ICD-9 — 3321

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
G6_PARKINSON, F5_PSYCH, NEURODIS

Extra metadata

First used in FinnGen datafreeze
DF2
Parent code in ICD-10
G20-G26
Name in latin
Parkinsonismus secundarius

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 11158 5439 5530
Only index persons 7519 3804 3715
Unadjusted period prevalence (%)
Whole population 0.16 0.16 0.15
Only index persons 0.14 0.14 0.14
Median age at first event (years)
Whole population 71.35 72.01 70.61
Only index persons 69.43 70.60 68.23

-FinnGen-

Key figures

All Female Male
Number of individuals 1060 468 592
Unadjusted period prevalence (%) 0.22 0.17 0.27
Median age at first event (years) 67.55 67.27 67.77

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1087
Matched controls
10869
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F32.9
ICD-10 Finland
Depressive episode, unspecified
44.1
322.1
196
54
AA1AD
NOMESCO Finland
CT of head and brain
10.0
310.6
491
824
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
+∞
307.7
383
*
N05AH03
ATC
olanzapine; systemic
325.2
307.7
432
22
G20
ICD-10 Finland
Parkinson disease
2826.0
307.7
362
*
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
+∞
307.7
312
*
N05BA06
ATC
lorazepam; systemic, sublingual
30.9
307.7
270
115
N03AG01
ATC
valproic acid; systemic, rectal
354.6
307.7
324
13
N06AB04
ATC
citalopram; systemic
12.7
307.7
420
515
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
+∞
307.7
373
*
N05AX08
ATC
risperidone; systemic
140.9
307.7
418
48
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
595.5
307.7
409
11
N05AA02
ATC
levomepromazine; systemic
115.3
307.7
276
32
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
+∞
307.7
517
*
N05AH04
ATC
quetiapine; oral
83.0
307.7
567
141
N05AB03
ATC
perphenazine; systemic, rectal
147.4
307.7
194
16
N05BA04
ATC
oxazepam; oral
9.7
306.1
506
893
N03AE01
ATC
clonazepam; systemic
30.6
270.9
184
72
T36
ICD-10 Finland
Poisoning by systemic antibiotics
108.1
258.5
133
14
N05AX12
ATC
aripiprazole; systemic
1535.6
256.9
240
*
N06AX11
ATC
mirtazapine; oral
8.1
255.4
503
1050
N05AD01
ATC
haloperidol; systemic
30.8
254.6
172
66
N04AA02
ATC
biperiden; systemic
1016.4
253.9
239
*
R25.1
ICD-10 Finland
Tremor, unspecified
41.6
250.9
154
43
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
134.8
238.5
120
10
N05AC02
ATC
thioridazine; oral
88.1
236.8
125
16
N05BA01
ATC
diazepam; systemic, rectal
10.1
235.7
316
422
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
19.1
234.3
195
123
P99
ICPC
Psychological disorders other
119.1
229.8
117
11
N06AX16
ATC
venlafaxine; oral
14.2
229.7
229
200
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
24.7
228.9
168
80
N05CD07
ATC
temazepam; oral
9.1
222.3
330
497
P29
ICPC
Psychological sympt/compl other
27.2
217.7
153
65
N05AN01
ATC
lithium; oral
807.6
208.9
199
*
R53
ICD-10 Finland
Malaise and fatigue
6.7
200.3
440
995
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
7.1
196.7
389
792
N06AB06
ATC
sertraline; oral
14.2
196.6
193
163
G21.0
ICD-10 Finland
Malignant neuroleptic syndrome
+∞
193.7
180
*
G21.8
ICD-10 Finland
Other secondary parkinsonism
+∞
193.7
180
*
F29
ICD-10 Finland
Unspecified nonorganic psychosis
719.6
188.9
181
*
F20.9
ICD-10 Finland
Schizophrenia, unspecified
+∞
184.8
172
*
S06.0
ICD-10 Finland
Concussion
24.9
182.4
132
60
F03
ICD-10 Finland
Unspecified dementia
42.3
176.3
107
28
N05BE01
ATC
buspirone; oral
65.7
173.9
96
16
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
57.7
168.1
95
18
N05AH02
ATC
clozapine; systemic
+∞
167.1
156
*
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
1879.9
166.0
157
*
N06AX03
ATC
mianserin; oral
20.7
166.0
130
71
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
36.6
163.3
103
31
A06AD11
ATC
lactulose; oral
6.3
161.4
344
740
N06DX01
ATC
memantine; oral
72.7
160.3
87
13
G47.3
ICD-10 Finland
Sleep apnoea
12.2
159.8
171
164
N05AF03
ATC
chlorprothixene; systemic
360.8
156.2
154
5
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
49.6
156.0
91
20
SPAT1240
SPAT
Therapeutic discussion
13.3
155.6
156
135
N06AB10
ATC
escitalopram; oral
7.9
155.2
246
390
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
46.1
150.1
89
21
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
217.1
147.9
150
8
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
+∞
147.3
138
*
N05CF01
ATC
zopiclone; oral
4.9
145.3
509
1657
P72
ICPC
Schizophrenia
793.5
144.5
139
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
9.8
142.0
178
212
C07AA05
ATC
propranolol; systemic
5.9
140.4
314
699
A28
ICPC
Limited function/disability NOS
5.4
138.9
358
903
R56.8
ICD-10 Finland
Other and unspecified convulsions
23.6
137.7
101
47
N03AX09
ATC
lamotrigine; oral
179.7
137.0
141
9
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
13.6
136.9
134
111
N87
ICPC
Parkinsonism
747.8
136.9
132
*
N04BC05
ATC
pramipexole; oral
10.0
132.5
163
189
L28
ICPC
Limited function/disability (L)
5.2
129.1
343
882
F51.0
ICD-10 Finland
Nonorganic insomnia
+∞
128.8
121
*
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
+∞
126.6
119
*
R41.0
ICD-10 Finland
Disorientation, unspecified
26.1
126.6
89
37
P20
ICPC
Memory disturbance
6.6
125.9
233
430
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
1346.0
125.6
120
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
10.8
124.3
143
151
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
8.8
121.1
165
217
G30.1
ICD-10 Finland
Alzheimer disease with late onset
47.4
120.6
71
16
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
16.0
120.1
106
73
N06AB03
ATC
fluoxetine; oral
7.7
119.0
183
277
N05AL01
ATC
sulpiride; systemic
69.1
118.8
65
10
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
4.2
117.1
478
1696
N04BD01
ATC
selegiline; oral
1233.4
115.9
111
*
N03AF01
ATC
carbamazepine; oral, rectal
15.2
114.8
104
75
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
214.0
112.9
115
6
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
+∞
112.5
106
*
N06DA03
ATC
rivastigmine; oral, transdermal
399.5
110.5
109
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.0
109.0
481
1787
N06AG02
ATC
moclobemide; oral
15.2
105.2
95
68
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
17.4
103.8
87
54
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
102.8
97
*
SPAT1234
SPAT
Support of social functional capacity
10.3
102.5
120
129
N28
ICPC
Limited function/disability (N)
41.0
101.8
62
16
XA800
NOMESCO Finland
Neuropsychological investigation
43.0
101.3
61
15
SPAT1222
SPAT
Counselling/guidance promoting independent living
5.0
101.0
261
645
SPAT1229
SPAT
Assessment of need for aid
8.0
100.1
146
207
N06AX12
ATC
bupropion; oral
18.5
99.8
81
47
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
+∞
98.5
93
*
N05AA01
ATC
chlorpromazine; systemic, rectal
271.9
98.4
99
*
N07BB01
ATC
disulfiram; oral
20.8
96.4
74
38
SPAT1216
SPAT
Assessment of functional ability
4.9
96.3
258
655
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
210.3
94.0
96
5
N06AA12
ATC
doxepin; systemic
9.9
92.6
111
123
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
966.7
92.2
89
*
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
966.7
92.2
89
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
5.1
91.5
226
535
N29
ICPC
Neurological sympt/complt other
32.8
91.0
59
19
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
+∞
90.9
86
*
N06AX21
ATC
duloxetine; oral
7.8
89.9
133
191
P76
ICPC
Depressive disorder
16.5
89.6
77
50
ZY010
NOMESCO Finland
Hospital outpatient
11.9
89.6
94
86
N06AX26
ATC
vortioxetine; oral
14.7
89.5
82
60
N06AA09
ATC
amitriptyline; systemic
7.0
87.6
144
232
N39.4
ICD-10 Finland
Other specified urinary incontinence
5.9
87.0
173
337
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
907.7
86.9
84
*
N05AF05
ATC
zuclopenthixol; systemic
+∞
86.6
82
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
4.4
85.8
263
737
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
+∞
85.6
81
*
N05AD03
ATC
melperone; systemic
37.1
84.8
53
15
R42
ICD-10 Finland
Dizziness and giddiness
3.9
84.5
329
1094
N06AB05
ATC
paroxetine; oral
11.3
83.2
90
86
IGY02
NOMESCO Finland
Psychiatric monitoring contact
439.8
83.2
82
*
P03
ICPC
Feeling depressed
10.4
81.8
94
98
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
81.3
77
*
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
+∞
80.2
76
*
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
12.6
79.8
80
68
N05BA12
ATC
alprazolam; oral
6.0
79.3
152
285
U04
ICPC
Incontinence urine
6.6
76.0
131
221
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
+∞
75.9
72
*
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
399.1
75.7
75
*
F41.1
ICD-10 Finland
Generalized anxiety disorder
21.4
75.4
57
28
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
21.4
75.4
57
28
G40.9
ICD-10 Finland
Epilepsy, unspecified
393.3
74.7
74
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.2
74.3
239
689
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
+∞
73.8
70
*
N05AF01
ATC
flupentixol; systemic
24.2
73.7
53
23
A04
ICPC
Weakness/tiredness general
4.2
73.6
229
644
N06AX05
ATC
trazodone; oral
24.8
73.0
52
22
N06AA04
ATC
clomipramine; systemic
41.6
72.5
44
11
N06DA02
ATC
donepezil; oral
104.9
71.9
78
8
188
Kela drug reimbursment
Psychosis requiring demanding treatment
+∞
71.7
68
*
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
+∞
71.7
68
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
7.6
71.0
106
153
G25.0
ICD-10 Finland
Essential tremor
16.1
70.4
61
40
SPAT1307
SPAT
Psychosocial counselling and guidance
13.7
69.6
66
51
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
90.8
68.9
76
9
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
17.0
68.9
58
36
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
154.0
68.8
72
5
F22.0
ICD-10 Finland
Delusional disorder
711.4
68.8
67
*
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
+∞
68.5
65
*
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
6.5
68.0
118
200
K59.0
ICD-10 Finland
Constipation
6.4
67.3
118
202
F05.9
ICD-10 Finland
Delirium, unspecified
183.9
66.8
69
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
9.3
66.7
83
96
G04BD12
ATC
mirabegron; oral
4.2
66.6
206
574
F32.1
ICD-10 Finland
Moderate depressive episode
18.3
66.6
54
31
SPAT1254
SPAT
Administration of medicine
4.0
65.7
221
654
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
+∞
65.3
62
*
I95.1
ICD-10 Finland
Orthostatic hypotension
8.1
64.5
90
120
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
175.4
63.7
66
*
P01
ICPC
Feeling anxious/nervous/tense
6.9
63.7
103
162
F31
ICD-10 Finland
Bipolar affective disorder
654.8
63.5
62
*
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
29.1
62.4
42
15
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
331.3
62.0
62
*
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
632.3
61.4
60
*
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
632.3
61.4
60
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.8
61.2
225
706
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
+∞
61.0
58
*
IGY99
NOMESCO Finland
Other psychiatric treatment contact
+∞
61.0
58
*
P74
ICPC
Anxiety disorder/anxiety state
15.3
60.8
54
37
TAB00
NOMESCO Finland
Lumbar puncture
14.3
60.8
56
41
F31.8
ICD-10 Finland
Other bipolar affective disorders
621.1
60.3
59
*
S01.0
ICD-10 Finland
Open wound of scalp
5.1
60.2
136
294
G72.8
ICD-10 Finland
Other specified myopathies
319.6
59.9
60
*
F06.7
ICD-10 Finland
Mild cognitive disorder
18.6
59.7
48
27
N04BC04
ATC
ropinirole; oral
610.0
59.3
58
*
N03AX14
ATC
levetiracetam; systemic
27.6
58.4
40
15
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.8
57.3
199
599
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
+∞
56.8
54
*
F34.1
ICD-10 Finland
Dysthymia
75.3
56.8
64
9
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
16.0
56.6
49
32
N30.0
ICD-10 Finland
Acute cystitis
3.6
56.2
223
733
W19
ICD-10 Finland
Unspecified fall
4.6
56.0
144
346
SPAT1301
SPAT
No procedures
2.9
55.9
387
1760
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
+∞
55.7
53
*
AA400
NOMESCO Finland
Electroconvulsive therapy
+∞
55.7
53
*
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
+∞
55.7
53
*
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
5.0
55.6
129
285
N06CA01
ATC
amitriptyline and psycholeptics; systemic
5.3
54.8
118
244
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
+∞
53.6
51
*
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
17.6
53.4
44
26
R55
ICD-10 Finland
Syncope and collapse
4.0
53.0
173
497
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.9
52.8
179
528
Z2445
NOMESCO Finland
Psychologist
70.4
52.7
60
9
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
+∞
52.5
50
*
K59.09
ICD-10 Finland
Constipation, unspecified
4.8
51.4
126
291
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
98.3
51.3
56
6
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
6.3
50.9
89
151
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
14.0
50.5
47
35
L89
ICD-10 Finland
Decubitus ulcer and pressure area
12.4
50.0
50
42
N06AA06
ATC
trimipramine; systemic
12.4
50.0
50
42
R33
ICD-10 Finland
Retention of urine
4.0
49.9
160
453
N04BD02
ATC
rasagiline; oral
510.3
49.8
49
*
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
5.6
48.8
98
190
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
+∞
48.3
46
*
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
+∞
48.3
46
*
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
6.6
47.3
79
128
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
47.2
45
*
193
Kela drug reimbursment
Rasagiline
+∞
47.2
45
*
C03CA01
ATC
furosemide; systemic
2.5
47.1
466
2488
R41.3
ICD-10 Finland
Other amnesia
12.6
46.4
46
38
R51.80
ICD-10 Finland
Headache
4.1
46.2
137
366
N05BA02
ATC
chlordiazepoxide; systemic
15.9
46.2
40
26
F61.0
ICD-10 Finland
Mixed personality disorders
+∞
46.2
44
*
F20.5
ICD-10 Finland
Residual schizophrenia
+∞
46.2
44
*
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
466.5
45.6
45
*
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
466.5
45.6
45
*
R50.9
ICD-10 Finland
Fever, unspecified
3.2
45.5
215
781
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
+∞
45.1
43
*
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
+∞
45.1
43
*
A06AC01
ATC
ispaghula (psylla seeds); oral
2.7
44.9
324
1479
IHZ05, ,
SPAT
13.1
44.5
43
34
N06AB08
ATC
fluvoxamine; oral
13.1
44.5
43
34
F10.20
ICD-10 Finland
Alcohol dependence currently independent
100.4
44.1
48
5
N04BX02
ATC
entacapone; oral
+∞
44.1
42
*
29580
ICD-8 Finland
Schizophrenia, Other
+∞
44.1
42
*
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
+∞
43.0
41
*
Z2446
NOMESCO Finland
Social worker
5.0
42.8
97
209
WYA20
NOMESCO Finland
Home visit
15.9
42.7
37
24
N03AX12
ATC
[U] gabapentin; oral
3.6
42.3
157
489
SPAT1053
SPAT
Memory test
3.2
42.3
191
673
N05CD02
ATC
nitrazepam; oral
10.2
42.1
48
49
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
+∞
41.9
40
*
R13
ICD-10 Finland
Dysphagia
4.9
41.9
98
217
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
6.4
41.9
72
120
F32
ICD-10 Finland
Depressive episode
11.4
40.9
43
39
N03AX16
ATC
[U] pregabalin
2.9
40.6
224
884
ZY000
NOMESCO Finland
Hospital inpatient
91.7
40.1
44
5
IGV01
NOMESCO Finland
Psychiatric network contact
+∞
39.8
38
*
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
+∞
39.8
38
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
+∞
39.8
38
*
F20.0
ICD-10 Finland
Paranoid schizophrenia
+∞
39.8
38
*
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
+∞
39.8
38
*
K08.3
ICD-10 Finland
Retained dental root
3.9
39.7
127
357
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.0
39.5
200
752
F60.9
ICD-10 Finland
Personality disorder, unspecified
401.3
39.3
39
*
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
3.3
38.8
164
554
N05AE04
ATC
ziprasidone; systemic
+∞
38.8
37
*
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
+∞
38.8
37
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.5
38.7
310
1476
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.5
38.6
100
240
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.3
38.1
163
554
SPAT1215
SPAT
Assessment of need for medical rehabilitation
7.0
38.1
59
88
F20
ICD-10 Finland
Schizophrenia
+∞
37.7
36
*
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
+∞
37.7
36
*
R5140
NOMESCO Finland
Monitoring the use of the aid
5.5
37.6
75
144
E86
ICD-10 Finland
Volume depletion
7.8
37.6
53
71
R1250
NOMESCO Finland
Evaluation of functional capability
11.5
37.3
39
35
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
379.8
37.2
37
*
G30.8
ICD-10 Finland
Other Alzheimer disease
134.7
36.9
39
*
29999
ICD-8 Finland
Unspecified psychosis
+∞
36.7
35
*
N05AX13
ATC
paliperidone; systemic
+∞
36.7
35
*
ZYC01
NOMESCO Finland
Remote contact by phone
4.9
36.5
84
183
G44.2
ICD-10 Finland
Tension-type headache
4.5
36.4
94
225
F99
ICD-10 Finland
Mental disorder, not otherwise specified
369.0
36.2
36
*
R32
ICD-10 Finland
Unspecified urinary incontinence
7.2
35.9
54
78
G21.2
ICD-10 Finland
Secondary parkinsonism due to other external agents
+∞
35.6
34
*
P06
ICPC
Sleep disturbance
4.4
35.6
94
229
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.8
35.5
119
345
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.3
35.5
74
148
N03AF02
ATC
oxcarbazepine; oral
44.6
35.2
43
10
P28
ICPC
Limited function/disability (P)
186.0
35.0
36
*
R4130
NOMESCO Finland
Speech therapy
10.3
34.6
39
39
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
+∞
34.6
33
*
SPAT1243
SPAT
Psychiatric/psychological examination
40.7
34.6
43
11
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
5.3
34.5
72
144
NA1AD
NOMESCO Finland
Cervical spine CT examination
6.6
34.5
57
91
K90
ICPC
Stroke/cerebrovascular accident
59.2
34.4
40
7
EBA30
NOMESCO Finland
Extraction of root of tooth
4.2
34.4
96
244
G02CB01
ATC
bromocriptine; systemic
12.5
34.3
34
28
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
8.9
34.2
43
50
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
7.3
34.1
51
73
P98
ICPC
Psychosis NOS/other
347.6
34.1
34
*
F01.9
ICD-10 Finland
Vascular dementia, unspecified
124.0
33.9
36
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
33.9
224
965
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.2
33.9
153
536
30041
ICD-8 Finland
Neuroses, Depressiva
+∞
33.5
32
*
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
+∞
33.5
32
*
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
+∞
33.5
32
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
+∞
33.5
32
*
G56.0
ICD-10 Finland
Carpal tunnel syndrome
6.1
33.3
59
101
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.3
32.9
319
1638
EBA00
NOMESCO Finland
Extraction of tooth
2.2
32.5
389
2178
29599
ICD-8 Finland
Schizophrenia, Unspecified type
+∞
32.5
31
*
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
+∞
32.5
31
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
+∞
32.5
31
*
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
170.0
31.9
33
*
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
+∞
31.4
30
*
F20.10
ICD-10 Finland
Raise schizophrenia continuously
+∞
31.4
30
*
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
+∞
31.4
30
*
2957A
ICD-9 Finland
Schizophrenic psychoses, Schizo-affective type
+∞
31.4
30
*
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
+∞
31.4
30
*
G25.1
ICD-10 Finland
Drug-induced tremor
321.7
31.0
31
*
SPAT1245
SPAT
Provision of support and information to patient’s family members
5.7
30.8
59
109
R60.0
ICD-10 Finland
Localized oedema
2.9
30.5
166
644
A29
ICPC
General symptom/complaint other
2.8
30.3
171
677
TKC20
NOMESCO Finland
Catheterisation of bladder
3.5
30.3
110
336
G25.2
ICD-10 Finland
Other specified forms of tremor
60.2
30.2
35
6
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
70.0
30.0
34
5
N04BC09
ATC
rotigotine; transdermal
310.6
29.9
30
*
UKC02
NOMESCO Finland
Cystoscopy
2.5
29.9
230
1060
IGY02, ,
SPAT
85.1
29.9
33
*
R35
ICD-10 Finland
Polyuria
3.6
29.7
104
310
SPAT1262
SPAT
Handing over of treatment supplies
2.6
29.6
201
873
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
51.6
29.5
35
7
SPAT1305
SPAT
Counselling and guidance related to physical exercise
3.4
29.5
114
362
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.8
29.3
68
149
F25.01
ICD-10 Finland
Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms
+∞
29.3
28
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
9.5
29.3
35
38
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
58.4
29.3
34
6
D12
ICPC
Constipation
4.9
29.1
66
142
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
299.6
28.9
29
*
N30.9
ICD-10 Finland
Cystitis, unspecified
3.8
28.9
91
252
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.2
28.8
312
1664
G04BD08
ATC
solifenacin; oral
3.8
28.8
94
267
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
4.4
28.7
75
181
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
28.6
342
1898
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
8.2
28.3
38
48
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
+∞
28.2
27
*
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
+∞
28.2
27
*
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
+∞
28.2
27
*
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
28.0
299
1584
G04BD07
ATC
tolterodine; oral
4.2
27.6
77
195
SPAT1260
SPAT
Consultation of another employee
2.5
27.6
197
874
R11
ICD-10 Finland
Nausea and vomiting
3.3
27.3
108
348
A01
ICPC
Pain general/multiple sites
3.2
27.2
114
380
SPAT1101
SPAT
Orthostatic test
4.6
27.2
66
150
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
+∞
27.2
26
*
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
+∞
27.2
26
*
F25.21
ICD-10 Finland
Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms
+∞
27.2
26
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
27.1
218
1021
J01CA08
ATC
pivmecillinam; oral
2.1
26.9
379
2229
Z75.5
ICD-10 Finland
Holiday relief care
42.4
26.9
33
8
J01EA01
ATC
trimethoprim; systemic
2.2
26.8
284
1496
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
2.0
26.7
435
2694
SPAT1167
SPAT
Insertion of urinary catheter
5.0
26.7
59
124
A10BA02
ATC
metformin; oral
2.1
26.5
343
1952
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.7
26.4
165
686
P70
ICPC
Dementia
26.5
26.3
36
14
H03AA01
ATC
levothyroxine sodium; systemic
2.3
26.2
247
1239
F31.2
ICD-10 Finland
Bipolar affective disorder, current episode manic with psychotic symptoms
+∞
26.1
25
*
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
+∞
26.1
25
*
X59
ICD-10 Finland
Exposure to unspecified factor
2.5
26.1
192
863
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
6.2
26.1
45
75
F41.09
ICD-10 Finland
UNS Panic Syndrome
61.6
26.1
30
5
P27
ICPC
Fear of mental disorder
61.6
26.1
30
5
EBA15
NOMESCO Finland
Extraction of multiple teeth
4.5
25.8
65
152
S72.0
ICD-10 Finland
Fracture of neck of femur
4.2
25.8
71
178
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
266.7
25.8
26
*
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
266.7
25.8
26
*
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
95.8
25.8
28
*
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.1
25.8
306
1683
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.9
25.7
78
210
N02AA05
ATC
oxycodone; systemic
2.3
25.7
235
1162
F10.25
ICD-10 Finland
Alcohol dependence continuous use
138.3
25.7
27
*
SPAT1231
SPAT
Assessment of adjustments needed in living environment
9.4
25.7
31
34
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.6
25.7
162
676
XF606
NOMESCO Finland
Ortostatic test
34.0
25.7
33
10
L17
ICPC
Foot/toe symptom/complaint
2.1
25.7
309
1708
N04BB01
ATC
amantadine; oral
8.0
25.6
35
45
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
5.3
25.4
52
102
F20.8
ICD-10 Finland
Other schizophrenia
+∞
25.1
24
*
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
+∞
25.1
24
*
F25.11
ICD-10 Finland
Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms
+∞
25.1
24
*
P73
ICPC
Affective psychosis
+∞
25.1
24
*
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
+∞
25.1
24
*
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
+∞
25.1
24
*
N02BE01
ATC
paracetamol; systemic, rectal
2.5
24.9
926
7621
R5110, ,
SPAT
3.1
24.8
109
374
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
7.9
24.8
34
44
SPAT1252
SPAT
Overall medication plan or its review
3.5
24.7
90
275
N05CF02
ATC
zolpidem; oral
2.6
24.6
153
633
U05
ICPC
Urination problems other
3.8
24.6
78
217
N03AX11
ATC
topiramate; oral
35.4
24.4
31
9
F20.34
ICD-10 Finland
Undifferentiated schizophrenia with partial recurrence
+∞
24.0
23
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
24.0
23
*
F25.1
ICD-10 Finland
Schizoaffective disorder, depressive type
+∞
24.0
23
*
30000
ICD-8 Finland
Neuroses, Anxiety neurosis
+∞
24.0
23
*
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
+∞
24.0
23
*
29570
ICD-8 Finland
Schizophrenia, Schizo-affective type
+∞
24.0
23
*
F25.2
ICD-10 Finland
Schizoaffective disorder, mixed type
+∞
24.0
23
*
103
Kela drug reimbursment
Diabetes, insulin-treated
2.1
24.0
320
1830
N99
ICPC
Neurological disease other
38.5
24.0
30
8
A69
ICPC
General and Unspecified, Other reason for encounter NEC
5.1
23.9
51
104
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
88.8
23.7
26
*
L84
ICD-10 Finland
Corns and callosities
5.1
23.7
50
101
K02.1
ICD-10 Finland
Caries of dentine
1.9
23.6
543
3737
G04BD09
ATC
trospium; oral
6.6
23.6
38
59
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
23.4
311
1774
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
34.2
23.4
30
9
SPAT1263
SPAT
Sampling
1.9
23.3
403
2522
U07
ICPC
Urine symptom/complaint other
2.9
23.3
121
456
N05BA05
ATC
potassium clorazepate; oral
25.3
23.1
32
13
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
55.3
23.1
27
5
N18
ICPC
Paralysis/weakness
37.2
23.1
29
8
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
7.8
23.0
32
42
A03FA02
ATC
cisapride; oral, rectal
3.3
23.0
93
303
29530
ICD-8 Finland
Schizophrenia, Paranoid type
+∞
23.0
22
*
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
+∞
23.0
22
*
2954A
ICD-9 Finland
Schizophrenic psychoses, Acute schizophrenic episode
+∞
23.0
22
*
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
+∞
23.0
22
*
2959C
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]
+∞
23.0
22
*
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
30.8
22.9
30
10
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.1
22.9
268
1458
SPAT1241
SPAT
Extensive assessment of psychosocial situation
85.3
22.7
25
*
SPAT1360
SPAT
Extensive global examination
3.4
22.7
87
274
G43.9
ICD-10 Finland
Migraine, unspecified
9.5
22.7
27
29
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
22.7
169
761
H02AA02
ATC
fludrocortisone; oral
21.2
22.7
33
16
M48.0
ICD-10 Finland
Spinal stenosis
2.7
22.6
133
534
Z02.4
ICD-10 Finland
Examination for driving licence
0.4
22.6
118
2632
Z00.0
ICD-10 Finland
General medical examination
2.3
22.4
206
1017
Z02.7
ICD-10 Finland
Issue of medical certificate
3.6
22.3
76
222
N19
ICPC
Speech disorder
53.2
22.2
26
5
N06AX22
ATC
agomelatine; oral
53.2
22.2
26
5
SAA01
NOMESCO Finland
Simple examination of mouth
1.9
22.1
661
4907
F21
ICD-10 Finland
Schizotypal disorder
+∞
21.9
21
*
F25.0
ICD-10 Finland
Schizoaffective disorder, manic type
+∞
21.9
21
*
G21
ICD-10 Finland
Secondary parkinsonism
+∞
21.9
21
*
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
+∞
21.9
21
*
F10.24
ICD-10 Finland
Alcohol depence active use
63.9
21.9
25
*
S97
ICPC
Chronic ulcer skin
3.3
21.8
86
276
IHZ04, ,
SPAT
81.8
21.7
24
*
F10.09
ICD-10 Finland
Alcohol intoxication UNS
224.3
21.7
22
*
G04CA02
ATC
tamsulosin; oral
2.0
21.6
316
1857
G56.2
ICD-10 Finland
Lesion of ulnar nerve
31.9
21.6
28
9
E66.8
ICD-10 Finland
Other obesity
5.5
21.5
42
79
F39
ICD-10 Finland
Unspecified mood [affective] disorder
44.3
21.5
26
6
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.1
21.4
95
327
M54.5
ICD-10 Finland
Low back pain
2.0
21.4
313
1839
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
8.0
21.4
29
37
SPAT1172
SPAT
Guidance concerning hydration
5.8
21.3
39
69
R1260
NOMESCO Finland
Evaluation of communicative skills
9.2
21.3
26
29
N17
ICPC
Vertigo/dizziness
2.5
21.2
143
614
Z3226
NOMESCO Finland
Physiotherapist
2.3
21.2
184
885
Z29
ICPC
Social problem NOS
8.6
21.1
27
32
SPAT1310
SPAT
Counselling related to known health issue
2.0
21.0
305
1787
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
61.3
20.9
24
*
F20.08
ICD-10 Finland
Paranoid schizophrenia other definite
+∞
20.9
20
*
30088
ICD-8 Finland
Neuroses, Other
+∞
20.9
20
*
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
7.2
20.9
31
44
R47.1
ICD-10 Finland
Dysarthria and anarthria
78.4
20.7
23
*
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
213.9
20.6
21
*
SPAT1251
SPAT
Organisation of medication
4.4
20.6
53
126
G04BD04
ATC
oxybutynin; oral, transdermal
3.4
20.6
78
244
P15
ICPC
Chronic alcohol abuse
17.3
20.6
32
19
SAA03
NOMESCO Finland
Extended examination of mouth
1.9
20.5
349
2153
A02BA02
ATC
ranitidine; systemic
2.2
20.5
213
1101
N06AX18
ATC
reboxetine; oral
42.5
20.5
25
6
T90
ICPC
Diabetes non-insulin dependent
2.0
20.5
272
1542
ACC51
NOMESCO Finland
Release of median nerve
49.0
20.2
24
5
A46
ICD-10 Finland
Erysipelas
2.3
20.2
181
881
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
20.2
495
3422
N05AB01
ATC
dixyrazine; systemic
27.6
20.1
27
10
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.2
20.1
54
133
K03.66
ICD-10 Finland
Tooth plaque
3.0
19.9
92
324
R06.0
ICD-10 Finland
Dyspnoea
2.0
19.9
280
1618
2959A
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]
+∞
19.8
19
*
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
+∞
19.8
19
*
3321A
ICD-9 Finland
Parkinson's disease, Secondary Parkinsonism
+∞
19.8
19
*
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
+∞
19.8
19
*
F23.3
ICD-10 Finland
Other acute predominantly delusional psychotic disorders
+∞
19.8
19
*
N05AX15
ATC
cariprazine; oral
+∞
19.8
19
*
29510
ICD-8 Finland
Schizophrenia, Hebephrenic type
+∞
19.8
19
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
19.6
182
898
SPAT1139
SPAT
Nutrition survey
5.2
19.6
41
82
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
46.9
19.2
23
5
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
5.7
19.2
36
65
S00.0
ICD-10 Finland
Superficial injury of scalp
6.2
19.1
33
55
XKD06
NOMESCO Finland
Physiologic investigation of micturition
5.1
18.9
40
81
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.5
18.8
132
576
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
+∞
18.8
18
*
F23.90
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
+∞
18.8
18
*
30188
ICD-8 Finland
Personality disorders, Alia definita
+∞
18.8
18
*
N05AE05
ATC
lurasidone; oral
+∞
18.8
18
*
IEV99
NOMESCO Finland
Other psychiatric network intervention
+∞
18.8
18
*
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
+∞
18.8
18
*
KMAK, ,
NOMESCO Finland
1.8
18.8
449
3062
C07AB07
ATC
bisoprolol; oral
1.8
18.7
544
3928
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
101.8
18.6
20
*
N06DA04
ATC
galantamine; oral
101.8
18.6
20
*
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
193.2
18.6
19
*
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
193.2
18.6
19
*
SPAT1249
SPAT
Treatment-related counselling outside office
1.8
18.6
367
2361
N02BF02
ATC
pregabalin; oral
3.7
18.4
59
165
H53.2
ICD-10 Finland
Diplopia
5.4
18.3
36
68
V03AA01, ,
ATC
17.9
18.3
28
16
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
7.6
18.3
26
35
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.0
18.2
220
1200
M79.6
ICD-10 Finland
Pain in limb
1.8
18.1
380
2487
A13
ICPC
Concern/fear medical treatment
5.6
18.0
34
62
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
6.0
18.0
32
55
R39.1
ICD-10 Finland
Other difficulties with micturition
4.6
17.9
43
97
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.9
17.9
89
327
N05AC01
ATC
periciazine; systemic
67.8
17.8
20
*
2959E
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]
+∞
17.8
17
*
G23.1
ICD-10 Finland
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
+∞
17.8
17
*
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
+∞
17.8
17
*
IGP01
NOMESCO Finland
Psychiatric family contact
+∞
17.8
17
*
IEY02
NOMESCO Finland
Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)
+∞
17.8
17
*
IER01
NOMESCO Finland
Psychoeducation, group
+∞
17.8
17
*
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
+∞
17.8
17
*
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
+∞
17.8
17
*
ICB03, ,
SPAT
+∞
17.8
17
*
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
182.8
17.6
18
*
97010
ICD-8 Finland
Adverse effect of psychotherapeutics, Tranquillisers
182.8
17.6
18
*
F41.3
ICD-10 Finland
Other mixed anxiety disorders
182.8
17.6
18
*
A02BC01
ATC
omeprazole; systemic
1.9
17.5
270
1602
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.8
17.4
90
337
ZXD05
NOMESCO Finland
Urgent procedure
1.9
17.4
291
1772
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.5
17.3
113
476
E66.01
ICD-10 Finland
Obesity due to excess calories
3.5
17.3
61
182
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
42.7
17.3
21
5
A99
ICPC
Disease/condition unspecnature/site
2.5
17.3
114
483
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
6.5
17.2
28
44
SFA30
NOMESCO Finland
Three-surface restoration
1.8
17.0
394
2643
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
7.6
17.0
24
32
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.2
17.0
68
220
R4120
NOMESCO Finland
Occupational therapy
3.6
17.0
56
160
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.7
16.9
494
3535
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
4.3
16.9
44
106
R44.3
ICD-10 Finland
Hallucinations, unspecified
64.4
16.8
19
*
J01DB01
ATC
cefalexin; oral
1.8
16.7
798
6542
2961C
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
+∞
16.7
16
*
183
Kela drug reimbursment
Lamotrigin and topiramate
+∞
16.7
16
*
29540
ICD-8 Finland
Acute schizophrenia episode
+∞
16.7
16
*
F30.9
ICD-10 Finland
Manic episode, unspecified
+∞
16.7
16
*
F20.02
ICD-10 Finland
Paranoid schizophrenia stable periodically
+∞
16.7
16
*
WX723
NOMESCO Finland
CPAP therapy
+∞
16.7
16
*
2962E
ICD-9 Finland
Affective psychoses, Major depressive disorder, single episode[PSYCH.BIPOLARIS MANICA,VAIKEA-ASTE,PSYKOOT PIIRTEIT]
+∞
16.7
16
*
G41.9
ICD-10 Finland
Status epilepticus, unspecified
+∞
16.7
16
*
30040
ICD-8 Finland
Neuroses, Neurotico-depressiva
+∞
16.7
16
*
F30.20
ICD-10 Finland
Mania with mood-congruent psychotic symptoms
+∞
16.7
16
*
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
+∞
16.7
16
*
G35
ICD-10 Finland
Multiple sclerosis
+∞
16.7
16
*
ZYY01
NOMESCO Finland
Contact between professionals
+∞
16.7
16
*
ZXY49
NOMESCO Finland
Other health care provider
+∞
16.7
16
*
85000
ICD-8 Finland
Concussion, Current or unspecified
+∞
16.7
16
*
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
6.6
16.7
27
42
SFA10
NOMESCO Finland
One-surface restoration
1.7
16.7
494
3547
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
91.5
16.6
18
*
Z3231
NOMESCO Finland
Registered nurse
1.9
16.6
260
1546
R63.1
ICD-10 Finland
Polydipsia
172.5
16.5
17
*
U02
ICPC
Urinary frequency/urgency
2.2
16.5
154
759
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.9
16.5
235
1354
IGY99, ,
SPAT
20.4
16.5
24
12
D21
ICPC
Swallowing problem
12.4
16.4
29
24
R00.0
ICD-10 Finland
Tachycardia, unspecified
4.3
16.3
42
100
S70.0
ICD-10 Finland
Contusion of hip
3.9
16.2
48
127
OAB43, ,
SPAT
0.2
16.2
27
1128
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
24.9
16.0
22
9
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.9
16.0
264
1593
D01AC02
ATC
miconazole; topical
2.6
16.0
97
394
R52.9
ICD-10 Finland
Pain, unspecified
2.5
16.0
102
425
WZA90
NOMESCO Finland
Other medical or dental certificate
2.0
15.9
211
1184
K59.1
ICD-10 Finland
Functional diarrhoea
3.2
15.8
65
214
R60.9
ICD-10 Finland
Oedema, unspecified
3.1
15.7
66
220
ZXY60
NOMESCO Finland
2-person team, nurses
+∞
15.7
15
*
N05AE03
ATC
sertindole; oral
+∞
15.7
15
*
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
+∞
15.7
15
*
F05.0
ICD-10 Finland
Delirium not superimposed on dementia, so described
+∞
15.7
15
*
F25
ICD-10 Finland
Schizoaffective disorders
+∞
15.7
15
*
2961D
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]
+∞
15.7
15
*
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
+∞
15.7
15
*
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
+∞
15.7
15
*
N05AX16
ATC
brexpiprazole; oral
+∞
15.7
15
*
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
+∞
15.7
15
*
29830
ICD-8 Finland
Other psychoses, Acute paranoid reaction
+∞
15.7
15
*
G31.0
ICD-10 Finland
Circumscribed brain atrophy
+∞
15.7
15
*
2953E
ICD-9 Finland
Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]
+∞
15.7
15
*
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
+∞
15.7
15
*
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
+∞
15.7
15
*
2961E
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]
+∞
15.7
15
*
F23.91
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
+∞
15.7
15
*
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.3
15.6
130
611
D11
ICPC
Diarrhoea
2.5
15.6
101
424
M03BX01
ATC
baclofen; systemic
19.5
15.6
23
12
F40.1
ICD-10 Finland
Social phobias
22.4
15.6
22
10
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
162.2
15.5
16
*
G30.0
ICD-10 Finland
Alzheimer disease with early onset
162.2
15.5
16
*
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
162.2
15.5
16
*
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
162.2
15.5
16
*
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
2.1
15.5
155
785
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
15.4
179
958
Z08
ICPC
Social welfare problem
29.1
15.2
20
7
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.9
15.2
244
1458
A01AB09
ATC
miconazole; local oral
2.6
15.1
94
387
F32.8
ICD-10 Finland
Other depressive episodes
45.7
15.1
18
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
15.0
361
2429
A02BC03
ATC
lansoprazole; oral
1.8
14.9
273
1698
R06.5
ICD-10 Finland
Mouth breathing
3.2
14.9
59
190
E66.9
ICD-10 Finland
Obesity, unspecified
5.6
14.8
28
51
XA400
NOMESCO Finland
EEG
57.5
14.8
17
*
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.8
14.8
79
301
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.3
14.8
119
551
J01MA02
ATC
ciprofloxacin; systemic
1.7
14.7
395
2735
A02BC05
ATC
esomeprazole; systemic
1.7
14.7
357
2405
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
25.4
14.7
20
8
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
+∞
14.6
14
*
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
+∞
14.6
14
*
G91.0
ICD-10 Finland
Communicating hydrocephalus
+∞
14.6
14
*
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
14.6
14
*
F20.01
ICD-10 Finland
Paranoid schizophrenia periodically with gradual deterioration
+∞
14.6
14
*
F20.20
ICD-10 Finland
Catatonic schizophrenia continuously
+∞
14.6
14
*
F23.8
ICD-10 Finland
Other acute and transient psychotic disorders
+∞
14.6
14
*
F61
ICD-10 Finland
Mixed and other personality disorders
+∞
14.6
14
*
IFA01, ,
SPAT
+∞
14.6
14
*
N05AH05
ATC
asenapine; oral
+∞
14.6
14
*
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.0
14.6
67
235
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.9
14.6
217
1263
IHZ07, ,
SPAT
81.2
14.6
16
*
WX290
NOMESCO Finland
Other blockage of nerve
1.7
14.6
381
2619
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
14.5
100
432
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
152.0
14.5
15
*
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
152.0
14.5
15
*
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
152.0
14.5
15
*
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
152.0
14.5
15
*
XKC03
NOMESCO Finland
Water cystometry
4.4
14.4
36
84
I95.9
ICD-10 Finland
Hypotension, unspecified
6.1
14.4
25
42
SPAT1246
SPAT
Screening of depression or other psychiatric problem
6.1
14.4
25
42
R07.3
ICD-10 Finland
Other chest pain
2.5
14.4
96
409
R1250, ,
SPAT
4.6
14.3
34
76
XKD00
NOMESCO Finland
Uroflowmetry
1.9
14.3
194
1095
J01MA12
ATC
levofloxacin; systemic
1.9
14.3
204
1171
M47.9
ICD-10 Finland
Spondylosis, unspecified
5.0
14.1
30
61
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.6
14.1
83
333
WYA10
NOMESCO Finland
Emergency care or similar visit
2.9
14.0
66
235
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
13.9
173
947
ICB01, ,
SPAT
30.5
13.9
18
6
R30.1
ICD-10 Finland
Vesical tenesmus
5.6
13.9
26
47
A02BA04
ATC
nizatidine; systemic
2.5
13.8
93
397
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
13.6
117
556
WX892
NOMESCO Finland
Monitored bed care
2.6
13.6
79
314
A08
ICPC
Swelling
2.9
13.6
64
228
F20.1
ICD-10 Finland
Hebephrenic schizophrenia
+∞
13.6
13
*
3004A
ICD-9 Finland
Neurotic disorders, Neurotic depression
+∞
13.6
13
*
F60.8
ICD-10 Finland
Other specific personality disorders
+∞
13.6
13
*
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
+∞
13.6
13
*
N05AL05
ATC
amisulpride; oral
+∞
13.6
13
*
N04BC01
ATC
bromocriptine; oral
+∞
13.6
13
*
G81.9
ICD-10 Finland
Hemiplegia, unspecified
+∞
13.6
13
*
F28
ICD-10 Finland
Other nonorganic psychotic disorders
+∞
13.6
13
*
F31.21
ICD-10 Finland
Bipolar disorder, manic episode with mood incongruent psychotic symptoms
+∞
13.6
13
*
F41.00
ICD-10 Finland
Moderate panic disorder
+∞
13.6
13
*
G40.10
ICD-10 Finland
Simple partial seizures
+∞
13.6
13
*
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
+∞
13.6
13
*
ACC53
NOMESCO Finland
Release of ulnar nerve
+∞
13.6
13
*
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
+∞
13.6
13
*
A05
ICPC
Feeling ill
3.4
13.5
50
154
IAB01, ,
SPAT
141.7
13.5
14
*
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
141.7
13.5
14
*
A27
ICPC
Fear of other disease NOS
3.1
13.5
57
191
A10AB05
ATC
insulin aspart; parenteral
2.7
13.1
73
284
F21, ,
ICPC
15.3
13.1
21
14
A10AE04
ATC
insulin glargine; parenteral
2.4
13.1
94
414
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
4.8
12.9
29
62
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
12.8
417
3009
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
12.8
568
4417
SFA20
NOMESCO Finland
Two-surface restoration
1.6
12.8
505
3820
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
5.2
12.7
26
51
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
4.5
12.7
31
71
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
4.1
12.6
34
84
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
+∞
12.5
12
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
+∞
12.5
12
*
N05BA09
ATC
clobazam; oral
+∞
12.5
12
*
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
+∞
12.5
12
*
WX780
NOMESCO Finland
Remote monitoring CPAP
+∞
12.5
12
*
2951C
ICD-9 Finland
Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]
+∞
12.5
12
*
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
+∞
12.5
12
*
N88
ICPC
Epilepsy
+∞
12.5
12
*
S09.9
ICD-10 Finland
Unspecified injury of head
6.3
12.5
21
34
K91
ICPC
Cerebrovascular disease
24.6
12.5
17
7
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
12.5
640
5137
-1, ,
NOMESCO Finland
1.7
12.5
264
1702
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
13.4
12.5
21
16
C10AA01
ATC
simvastatin; oral
1.6
12.4
447
3299
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
4.8
12.4
28
60
AA1AA
NOMESCO Finland
Head X-ray examination
11.8
12.3
22
19
A02BC02
ATC
pantoprazole; systemic
1.6
12.3
647
5214
S22
ICPC
Nail symptom/complaint
2.7
12.3
67
258
R40.2
ICD-10 Finland
Coma, unspecified
14.5
12.3
20
14
L60.0
ICD-10 Finland
Ingrowing nail
3.3
12.3
46
143
WX722
NOMESCO Finland
PEEP
4.0
12.2
34
86
ECB00
NOMESCO Finland
Suture of gingiva
3.4
12.1
43
129
N02BF01
ATC
gabapentin; oral
2.6
12.1
71
284
C07AB02
ATC
metoprolol; systemic
1.8
12.1
222
1373
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.8
12.1
235
1478
S42.2
ICD-10 Finland
Fracture of upper end of humerus
3.0
12.1
54
187
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
21.6
12.0
17
8
E9509
ICD-8 Finland
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
21.6
12.0
17
8
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
21.6
12.0
17
8
G04BD11
ATC
fesoterodine; oral
3.8
12.0
37
101
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.1
12.0
33
83
SPAT1276
SPAT
Outlining of treatment with patient or their family members
4.5
12.0
29
66
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.1
11.9
126
649
P50
ICPC
Psychological, Medication/prescr/renewal
47.2
11.9
14
*
SPAT1235
SPAT
Mental health, emotional support
47.2
11.9
14
*
R29.6
ICD-10 Finland
Tendency to fall, not elsewhere classified
47.2
11.9
14
*
S00.8
ICD-10 Finland
Superficial injury of other parts of head
5.9
11.8
21
36
N01
ICPC
Headache
2.6
11.8
69
276
Z50.1
ICD-10 Finland
Other physical therapy
2.9
11.7
56
201
D64.9
ICD-10 Finland
Anaemia, unspecified
2.0
11.7
132
697
R4110, ,
SPAT
2.1
11.7
122
626
F05.8
ICD-10 Finland
Other delirium
30.4
11.7
15
5
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
30.4
11.7
15
5
Z03
ICPC
Housing/neighbourhood problem
30.4
11.7
15
5
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
30.4
11.7
15
5
A10BH01
ATC
sitagliptin; oral
2.2
11.7
100
475
C09AA05
ATC
ramipril; oral
1.7
11.6
280
1864
G72.9
ICD-10 Finland
Myopathy, unspecified
65.7
11.6
13
*
E87.6
ICD-10 Finland
Hypokalaemia
3.3
11.6
44
138
E0000UV, ,
ATC
1.6
11.6
374
2679
S72.1
ICD-10 Finland
Pertrochanteric fracture
3.9
11.5
34
90
B01AC07
ATC
dipyridamole; systemic
3.1
11.5
49
165
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
+∞
11.5
11
*
F20.6
ICD-10 Finland
Simple schizophrenia
+∞
11.5
11
*
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
+∞
11.5
11
*
F20.19
ICD-10 Finland
Hebefren schizophrenia UNS
+∞
11.5
11
*
F41.01
ICD-10 Finland
Severe panic disorder
+∞
11.5
11
*
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
+∞
11.5
11
*
30180
ICD-8 Finland
Personality disorders, Immatura
+∞
11.5
11
*
2971A
ICD-9 Finland
Paranoid states, Paranoia
+∞
11.5
11
*
F33.31
ICD-10 Finland
Recurrent depression, severe episode of somatic syndrome
+∞
11.5
11
*
F20.29
ICD-10 Finland
Catat schizophrenia UNS
+∞
11.5
11
*
9690A
ICD-9 Finland
Poisoning by psychotropic agents, Antidepressants
+∞
11.5
11
*
3320A
ICD-9 Finland
Parkinson's disease, Paralysis agitans
+∞
11.5
11
*
I63.8
ICD-10 Finland
Other cerebral infarction
+∞
11.5
11
*
F33.8
ICD-10 Finland
Other recurrent depressive disorders
+∞
11.5
11
*
F23.9
ICD-10 Finland
Acute and transient psychotic disorder, unspecified
+∞
11.5
11
*
IFA99, ,
SPAT
+∞
11.5
11
*
G30
ICD-10 Finland
Alzheimer disease
+∞
11.5
11
*
2988A
ICD-9 Finland
Other nonorganic psychoses, Other and unspecified reactive psychosis
+∞
11.5
11
*
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
+∞
11.5
11
*
IAB12
NOMESCO Finland
Psychiatric psychosis consultation
+∞
11.5
11
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
+∞
11.5
11
*
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
+∞
11.5
11
*
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
13.8
11.5
19
14
XF600
NOMESCO Finland
Bloodpressure measurement
2.7
11.4
64
250
P17
ICPC
Tobacco abuse
15.2
11.3
18
12
M43.1
ICD-10 Finland
Spondylolisthesis
3.5
11.3
39
115
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
3.7
11.3
35
96
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
5.0
11.2
24
49
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
4.8
11.2
25
53
F41.8
ICD-10 Finland
Other specified anxiety disorders
12.9
11.2
19
15
Z72.1
ICD-10 Finland
Alcohol use
25.3
11.2
15
6
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
11.1
126
666
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
4.3
11.1
28
66
G47.9
ICD-10 Finland
Sleep disorder, unspecified
5.8
11.0
20
35
N05CD08
ATC
midazolam; nasal, systemic
4.4
11.0
27
62
S01.8
ICD-10 Finland
Open wound of other parts of head
4.7
11.0
25
54
R47.0
ICD-10 Finland
Dysphasia and aphasia
43.8
10.9
13
*
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
5.5
10.9
21
39
NB6AA
NOMESCO Finland
Humerus X-ray examination
4.4
10.8
27
63
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
3.2
10.8
42
134
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
10.8
331
2335
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
10.8
160
926
N04BC06
ATC
cabergoline; oral
28.3
10.7
14
5
SPAT1377
SPAT
Polysomnography
5.6
10.7
20
36
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
3.1
10.7
44
145
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
21.7
10.7
15
7
F43.1
ICD-10 Finland
Post-traumatic stress disorder
21.7
10.7
15
7
L84
ICPC
Back syndrome without radiat pain
2.8
10.7
52
189
T82
ICPC
Obesity
4.2
10.7
28
68
9691A
ICD-9 Finland
Poisoning by psychotropic agents, Phenothiazine-based tranquillisers
60.6
10.6
12
*
A41.9
ICD-10 Finland
Sepsis, unspecified
3.0
10.6
47
162
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.7
10.6
33
91
S20
ICPC
Corn/callosity
4.1
10.5
28
69
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
111.0
10.4
11
*
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
111.0
10.4
11
*
G21.4
ICD-10 Finland
Vascular parkinsonism
+∞
10.4
10
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
+∞
10.4
10
*
ICB06, ,
NOMESCO Finland
+∞
10.4
10
*
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
+∞
10.4
10
*
ZXY03
NOMESCO Finland
Occupational therapist
+∞
10.4
10
*
2962C
ICD-9 Finland
Affective psychoses, Major depressive disorder, single episode[PSYCHOSIS BIPOLARIS MANICA,KESKIVAIKEA]
+∞
10.4
10
*
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
+∞
10.4
10
*
29500
ICD-8 Finland
Schizophrenia, Simple type
+∞
10.4
10
*
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
+∞
10.4
10
*
N86
ICPC
Multiple sclerosis
+∞
10.4
10
*
G47.0
ICD-10 Finland
Disorders of initiating and maintaining sleep [insomnias]
+∞
10.4
10
*
IEY06
NOMESCO Finland
Psychiatric treatment and rehabilitation coaching
+∞
10.4
10
*
G24.9
ICD-10 Finland
Dystonia, unspecified
+∞
10.4
10
*
F05.1
ICD-10 Finland
Delirium superimposed on dementia
+∞
10.4
10
*
F20.03
ICD-10 Finland
Paranoid schizophrenia periodically with gradual improvement
+∞
10.4
10
*
N04BC02
ATC
pergolide; oral
+∞
10.4
10
*
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
+∞
10.4
10
*
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
+∞
10.4
10
*
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
+∞
10.4
10
*
F009, G309,
ICD-10 Finland
+∞
10.4
10
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
+∞
10.4
10
*
F25.80
ICD-10 Finland
Other specified schizoaffective disorder with only concomitant bipolar and schizophrenic symptoms
+∞
10.4
10
*
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
+∞
10.4
10
*
F20.32
ICD-10 Finland
Undifferentiated schizophrenia stable periodically
+∞
10.4
10
*
30300
ICD-8 Finland
Alcoholism, Episodic excessive drinking
+∞
10.4
10
*
ZYY79
NOMESCO Finland
Other indirect service without contact with patient
+∞
10.4
10
*
R27.0
ICD-10 Finland
Ataxia, unspecified
+∞
10.4
10
*
ZYD01
NOMESCO Finland
Emergency clinic
+∞
10.4
10
*
SPAT1050
SPAT
Extensive neurological examination
5.5
10.4
20
37
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.9
10.4
47
164
A10BH05
ATC
linagliptin; oral
2.6
10.3
58
227
R25.2
ICD-10 Finland
Cramp and spasm
5.0
10.3
22
45
SPE90
NOMESCO Finland
Other partial denture
3.9
10.2
29
75
J01MA06
ATC
norfloxacin; oral
1.9
10.1
126
687
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.7
10.1
207
1314
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.3
10.1
75
335
XG466
NOMESCO Finland
Sleep oxymetry
4.9
10.0
22
46
L03
ICPC
Low back symptom/complaint
1.7
10.0
220
1423
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
9.2
10.0
20
22
H02AB02
ATC
dexamethasone; systemic
0.3
10.0
29
892
OAA67, ,
SPAT
0.2
10.0
14
662
OAB95, ,
SPAT
0.0
9.9
*
277
R52.2
ICD-10 Finland
Other chronic pain
4.0
9.9
28
72
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.1
9.9
98
493
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
9.9
158
935
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.9
9.9
47
169
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
8.2
9.9
21
26
N06AX17
ATC
milnacipran; oral
26.3
9.8
13
5
SPAT1304
SPAT
Counselling and guidance related to ageing
2.3
9.8
78
359
G51.0
ICD-10 Finland
Bell palsy
20.2
9.8
14
7
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
20.2
9.8
14
7
N06AA22, ,
ATC
20.2
9.8
14
7
SPAT1284
SPAT
Extensive health certificate
4.0
9.8
27
68
S01.9
ICD-10 Finland
Open wound of head, part unspecified
4.6
9.8
23
51
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.8
9.8
167
1007
N06AC02, ,
ATC
55.5
9.7
11
*
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.1
9.6
93
464
N06AA10
ATC
nortriptyline; systemic
9.2
9.5
19
21
Z71.8
ICD-10 Finland
Other specified counselling
1.6
9.5
275
1903
R5140, ,
SPAT
7.2
9.5
22
31
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
15.2
9.5
15
10
OAA80, ,
SPAT
0.2
9.5
7
408
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
3.0
9.5
42
145
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.1
9.4
89
439
S10
ICPC
Boil/carbuncle
2.5
9.4
57
232
SPAT1014
SPAT
Treatment of eyes
4.3
9.4
24
57
F20.38
ICD-10 Finland
Undifferentiated schizophrenia other definite
+∞
9.4
9
*
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
9.4
9
*
2951E
ICD-9 Finland
Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]
+∞
9.4
9
*
29630
ICD-8 Finland
Affective psychoses, Manic-depressive psychosis, circular type
+∞
9.4
9
*
29520
ICD-8 Finland
Schizophrenia, Catatonic type
+∞
9.4
9
*
G40.89
ICD-10 Finland
Other epilepsy
+∞
9.4
9
*
IEY01
NOMESCO Finland
Psychoeducation, individual
+∞
9.4
9
*
G90.3
ICD-10 Finland
Multi-system degeneration
+∞
9.4
9
*
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
+∞
9.4
9
*
N03AX18
ATC
lacosamide; systemic
+∞
9.4
9
*
G24.0
ICD-10 Finland
Drug-induced dystonia
+∞
9.4
9
*
29610
ICD-8 Finland
Affective psychoses, Manic-depression psychosis, manic type
+∞
9.4
9
*
ZXY57
NOMESCO Finland
2-person team, nurse-social worker
+∞
9.4
9
*
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
+∞
9.4
9
*
30310
ICD-8 Finland
Alcoholism, Habitual excessive drinking
+∞
9.4
9
*
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
+∞
9.4
9
*
2961B
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,LIEVÄASTEINEN]
+∞
9.4
9
*
F23.29
ICD-10 Finland
Acute schizophrenia-like psychosis UNS
+∞
9.4
9
*
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
+∞
9.4
9
*
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
21.9
9.4
13
6
D10
ICPC
Vomiting
3.1
9.3
39
130
Z46.9
ICD-10 Finland
Fitting and adjustment of unspecified device
4.6
9.3
22
49
C01CA01
ATC
etilefrine; systemic
8.8
9.3
19
22
F43.29
ICD-10 Finland
Adaptation disorder UNS
10.8
9.3
17
16
C05AA08
ATC
fluocortolone; rectal, topical
1.9
9.3
121
670
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.4
9.3
61
258
D09
ICPC
Nausea
3.3
9.2
35
110
R51
ICD-10 Finland
Headache
3.4
9.2
32
95
R20.2
ICD-10 Finland
Paraesthesia of skin
2.8
9.2
45
164
SPAT1244
SPAT
Occupational therapy
13.8
9.2
15
11
A01AB04
ATC
amphotericin B; local oral
2.6
9.2
52
205
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.6
9.2
53
211
K04.1
ICD-10 Finland
Necrosis of pulp
2.1
9.1
91
459
-, ,
ICD-10 Finland
3.8
9.1
27
72
G45.4
ICD-10 Finland
Transient global amnesia
11.6
9.1
16
14
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
11.6
9.1
16
14
SCA02
NOMESCO Finland
Preventive oral health care
2.1
9.1
82
398
130
Kela drug reimbursment
Malignant tumour
0.3
9.1
29
848
S20.2
ICD-10 Finland
Contusion of thorax
2.7
9.0
48
183
NF1AA
NOMESCO Finland
Hip X-ray examination
2.1
9.0
90
454
SFA00
NOMESCO Finland
Small restoration
1.9
9.0
118
655
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
8.9
74
347
IAA01, ,
SPAT
24.2
8.9
12
5
P18
ICPC
Medication abuse
24.2
8.9
12
5
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.1
8.9
88
442
B01AC04
ATC
clopidogrel; oral
1.8
8.9
146
870
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
6.9
8.9
21
31
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.7
8.9
48
185
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.7
8.9
48
185
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
8.7
8.8
18
21
F51.9
ICD-10 Finland
Nonorganic sleep disorder, unspecified
10.8
8.8
16
15
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.2
8.8
72
336
OAB48, ,
SPAT
0.2
8.8
12
575
IHZ05
NOMESCO Finland
Therapeutic conversation
50.4
8.7
10
*
U28
ICPC
Limited function/disability (U)
6.7
8.7
21
32
S02.20
ICD-10 Finland
Fracture of nasal bones, closed
4.4
8.6
21
48
Z01.2
ICD-10 Finland
Dental examination
1.5
8.6
369
2777
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.9
8.6
111
614
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
9.1
8.5
17
19
I50.9
ICD-10 Finland
Heart failure, unspecified
1.7
8.5
178
1133
R2130, ,
SPAT
6.5
8.5
21
33
R44.1
ICD-10 Finland
Visual hallucinations
27.7
8.5
11
*
E66.00
ICD-10 Finland
Metabolic syndrome
2.8
8.5
41
149
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
3.9
8.4
24
62
SPAT1312
SPAT
General health counselling
1.6
8.4
261
1830
F60.5
ICD-10 Finland
Anankastic personality disorder
90.7
8.4
9
*
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
90.7
8.4
9
*
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
90.7
8.4
9
*
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
90.7
8.4
9
*
T90.5
ICD-10 Finland
Sequelae of intracranial injury
90.7
8.4
9
*
IEY19
NOMESCO Finland
Psychiatric health counselling and guidance
90.7
8.4
9
*
F80.1
ICD-10 Finland
Expressive language disorder
90.7
8.4
9
*
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
90.7
8.4
9
*
U13
ICPC
Bladder symptom/complaint other
3.2
8.4
32
101
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
8.4
87
445
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
+∞
8.3
8
*
2967A
ICD-9 Finland
Affective psychoses, Bipolar affective disorder, unspecified
+∞
8.3
8
*
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
+∞
8.3
8
*
F01.10
ICD-10 Finland
Multi-infarct dementia without additional symptoms
+∞
8.3
8
*
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
+∞
8.3
8
*
G93.1
ICD-10 Finland
Anoxic brain damage, not elsewhere classified
+∞
8.3
8
*
29620
ICD-8 Finland
Affective psychoses, Manic depressive psychosis, depressed type
+∞
8.3
8
*
30099
ICD-8 Finland
Neuroses, Unspecified neurosis
+∞
8.3
8
*
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
+∞
8.3
8
*
F45.0
ICD-10 Finland
Somatization disorder
+∞
8.3
8
*
F30.1
ICD-10 Finland
Mania without psychotic symptoms
+∞
8.3
8
*
F06.0
ICD-10 Finland
Organic hallucinosis
+∞
8.3
8
*
P63
ICPC
Psychological, Follow-up encounter unspecified
+∞
8.3
8
*
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
+∞
8.3
8
*
ZXY58
NOMESCO Finland
2-person team, nurse-occupational therapist
+∞
8.3
8
*
29800
ICD-8 Finland
Other psychoses, Reactive depressive psychosis
+∞
8.3
8
*
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
+∞
8.3
8
*
ZXY59
NOMESCO Finland
2-person team, nurse-other special worker
+∞
8.3
8
*
ZXY56
NOMESCO Finland
2-person team, nurse-psychologist
+∞
8.3
8
*
IEP99
NOMESCO Finland
Other psychiatric family intervention
+∞
8.3
8
*
Z91.5
ICD-10 Finland
Personal history of self-harm
+∞
8.3
8
*
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
+∞
8.3
8
*
F0019, G301,
ICD-10 Finland
+∞
8.3
8
*
3540A
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome
+∞
8.3
8
*
34599
ICD-8 Finland
Epilepsy, Other and unspecified
+∞
8.3
8
*
F60.0
ICD-10 Finland
Paranoid personality disorder
+∞
8.3
8
*
F02.09*G31.0
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
+∞
8.3
8
*
F0009, G300,
ICD-10 Finland
+∞
8.3
8
*
W17
ICD-10 Finland
Other fall from one level to another
2.9
8.3
39
139
P58
ICPC
Psychological, Therapeutic counselling/listening
8.6
8.3
17
20
Z43.5
ICD-10 Finland
Attention to cystostomy
10.8
8.3
15
14
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.6
8.3
27
77
U01
ICPC
Dysuria/painful urination
2.2
8.2
67
312
R31
ICD-10 Finland
Unspecified haematuria
1.9
8.2
112
630
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
8.2
619
5182
Z10.0
ICD-10 Finland
Occupational health examination
0.1
8.2
5
333
L12
ICPC
Hand/finger symptom/complaint
1.8
8.2
132
782
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.8
8.2
127
744
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
8.2
65
300
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.7
8.1
42
158
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
8.1
154
955
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
8.1
324
2397
SPAT1227
SPAT
Substance abuse rehabilitation
33.6
8.1
10
*
Z75.9
ICD-10 Finland
Unspecified problem related to medical facilities and other health care
33.6
8.1
10
*
G62.8
ICD-10 Finland
Other specified polyneuropathies
33.6
8.1
10
*
F01.2
ICD-10 Finland
Subcortical vascular dementia
33.6
8.1
10
*
WX872
NOMESCO Finland
Intensive care
2.4
8.1
55
237
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.7
8.0
25
69
SGA01
NOMESCO Finland
Emergency treatment
1.8
8.0
114
649
WX882
NOMESCO Finland
High dependency care
3.5
8.0
27
79
SPAT1081
SPAT
Cardiorespiratory global assessment
2.3
8.0
57
251
XKD03
NOMESCO Finland
Urethral pressure profilometry
3.8
7.9
24
65
N05AB02
ATC
fluphenazine; systemic
13.1
7.9
13
10
S16
ICPC
Bruise/contusion
3.2
7.9
31
100
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.2
7.9
5
323
A03CA02
ATC
clidinium and psycholeptics; oral
2.4
7.8
55
241
R02
ICPC
Shortness of breath/dyspnoea
1.8
7.8
118
686
T08
ICPC
Weight loss
3.9
7.7
22
57
X72
ICPC
Genital candidiasis female
15.1
7.7
12
8
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.7
7.7
41
157
S22.3
ICD-10 Finland
Fracture of rib
2.2
7.7
64
301
U29
ICPC
Urinary symptom/complaint other
3.1
7.7
32
107
R30.0
ICD-10 Finland
Dysuria
2.9
7.6
36
129
AXX01
NOMESCO Finland
Memory assessment
18.5
7.6
11
6
T68
ICD-10 Finland
Hypothermia
18.5
7.6
11
6
Z28
ICPC
Limited function/disability (Z)
18.5
7.6
11
6
TKC22
NOMESCO Finland
Catheterisation instruction
3.2
7.6
30
97
-50
ICPC
Medication/prescr/renewal
2.6
7.6
42
164
N08
ICPC
Abnormal involuntary movements
25.2
7.6
10
*
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.3
7.6
28
87
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
10.1
7.5
14
14
B01AA03
ATC
warfarin; systemic
1.6
7.5
210
1434
Z00.8
ICD-10 Finland
Other general examinations
2.1
7.5
67
324
SPAT1285
SPAT
Provision of consultation response
2.5
7.5
46
189
PA6AD
NOMESCO Finland
CT of neck arteries
4.3
7.5
19
45
J01XE01
ATC
nitrofurantoin; oral
4.3
7.5
19
45
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.4
7.5
51
220
K07
ICPC
Swollen ankles/oedema
2.3
7.5
54
239
M02AA07
ATC
piroxicam; topical
1.5
7.5
329
2476
B34.9
ICD-10 Finland
Viral infection, unspecified
3.6
7.4
24
68
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
80.6
7.4
8
*
S06.3
ICD-10 Finland
Focal brain injury
80.6
7.4
8
*
P80
ICPC
Personality disorder
80.6
7.4
8
*
F22.8
ICD-10 Finland
Other persistent delusional disorders
80.6
7.4
8
*
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
80.6
7.4
8
*
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.8
7.4
113
658
N03AB02
ATC
phenytoin; systemic
13.5
7.4
12
9
SPAT1100
SPAT
Long-term monitoring of blood pressure
2.1
7.4
68
333
SPAT1281
SPAT
Other administrative function
2.1
7.4
65
313
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
4.1
7.4
20
50
K04.0
ICD-10 Finland
Pulpitis
2.2
7.3
63
300
L30.3
ICD-10 Finland
Infective dermatitis
2.9
7.3
34
121
D07AB02
ATC
hydrocortisone butyrate; topical
1.5
7.3
255
1829
R4120, ,
SPAT
10.9
7.3
13
12
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
7.3
134
823
3000C
ICD-9 Finland
Neurotic disorders, Anxiety states[YLEISTYNYT TUSKAISUUS]
+∞
7.3
7
*
F13.2
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome
+∞
7.3
7
*
G21.3
ICD-10 Finland
Postencephalitic parkinsonism
+∞
7.3
7
*
F01.1
ICD-10 Finland
Multi-infarct dementia
+∞
7.3
7
*
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
+∞
7.3
7
*
G23.8
ICD-10 Finland
Other specified degenerative diseases of basal ganglia
+∞
7.3
7
*
35399
ICD-8 Finland
Sciatica
+∞
7.3
7
*
N04BX04
ATC
opicapone; oral
+∞
7.3
7
*
AAF15
NOMESCO Finland
Ventriculoatrial shunt
+∞
7.3
7
*
S06.2
ICD-10 Finland
Diffuse brain injury
+∞
7.3
7
*
RT250, ,
NOMESCO Finland
+∞
7.3
7
*
3090A
ICD-9 Finland
Adjustment reaction, Brief depressive reaction
+∞
7.3
7
*
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
+∞
7.3
7
*
IEY21
NOMESCO Finland
Other intensified psychiatric treatment
+∞
7.3
7
*
F06.30
ICD-10 Finland
Organic manic syndrome
+∞
7.3
7
*
N04AA01
ATC
trihexyphenidyl; oral
+∞
7.3
7
*
29560
ICD-8 Finland
Residual schizophrenia
+∞
7.3
7
*
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
+∞
7.3
7
*
29899
ICD-8 Finland
Other psychoses, Reactive psychosis, unspecified
+∞
7.3
7
*
F60.2
ICD-10 Finland
Dissocial personality disorder
+∞
7.3
7
*
F23.20
ICD-10 Finland
Acute schizophrenia-like psychosis without acute stress factor
+∞
7.3
7
*
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
+∞
7.3
7
*
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
+∞
7.3
7
*
IAB14
NOMESCO Finland
Geriatric psychiatry consultation
+∞
7.3
7
*
F50.9
ICD-10 Finland
Eating disorder, unspecified
+∞
7.3
7
*
ZXY61
NOMESCO Finland
2-person team, special workers
+∞
7.3
7
*
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
+∞
7.3
7
*
G46.3*I67.9
ICD-10 Finland
Brain stem stroke syndrome (I60-I67+)
+∞
7.3
7
*
2962D
ICD-9 Finland
Affective psychoses, Major depressive disorder, single episode[PSYCHOSIS BIPOLARIS MANICA,VAIKEA-ASTEINEN]
+∞
7.3
7
*
3000A
ICD-9 Finland
Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]
+∞
7.3
7
*
ZYB07
NOMESCO Finland
Outreach service at sheltered housing unit
+∞
7.3
7
*
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
9.4
7.3
14
15
SPAT1325
SPAT
Vaccination
1.5
7.3
311
2325
R4110
NOMESCO Finland
Physiotherapy
1.5
7.3
246
1753
SCA01
NOMESCO Finland
Preventive oral health care, short
1.6
7.3
207
1420
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
15.9
7.2
11
7
J01FF01
ATC
clindamycin; systemic
1.5
7.2
228
1600
D01AA02
ATC
natamycin; topical
3.7
7.2
22
60
M01AH02
ATC
rofecoxib; oral
1.8
7.2
109
633
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.9
7.2
96
536
OAB50, ,
SPAT
2.1
7.2
65
316
R26.2
ICD-10 Finland
Difficulty in walking, not elsewhere classified
4.5
7.2
17
38
K22.1
ICD-10 Finland
Ulcer of oesophagus
3.6
7.2
23
65
M54.8
ICD-10 Finland
Other dorsalgia
2.9
7.2
33
117
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
30.2
7.2
9
*
G56.3
ICD-10 Finland
Lesion of radial nerve
30.2
7.2
9
*
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
2.7
7.1
36
134
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
20.2
7.1
10
5
N06BA04
ATC
methylphenidate; oral
20.2
7.1
10
5
B18.2
ICD-10 Finland
Chronic viral hepatitis C
20.2
7.1
10
5
A03
ICPC
Fever
1.7
7.1
126
766
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
7.1
219
1528
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
4.1
7.1
19
47
N27
ICPC
Fear of neurological disease other
6.1
7.1
18
30
F90.0
ICD-10 Finland
Disturbance of activity and attention
12.1
7.1
12
10
S29
ICPC
Skin symptom/complaint other
1.6
7.1
183
1227
SPF30
NOMESCO Finland
Relining of denture
3.7
7.0
22
61
D01AE15
ATC
terbinafine; topical
2.0
7.0
71
360
L75
ICPC
Fracture: femur
4.2
7.0
18
43
J46
ICD-10 Finland
Status asthmaticus
3.2
7.0
27
86
H13
ICPC
Plugged feeling ear
1.6
7.0
196
1338
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
2.8
6.9
33
119
JN3AD
NOMESCO Finland
Abdominal CT examination
1.8
6.9
111
656
A02BX02
ATC
sucralfate; oral
2.5
6.9
42
172
Y94.0
ICD-10 Finland
Accident at home
4.0
6.9
19
48
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.2
6.9
5
296
L19
ICPC
Muscle symptom/complaint NOS
3.2
6.9
26
82
L29
ICPC
Musculoskeletal sympt/complt other
2.0
6.8
74
385
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.5
6.8
43
179
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.2
6.8
59
282
K56.0
ICD-10 Finland
Paralytic ileus
6.7
6.8
16
24
T74.1
ICD-10 Finland
Physical abuse
11.0
6.8
12
11
ZYY79, ,
SPAT
11.0
6.8
12
11
R68.2
ICD-10 Finland
Dry mouth, unspecified
11.0
6.8
12
11
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.8
6.8
32
115
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.4
6.8
338
2596
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.9
6.8
78
415
R26.0
ICD-10 Finland
Ataxic gait
40.3
6.8
8
*
AAF00
NOMESCO Finland
Ventriculostomy
40.3
6.8
8
*
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
40.3
6.8
8
*
R5130, ,
SPAT
16.8
6.7
10
6
R44.0
ICD-10 Finland
Auditory hallucinations
16.8
6.7
10
6
Z73.8
ICD-10 Finland
Other problems related to life-management difficulty
16.8
6.7
10
6
A10AE05
ATC
insulin detemir; parenteral
2.5
6.7
41
168
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.8
6.7
106
623
Z51.88
ICD-10 Finland
Other specified medical care
3.3
6.7
24
73
A07AA02
ATC
nystatin; oral
2.2
6.7
52
238
Z71.9
ICD-10 Finland
Counselling, unspecified
2.0
6.7
72
374
Z60.8
ICD-10 Finland
Other problems related to social environment
22.7
6.7
9
*
E03.89
ICD-10 Finland
Other specified hypothyroidism
2.6
6.7
36
139
A06AC51
ATC
ispaghula, combinations; oral
2.5
6.7
41
169
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
6.7
85
468
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.7
6.7
113
679
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
4.1
6.6
18
45
UJF32
NOMESCO Finland
Coloscopy
1.5
6.6
231
1653
Z50.5
ICD-10 Finland
Speech therapy
7.9
6.6
14
18
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.8
6.6
31
111
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
3.1
6.6
26
84
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.2
6.6
53
246
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.8
6.6
96
551
B03BA03
ATC
hydroxocobalamin; parenteral
2.2
6.6
56
266
7803A
ICD-9 Finland
General symptoms, Convulsions
12.3
6.6
11
9
R63.4
ICD-10 Finland
Abnormal weight loss
2.5
6.6
40
164
X57
ICD-10 Finland
Unspecified privation
3.4
6.6
23
69
L76
ICPC
Fracture: other
3.0
6.6
28
95
K96
ICPC
Haemorrhoids
3.0
6.6
28
95
D07AA02
ATC
hydrocortisone; topical
1.7
6.5
110
659
SPAT1211
SPAT
Application of soft bandage
2.0
6.5
69
356
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.5
6.5
41
171
C08CA01
ATC
amlodipine; oral
1.4
6.5
367
2878
C10AA03
ATC
pravastatin; oral
2.0
6.5
72
378
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
2.5
6.5
39
159
A97
ICPC
No disease
1.6
6.5
179
1217
Y96.9
ICD-10 Finland
Unspecified type of accident
5.4
6.5
18
34
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
6.5
317
2423
S01
ICD-10 Finland
Open wound of head
5.7
6.5
17
30
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.1
6.5
57
275
P25
ICPC
Phase of life problem adult
3.5
6.5
21
60
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
2.7
6.5
33
124
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
3.2
6.4
24
75
G12.2
ICD-10 Finland
Motor neuron disease
70.2
6.4
7
*
IAB11
NOMESCO Finland
Psychiatric mood consultation
70.2
6.4
7
*
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
70.2
6.4
7
*
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
70.2
6.4
7
*
N07
ICPC
Convulsion/seizure
70.2
6.4
7
*
X84
ICD-10 Finland
Intentional self-harm by unspecified means
70.2
6.4
7
*
ICZ04
NOMESCO Finland
Preparation of psychiatric treatment plan
70.2
6.4
7
*
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
70.2
6.4
7
*
N05AA03
ATC
promazine; systemic
70.2
6.4
7
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.0
6.4
27
91
SXA20
NOMESCO Finland
Local application of medicine to mouth
2.5
6.4
39
160
R00.1
ICD-10 Finland
Bradycardia, unspecified
2.6
6.4
36
142
SPAT1104
SPAT
Monitoring of emergency patient
2.2
6.4
54
256
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.7
6.4
32
119
I84.5
ICD-10 Finland
External hemorrhoids without complication
3.1
6.3
25
81
EMAK, ,
NOMESCO Finland
2.8
6.3
31
114
F41.0
ICD-10 Finland
Panic disorder [episodic paroxysmal anxiety]
11.1
6.3
11
10
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.9
6.3
74
397
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.4
6.3
41
174
J01DA01
ATC
[U] cefalexin
1.4
6.3
540
4537
WX730
NOMESCO Finland
Conventional respirator
3.9
6.3
18
47
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.8
6.3
98
575
I49.5
ICD-10 Finland
Sick sinus syndrome
2.3
6.3
44
193
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
0.2
6.3
*
255
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
+∞
6.3
6
*
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
+∞
6.3
6
*
G82.2
ICD-10 Finland
Paraplegia, unspecified
+∞
6.3
6
*
F60.7
ICD-10 Finland
Dependent personality disorder
+∞
6.3
6
*
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
+∞
6.3
6
*
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
+∞
6.3
6
*
109
Kela drug reimbursment
Multiple sclerosis
+∞
6.3
6
*
F23.00
ICD-10 Finland
Acute polymorphic psychosis without actual schizophrenic disease picture without acute stress factor
+∞
6.3
6
*
2956C
ICD-9 Finland
Schizophrenic psychoses, Residual schizophrenia[RESIDUAALINEN SKITSOFRENIA,KROONINEN]
+∞
6.3
6
*
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
+∞
6.3
6
*
F60.1
ICD-10 Finland
Schizoid personality disorder
+∞
6.3
6
*
IER04, ,
SPAT
+∞
6.3
6
*
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
+∞
6.3
6
*
F0029, G308,
ICD-10 Finland
+∞
6.3
6
*
IAZ99, ,
SPAT
+∞
6.3
6
*
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
+∞
6.3
6
*
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
+∞
6.3
6
*
G25
ICD-10 Finland
Other extrapyramidal and movement disorders
+∞
6.3
6
*
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
+∞
6.3
6
*
F50.0
ICD-10 Finland
Anorexia nervosa
+∞
6.3
6
*
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
+∞
6.3
6
*
I69.4
ICD-10 Finland
Sequelae of stroke, not specified as haemorrhage or infarction
+∞
6.3
6
*
79301
ICD-8 Finland
Observation, without need for further medical care, Observatio post tentationem suicidii
+∞
6.3
6
*
30120
ICD-8 Finland
Personality disorders, Schizoid
+∞
6.3
6
*
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
+∞
6.3
6
*
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
+∞
6.3
6
*
G99.2*M47.1
ICD-10 Finland
Spondylogenic compression of spinal cord
+∞
6.3
6
*
OAB76
NOMESCO Finland
General guidance on nutrition and food
+∞
6.3
6
*
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
+∞
6.3
6
*
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
+∞
6.3
6
*
29820
ICD-8 Finland
Other psychoses, Reactive confusion
+∞
6.3
6
*
29550
ICD-8 Finland
Latent schizophrenia
+∞
6.3
6
*
3170A
ICD-9 Finland
Mild mental retardation[LIEVÄ ÄLYLL.KEHITYSVAMMAISUUS,EI KÄYTÄYTYM.HÄIRIÖTÄ]
+∞
6.3
6
*
2962B
ICD-9 Finland
Affective psychoses, Major depressive disorder, single episode[PSYCHOSIS BIPOLARIS MANICA,LIEVÄASTEINEN]
+∞
6.3
6
*
F20.12
ICD-10 Finland
Hebefren schizophrenia stable periodically
+∞
6.3
6
*
G40
ICD-10 Finland
Epilepsy
+∞
6.3
6
*
3000B
ICD-9 Finland
Neurotic disorders, Anxiety states[PANIIKKIHÄIRIÖ]
+∞
6.3
6
*
RS140, ,
NOMESCO Finland
+∞
6.3
6
*
IEV99, ,
SPAT
+∞
6.3
6
*
R81
ICPC
Pneumonia
2.5
6.2
38
156
B35.3
ICD-10 Finland
Tinea pedis
2.5
6.2
38
156
Z50.7
ICD-10 Finland
Occupational therapy and vocational rehabilitation, not elsewhere classified
26.8
6.2
8
*
Z72.8
ICD-10 Finland
Other problems related to lifestyle
26.8
6.2
8
*
AA1DD
NOMESCO Finland
Head and neck CT
26.8
6.2
8
*
E9599
ICD-8 Finland
Late effect of self-inflicted injury
26.8
6.2
8
*
M62.8
ICD-10 Finland
Other specified disorders of muscle
26.8
6.2
8
*
Z71.4
ICD-10 Finland
Alcohol abuse counselling and surveillance
26.8
6.2
8
*
X61
ICD-10 Finland
Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified
26.8
6.2
8
*
G24.3
ICD-10 Finland
Spasmodic torticollis
26.8
6.2
8
*
R45.1
ICD-10 Finland
Restlessness and agitation
26.8
6.2
8
*
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.6
6.2
147
964
L14
ICPC
Leg/thigh symptom/complaint
2.0
6.2
70
370
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.0
6.2
62
314
G03DC03
ATC
lynestrenol; oral
4.0
6.2
17
43
S17
ICPC
Abrasion/scratch/blister
3.4
6.2
21
62
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
6.2
192
1341
M03BC51
ATC
orphenadrine, combinations; systemic
1.5
6.1
195
1367
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.7
6.1
31
116
S23.4
ICD-10 Finland
Sprain and strain of ribs and sternum
3.8
6.1
18
48
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.2
6.1
52
248
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
8.7
6.1
12
14
TLC00
NOMESCO Finland
Insertion of intrauterine device
3.2
6.0
23
73
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
6.0
72
388
L02
ICPC
Back symptom/complaint
1.9
6.0
70
374
SGA02
NOMESCO Finland
Opening and preparing the root canals
1.7
6.0
102
613

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
quetiapine; oral
N05AH04 [21604544]
4.7e+00
4.6e+00
4.1e+00
1.0e+50
4.5e+00
4.8e+00
4.8e+00
cases:19.67%
controls:0.22%
cases:17.73%
controls:0.22%
cases:6.37%
controls:0.11%
cases:0.46%
controls:0.00%
cases:6.55%
controls:0.07%
cases:21.83%
controls:0.24%
cases:31.82%
controls:0.37%
213
24
870
10790
192
24
891
10790
69
12
1014
10802
5
0
1078
10814
70
8
999
10785
219
25
784
10372
246
32
527
8541
Neurology
13 [38004458]
3.4e+00
4.4e+00
4.5e+00
—
5.3e+00
5.1e+00
4.0e+00
cases:33.24%
controls:1.58%
cases:31.12%
controls:0.57%
cases:9.33%
controls:0.11%
—
—
cases:13.75%
controls:0.08%
cases:49.65%
controls:0.59%
cases:47.48%
controls:1.64%
360
171
723
10643
337
62
746
10752
101
12
982
10802
—
147
9
922
10784
498
61
505
10336
367
141
406
8432
levodopa and decarboxylase inhibitor; oral
N04BA02 [21604465]
5.2e+00
5.9e+00
—
1.0e+50
1.0e+50
6.6e+00
6.2e+00
cases:10.53%
controls:0.06%
cases:14.59%
controls:0.05%
—
—
cases:3.79%
controls:0.00%
cases:10.01%
controls:0.00%
cases:25.42%
controls:0.05%
cases:26.39%
controls:0.07%
114
7
969
10807
158
5
925
10809
—
41
0
1042
10814
107
0
962
10793
255
5
748
10392
204
6
569
8567
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
3.8e+00
3.8e+00
3.7e+00
—
—
4.0e+00
3.9e+00
cases:11.08%
controls:0.27%
cases:9.33%
controls:0.23%
cases:3.05%
controls:0.07%
—
—
—
—
cases:10.97%
controls:0.22%
cases:16.69%
controls:0.42%
120
29
963
10785
101
25
982
10789
33
8
1050
10806
—
—
110
23
893
10374
129
36
644
8537
Psychiatry
26 [38004469]
6.0e+00
6.7e+00
—
1.0e+50
—
—
6.3e+00
cases:35.18%
controls:0.13%
cases:28.25%
controls:0.05%
—
—
cases:8.40%
controls:0.00%
—
—
—
—
cases:42.43%
controls:0.14%
381
14
702
10800
306
5
777
10809
—
91
0
992
10814
—
—
328
12
445
8561
Inpatient Hospital
21 [8717]
1.5e+00
1.8e+00
2.5e+00
6.6e+00
2.9e+00
1.9e+00
1.7e+00
cases:57.62%
controls:24.10%
cases:36.84%
controls:8.75%
cases:14.68%
controls:1.38%
cases:26.13%
controls:0.05%
cases:18.52%
controls:1.30%
cases:37.59%
controls:8.58%
cases:59.25%
controls:21.31%
624
2606
459
8208
399
946
684
9868
159
149
924
10665
283
5
800
10809
198
140
871
10653
377
892
626
9505
458
1827
315
6746
pramipexole; oral
N04BC05 [21604477]
2.6e+00
2.9e+00
3.3e+00
1.0e+50
3.1e+00
3.4e+00
3.0e+00
cases:4.71%
controls:0.36%
cases:4.06%
controls:0.22%
cases:1.29%
controls:0.05%
cases:0.74%
controls:0.00%
cases:1.96%
controls:0.09%
cases:5.98%
controls:0.21%
cases:8.93%
controls:0.50%
51
39
1032
10775
44
24
1039
10790
14
5
1069
10809
8
0
1075
10814
21
10
1048
10783
60
22
943
10375
69
43
704
8530
Taking care of patient’s/customer’s hygiene
SPAT1137 [2001700238]
3.1e+00
2.9e+00
3.0e+00
—
3.1e+00
3.1e+00
2.7e+00
cases:2.49%
controls:0.11%
cases:2.68%
controls:0.16%
cases:1.66%
controls:0.08%
—
—
cases:1.87%
controls:0.08%
cases:4.09%
controls:0.19%
cases:5.95%
controls:0.42%
27
12
1056
10802
29
17
1054
10797
18
9
1065
10805
—
20
9
1049
10784
41
20
962
10377
46
36
727
8537
Home Visit
OMOP4822459 [581476]
2.1e+00
2.5e+00
2.9e+00
2.7e+00
2.9e+00
2.6e+00
2.2e+00
cases:17.08%
controls:2.40%
cases:14.96%
controls:1.41%
cases:8.13%
controls:0.51%
cases:2.77%
controls:0.18%
cases:7.76%
controls:0.47%
cases:19.84%
controls:1.88%
cases:35.45%
controls:5.54%
185
259
898
10555
162
153
921
10661
88
55
995
10759
30
20
1053
10794
83
51
986
10742
199
195
804
10202
274
475
499
8098
clonazepam; oral, parenteral
N03AE01 [21604415]
3.2e+00
3.6e+00
—
—
2.9e+00
4.0e+00
3.9e+00
cases:5.54%
controls:0.25%
cases:5.08%
controls:0.15%
—
—
—
—
cases:0.84%
controls:0.05%
cases:5.48%
controls:0.11%
cases:8.80%
controls:0.19%
60
27
1023
10787
55
16
1028
10798
—
—
9
5
1060
10788
55
11
948
10386
68
16
705
8557
duloxetine; oral
N06AX21 [21604749]
2.7e+00
3.0e+00
3.1e+00
—
2.9e+00
3.2e+00
2.6e+00
cases:4.16%
controls:0.28%
cases:3.14%
controls:0.17%
cases:1.39%
controls:0.06%
—
—
cases:1.22%
controls:0.06%
cases:3.19%
controls:0.13%
cases:4.92%
controls:0.38%
45
30
1038
10784
34
18
1049
10796
15
7
1068
10807
—
13
7
1056
10786
32
14
971
10383
38
33
735
8540
Limited function/disability NOS
A28 [2002000162]
1.9e+00
2.4e+00
2.7e+00
2.7e+00
2.6e+00
2.3e+00
2.3e+00
cases:6.37%
controls:1.04%
cases:6.28%
controls:0.61%
cases:3.69%
controls:0.27%
cases:1.20%
controls:0.08%
cases:4.02%
controls:0.30%
cases:8.37%
controls:0.87%
cases:18.37%
controls:2.30%
69
112
1014
10702
68
66
1015
10748
40
29
1043
10785
13
9
1070
10805
43
32
1026
10761
84
90
919
10307
142
197
631
8376
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
2.4e+00
2.8e+00
3.2e+00
—
3.1e+00
2.6e+00
2.6e+00
cases:12.10%
controls:1.22%
cases:8.59%
controls:0.59%
cases:2.59%
controls:0.11%
—
—
cases:2.43%
controls:0.11%
cases:7.58%
controls:0.63%
cases:12.94%
controls:1.05%
131
132
952
10682
93
64
990
10750
28
12
1055
10802
—
26
12
1043
10781
76
66
927
10331
100
90
673
8483
Administration of medicine
SPAT1254 [2001700355]
1.7e+00
2.5e+00
2.4e+00
2.8e+00
2.8e+00
2.3e+00
2.0e+00
cases:4.89%
controls:0.95%
cases:4.62%
controls:0.38%
cases:1.85%
controls:0.17%
cases:0.92%
controls:0.06%
cases:2.15%
controls:0.14%
cases:5.48%
controls:0.57%
cases:9.57%
controls:1.48%
53
103
1030
10711
50
41
1033
10773
20
18
1063
10796
10
6
1073
10808
23
15
1046
10778
55
59
948
10338
74
127
699
8446
Support of social functional capacity
SPAT1234 [2001700335]
3.5e+00
3.3e+00
3.1e+00
—
—
3.0e+00
3.1e+00
cases:2.59%
controls:0.08%
cases:2.77%
controls:0.10%
cases:1.48%
controls:0.06%
—
—
—
—
cases:3.09%
controls:0.16%
cases:5.56%
controls:0.26%
28
9
1055
10805
30
11
1053
10803
16
7
1067
10807
—
—
31
17
972
10380
43
22
730
8551
Sleep apnoea
G47.3 [45562094]
4.1e+00
4.3e+00
1.0e+50
1.0e+50
—
4.0e+00
3.5e+00
cases:6.28%
controls:0.11%
cases:3.97%
controls:0.06%
cases:1.20%
controls:0.00%
cases:1.20%
controls:0.00%
—
—
cases:4.59%
controls:0.09%
cases:6.73%
controls:0.21%
68
12
1015
10802
43
6
1040
10808
13
0
1070
10814
13
0
1070
10814
—
46
9
957
10388
52
18
721
8555
citalopram; oral, parenteral
N06AB04 [21604712]
2.6e+00
2.7e+00
2.8e+00
—
2.9e+00
2.4e+00
2.4e+00
cases:13.11%
controls:1.16%
cases:9.97%
controls:0.74%
cases:2.59%
controls:0.17%
—
—
cases:2.34%
controls:0.13%
cases:8.47%
controls:0.83%
cases:11.25%
controls:1.17%
142
125
941
10689
108
80
975
10734
28
18
1055
10796
—
25
14
1044
10779
85
86
918
10311
87
100
686
8473
colecalciferol; oral
A11CC05 [21600820]
2.8e+00
3.1e+00
—
—
3.2e+00
3.4e+00
3.2e+00
cases:1.57%
controls:0.10%
cases:2.40%
controls:0.11%
—
—
—
—
cases:1.12%
controls:0.05%
cases:3.19%
controls:0.11%
cases:4.79%
controls:0.21%
17
11
1066
10803
26
12
1057
10802
—
—
12
5
1057
10788
32
11
971
10386
37
18
736
8555
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
1.6e+00
2.2e+00
3.7e+00
1.0e+50
4.0e+00
2.3e+00
1.7e+00
cases:11.82%
controls:2.73%
cases:8.96%
controls:1.10%
cases:4.80%
controls:0.13%
cases:5.36%
controls:0.00%
cases:7.39%
controls:0.14%
cases:8.28%
controls:0.90%
cases:20.18%
controls:4.48%
128
295
955
10519
97
119
986
10695
52
14
1031
10800
58
0
1025
10814
79
15
990
10778
83
94
920
10303
156
384
617
8189
escitalopram; oral
N06AB10 [21604718]
2.4e+00
2.5e+00
2.7e+00
—
2.7e+00
2.7e+00
2.4e+00
cases:8.22%
controls:0.82%
cases:5.91%
controls:0.49%
cases:2.12%
controls:0.15%
—
—
cases:1.96%
controls:0.13%
cases:6.98%
controls:0.51%
cases:9.18%
controls:0.92%
89
89
994
10725
64
53
1019
10761
23
16
1060
10798
—
21
14
1048
10779
70
53
933
10344
71
79
702
8494
oxazepam; oral
N05BA04 [21604569]
2.4e+00
2.4e+00
2.9e+00
—
2.7e+00
2.5e+00
2.5e+00
cases:17.82%
controls:2.03%
cases:11.54%
controls:1.15%
cases:5.63%
controls:0.34%
—
—
cases:3.84%
controls:0.28%
cases:12.76%
controls:1.23%
cases:21.86%
controls:2.33%
193
219
890
10595
125
124
958
10690
61
37
1022
10777
—
41
30
1028
10763
128
128
875
10269
169
200
604
8373
In Home Supportive Care Agency
253Z00000X [38004206]
2.9e+00
3.2e+00
2.8e+00
—
—
3.1e+00
3.0e+00
cases:1.75%
controls:0.10%
cases:1.85%
controls:0.07%
cases:0.92%
controls:0.06%
—
—
—
—
cases:2.39%
controls:0.11%
cases:4.01%
controls:0.20%
19
11
1064
10803
20
8
1063
10806
10
6
1073
10808
—
—
24
11
979
10386
31
17
742
8556
Limited function/disability (L)
L28 [2002000647]
1.7e+00
2.6e+00
3.0e+00
—
3.2e+00
2.5e+00
2.0e+00
cases:6.56%
controls:1.23%
cases:7.02%
controls:0.58%
cases:1.66%
controls:0.08%
—
—
cases:2.34%
controls:0.10%
cases:7.48%
controls:0.68%
cases:15.14%
controls:2.31%
71
133
1012
10681
76
63
1007
10751
18
9
1065
10805
—
25
11
1044
10782
75
71
928
10326
117
198
656
8375
Counselling/guidance promoting independent living
SPAT1222 [2001700323]
1.9e+00
2.5e+00
3.0e+00
—
2.8e+00
2.6e+00
2.1e+00
cases:6.93%
controls:1.09%
cases:5.72%
controls:0.51%
cases:2.49%
controls:0.13%
—
—
cases:2.43%
controls:0.15%
cases:6.38%
controls:0.52%
cases:11.38%
controls:1.52%
75
118
1008
10696
62
55
1021
10759
27
14
1056
10800
—
26
16
1043
10777
64
54
939
10343
88
130
685
8443
Psychological sympt/compl other
P29 [2002000823]
3.8e+00
3.4e+00
1.0e+50
—
1.0e+50
3.5e+00
4.1e+00
cases:3.51%
controls:0.08%
cases:1.57%
controls:0.06%
cases:0.46%
controls:0.00%
—
—
cases:0.65%
controls:0.00%
cases:1.89%
controls:0.06%
cases:6.47%
controls:0.12%
38
9
1045
10805
17
6
1066
10808
5
0
1078
10814
—
7
0
1062
10793
19
6
984
10391
50
10
723
8563
melatonin; oral
N05CH01 [21604659]
1.7e+00
2.3e+00
3.0e+00
—
3.0e+00
2.4e+00
2.4e+00
cases:4.89%
controls:0.91%
cases:4.52%
controls:0.48%
cases:1.94%
controls:0.10%
—
—
cases:1.96%
controls:0.10%
cases:5.38%
controls:0.53%
cases:12.55%
controls:1.33%
53
98
1030
10716
49
52
1034
10762
21
11
1062
10803
—
21
11
1048
10782
54
55
949
10342
97
114
676
8459
levomepromazine; oral, parenteral
N05AA02 [21604493]
4.8e+00
4.9e+00
1.0e+50
1.0e+50
—
5.0e+00
—
cases:10.62%
controls:0.10%
cases:7.85%
controls:0.06%
cases:1.48%
controls:0.00%
cases:0.46%
controls:0.00%
—
—
cases:6.88%
controls:0.05%
—
—
115
11
968
10803
85
7
998
10807
16
0
1067
10814
5
0
1078
10814
—
69
5
934
10392
—
temazepam; oral
N05CD07 [21604642]
2.4e+00
2.3e+00
2.7e+00
—
2.3e+00
2.5e+00
2.4e+00
cases:16.53%
controls:1.84%
cases:12.28%
controls:1.39%
cases:3.79%
controls:0.27%
—
—
cases:3.37%
controls:0.33%
cases:13.66%
controls:1.32%
cases:19.53%
controls:2.25%
179
199
904
10615
133
150
950
10664
41
29
1042
10785
—
36
36
1033
10757
137
137
866
10260
151
193
622
8380
Functional capacity evaluation
443351003 [40481051]
1.9e+00
2.6e+00
2.3e+00
—
2.6e+00
2.6e+00
2.3e+00
cases:6.83%
controls:1.04%
cases:5.63%
controls:0.46%
cases:1.48%
controls:0.16%
—
—
cases:1.68%
controls:0.13%
cases:6.68%
controls:0.54%
cases:12.68%
controls:1.41%
74
112
1009
10702
61
50
1022
10764
16
17
1067
10797
—
18
14
1051
10779
67
56
936
10341
98
121
675
8452
Weakness/tiredness general
A04 [2002000145]
1.9e+00
2.2e+00
2.9e+00
—
3.0e+00
2.0e+00
1.9e+00
cases:4.16%
controls:0.67%
cases:2.95%
controls:0.34%
cases:1.20%
controls:0.06%
—
—
cases:1.68%
controls:0.08%
cases:3.09%
controls:0.42%
cases:7.89%
controls:1.21%
45
72
1038
10742
32
37
1051
10777
13
7
1070
10807
—
18
9
1051
10784
31
44
972
10353
61
104
712
8469
mirtazapine; oral
N06AX11 [21604740]
2.1e+00
2.3e+00
2.6e+00
—
2.4e+00
2.5e+00
2.0e+00
cases:16.34%
controls:2.41%
cases:13.30%
controls:1.44%
cases:5.26%
controls:0.41%
—
—
cases:4.21%
controls:0.42%
cases:15.55%
controls:1.51%
cases:20.31%
controls:3.24%
177
261
906
10553
144
156
939
10658
57
44
1026
10770
—
45
45
1024
10748
156
157
847
10240
157
278
616
8295
Internal Medicine
11 [38004456]
1.0e+00
1.1e+00
2.0e+00
5.5e+00
1.9e+00
1.2e+00
1.1e+00
cases:38.87%
controls:18.61%
cases:20.31%
controls:7.85%
cases:8.68%
controls:1.26%
cases:12.10%
controls:0.06%
cases:7.76%
controls:1.24%
cases:21.93%
controls:7.91%
cases:41.01%
controls:18.49%
421
2012
662
8802
220
849
863
9965
94
136
989
10678
131
6
952
10808
83
134
986
10659
220
822
783
9575
317
1585
456
6988
No procedures
SPAT1301 [2001700402]
1.1e+00
1.6e+00
2.4e+00
3.0e+00
2.6e+00
1.5e+00
1.3e+00
cases:12.00%
controls:4.24%
cases:6.74%
controls:1.39%
cases:2.59%
controls:0.25%
cases:1.11%
controls:0.06%
cases:2.71%
controls:0.20%
cases:7.08%
controls:1.64%
cases:16.95%
controls:5.24%
130
459
953
10355
73
150
1010
10664
28
27
1055
10787
12
6
1071
10808
29
22
1040
10771
71
170
932
10227
131
449
642
8124
lactulose; oral
A06AD11 [21600571]
2.3e+00
2.4e+00
2.2e+00
—
1.9e+00
2.4e+00
2.2e+00
cases:8.49%
controls:0.94%
cases:5.08%
controls:0.46%
cases:1.02%
controls:0.11%
—
—
cases:0.84%
controls:0.13%
cases:6.78%
controls:0.68%
cases:13.20%
controls:1.66%
92
102
991
10712
55
50
1028
10764
11
12
1072
10802
—
9
14
1060
10779
68
71
935
10326
102
142
671
8431
Nursing episode
950 [44777714]
2.0e+00
2.2e+00
2.4e+00
—
2.5e+00
2.3e+00
2.0e+00
cases:5.54%
controls:0.80%
cases:5.17%
controls:0.58%
cases:2.49%
controls:0.23%
—
—
cases:2.25%
controls:0.19%
cases:6.98%
controls:0.72%
cases:11.90%
controls:1.88%
60
86
1023
10728
56
63
1027
10751
27
25
1056
10789
—
24
21
1045
10772
70
75
933
10322
92
161
681
8412
acetylsalicylic acid; oral
B01AC06 [21600991]
1.7e+00
2.1e+00
2.4e+00
—
2.9e+00
2.3e+00
1.9e+00
cases:9.05%
controls:1.86%
cases:5.72%
controls:0.77%
cases:1.85%
controls:0.17%
—
—
cases:2.25%
controls:0.12%
cases:7.48%
controls:0.78%
cases:11.00%
controls:1.89%
98
201
985
10613
62
83
1021
10731
20
18
1063
10796
—
24
13
1045
10780
75
81
928
10316
85
162
688
8411
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
3.0e+00
3.3e+00
1.0e+50
—
1.0e+50
4.0e+00
2.9e+00
cases:3.69%
controls:0.18%
cases:2.22%
controls:0.08%
cases:0.83%
controls:0.00%
—
—
cases:0.84%
controls:0.00%
cases:2.59%
controls:0.05%
cases:2.98%
controls:0.16%
40
20
1043
10794
24
9
1059
10805
9
0
1074
10814
—
9
0
1060
10793
26
5
977
10392
23
14
750
8559
General Practice
1 [38004446]
1.6e+00
2.1e+00
2.7e+00
—
2.9e+00
2.1e+00
1.8e+00
cases:33.15%
controls:8.98%
cases:24.28%
controls:3.74%
cases:8.40%
controls:0.61%
—
—
cases:9.26%
controls:0.55%
cases:25.72%
controls:4.22%
cases:48.12%
controls:13.41%
359
971
724
9843
263
404
820
10410
91
66
992
10748
—
99
59
970
10734
258
439
745
9958
372
1150
401
7423
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
9.1e-01
1.3e+00
1.9e+00
3.9e+00
2.3e+00
1.4e+00
1.3e+00
cases:22.99%
controls:10.72%
cases:16.62%
controls:5.10%
cases:4.99%
controls:0.78%
cases:3.05%
controls:0.06%
cases:7.58%
controls:0.80%
cases:19.64%
controls:5.44%
cases:40.62%
controls:15.09%
249
1159
834
9655
180
552
903
10262
54
84
1029
10730
33
7
1050
10807
81
86
988
10707
197
566
806
9831
314
1294
459
7279
mianserin; oral
N06AX03 [21604732]
3.2e+00
3.2e+00
—
—
—
2.9e+00
3.7e+00
cases:2.31%
controls:0.09%
cases:1.39%
controls:0.06%
—
—
—
—
—
—
cases:1.60%
controls:0.09%
cases:2.33%
controls:0.06%
25
10
1058
10804
15
6
1068
10808
—
—
—
16
9
987
10388
18
5
755
8568
propranolol; oral, parenteral
C07AA05 [21601670]
1.9e+00
2.3e+00
2.6e+00
1.0e+50
2.3e+00
2.1e+00
1.8e+00
cases:11.54%
controls:1.98%
cases:9.42%
controls:1.05%
cases:2.49%
controls:0.18%
cases:0.74%
controls:0.00%
cases:1.96%
controls:0.19%
cases:9.07%
controls:1.16%
cases:12.29%
controls:2.33%
125
214
958
10600
102
114
981
10700
27
20
1056
10794
8
0
1075
10814
21
21
1048
10772
91
121
912
10276
95
200
678
8373
Dizziness and giddiness
R42 [45568132]
1.9e+00
2.0e+00
3.5e+00
1.0e+50
2.3e+00
1.5e+00
1.6e+00
cases:9.60%
controls:1.55%
cases:5.08%
controls:0.71%
cases:1.57%
controls:0.05%
cases:0.92%
controls:0.00%
cases:0.75%
controls:0.07%
cases:2.99%
controls:0.71%
cases:9.44%
controls:2.08%
104
168
979
10646
55
77
1028
10737
17
5
1066
10809
10
0
1073
10814
8
8
1061
10785
30
74
973
10323
73
178
700
8395
Supine thorax X-ray examination
GD1QA [2001303648]
2.2e+00
2.7e+00
3.2e+00
—
—
2.6e+00
2.2e+00
cases:6.56%
controls:0.75%
cases:4.25%
controls:0.31%
cases:1.94%
controls:0.08%
—
—
—
—
cases:5.38%
controls:0.43%
cases:13.07%
controls:1.68%
71
81
1012
10733
46
33
1037
10781
21
9
1062
10805
—
—
54
45
949
10352
101
144
672
8429
Observation for suspected nervous system disorder
Z03.3 [45609903]
2.7e+00
3.7e+00
—
1.0e+50
1.0e+50
3.5e+00
2.8e+00
cases:2.68%
controls:0.18%
cases:2.31%
controls:0.06%
—
—
cases:0.92%
controls:0.00%
cases:0.56%
controls:0.00%
cases:2.29%
controls:0.07%
cases:3.10%
controls:0.20%
29
20
1054
10794
25
6
1058
10808
—
10
0
1073
10814
6
0
1063
10793
23
7
980
10390
24
17
749
8556
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
2.9e+00
3.3e+00
1.0e+50
1.0e+50
—
3.7e+00
2.7e+00
cases:3.79%
controls:0.21%
cases:2.40%
controls:0.09%
cases:0.55%
controls:0.00%
cases:1.94%
controls:0.00%
—
—
cases:1.99%
controls:0.05%
cases:3.10%
controls:0.22%
41
23
1042
10791
26
10
1057
10804
6
0
1077
10814
21
0
1062
10814
—
20
5
983
10392
24
19
749
8554
Outpatient Visit
OP [9202]
1.0e+00
8.9e-01
1.1e+00
5.4e+00
1.4e+00
1.4e+00
1.1e+00
cases:83.84%
controls:64.55%
cases:68.05%
controls:46.60%
cases:24.38%
controls:9.31%
cases:42.01%
controls:0.33%
cases:27.97%
controls:8.87%
cases:77.07%
controls:45.98%
cases:90.17%
controls:74.54%
908
6980
175
3834
737
5039
346
5775
264
1007
819
9807
455
36
628
10778
299
957
770
9836
773
4781
230
5616
697
6390
76
2183
acetylsalicylic acid, combinations excl. psycholeptics
N02BA51 [21604320]
2.9e+00
3.1e+00
—
—
—
3.3e+00
3.0e+00
cases:3.69%
controls:0.20%
cases:2.59%
controls:0.12%
—
—
—
—
—
—
cases:2.89%
controls:0.11%
cases:3.10%
controls:0.16%
40
22
1043
10792
28
13
1055
10801
—
—
—
29
11
974
10386
24
14
749
8559
platelet aggregation inhibitors excl. heparin - combinations
B01AC30 [21601005]
2.9e+00
3.1e+00
—
—
—
3.3e+00
3.0e+00
cases:3.69%
controls:0.20%
cases:2.59%
controls:0.12%
—
—
—
—
—
—
cases:2.89%
controls:0.11%
cases:3.10%
controls:0.16%
40
22
1043
10792
28
13
1055
10801
—
—
—
29
11
974
10386
24
14
749
8559
Neurosurgery
14 [38004459]
2.2e+00
2.6e+00
2.6e+00
—
—
2.7e+00
2.2e+00
cases:6.09%
controls:0.70%
cases:3.42%
controls:0.27%
cases:1.11%
controls:0.08%
—
—
—
—
cases:4.49%
controls:0.32%
cases:6.99%
controls:0.84%
66
76
1017
10738
37
29
1046
10785
12
9
1071
10805
—
—
45
33
958
10364
54
72
719
8501
venlafaxine; oral
N06AX16 [21604745]
3.1e+00
3.3e+00
—
—
—
3.2e+00
2.7e+00
cases:7.11%
controls:0.36%
cases:5.36%
controls:0.20%
—
—
—
—
—
—
cases:5.38%
controls:0.24%
cases:6.47%
controls:0.45%
77
39
1006
10775
58
22
1025
10792
—
—
—
54
25
949
10372
50
39
723
8534
Counselling and guidance related to nutrition and weight management
SPAT1306 [2001700407]
1.2e+00
1.9e+00
2.6e+00
—
2.8e+00
2.2e+00
1.5e+00
cases:3.69%
controls:1.14%
cases:2.77%
controls:0.42%
cases:1.29%
controls:0.10%
—
—
cases:1.68%
controls:0.10%
cases:3.39%
controls:0.38%
cases:6.08%
controls:1.43%
40
123
1043
10691
30
45
1053
10769
14
11
1069
10803
—
18
11
1051
10782
34
40
969
10357
47
123
726
8450
Malaise and fatigue
R53 [45553741]
2.0e+00
2.5e+00
3.3e+00
—
—
2.4e+00
2.1e+00
cases:8.68%
controls:1.26%
cases:5.82%
controls:0.53%
cases:2.40%
controls:0.09%
—
—
—
—
cases:5.48%
controls:0.55%
cases:14.36%
controls:2.02%
94
136
989
10678
63
57
1020
10757
26
10
1057
10804
—
—
55
57
948
10340
111
173
662
8400
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
2.9e+00
3.5e+00
—
1.0e+50
—
3.5e+00
2.3e+00
cases:3.97%
controls:0.23%
cases:2.86%
controls:0.09%
—
—
cases:1.39%
controls:0.00%
—
—
cases:2.59%
controls:0.08%
cases:4.92%
controls:0.52%
43
25
1040
10789
31
10
1052
10804
—
15
0
1068
10814
—
26
8
977
10389
38
45
735
8528
Office Visit
OMOP4822458 [581477]
1.4e+00
1.7e+00
2.3e+00
—
3.5e+00
1.7e+00
1.4e+00
cases:18.47%
controls:5.07%
cases:8.86%
controls:1.67%
cases:3.23%
controls:0.33%
—
—
cases:6.45%
controls:0.20%
cases:9.87%
controls:1.88%
cases:18.50%
controls:5.32%
200
548
883
10266
96
181
987
10633
35
36
1048
10778
—
69
22
1000
10771
99
195
904
10202
143
456
630
8117
sertraline; oral
N06AB06 [21604714]
2.8e+00
3.3e+00
—
—
—
3.3e+00
2.6e+00
cases:4.80%
controls:0.30%
cases:3.05%
controls:0.11%
—
—
—
—
—
—
cases:3.19%
controls:0.12%
cases:4.53%
controls:0.35%
52
32
1031
10782
33
12
1050
10802
—
—
—
32
12
971
10385
35
30
738
8543
Therapeutic discussion
SPAT1240 [2001700341]
2.8e+00
3.5e+00
1.0e+50
—
—
3.1e+00
2.6e+00
cases:5.45%
controls:0.33%
cases:3.23%
controls:0.10%
cases:0.55%
controls:0.00%
—
—
—
—
cases:2.49%
controls:0.12%
cases:5.30%
controls:0.41%
59
36
1024
10778
35
11
1048
10803
6
0
1077
10814
—
—
25
12
978
10385
41
35
732
8538
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
1.3e+00
2.3e+00
1.9e+00
—
2.7e+00
2.0e+00
1.9e+00
cases:4.71%
controls:1.34%
cases:3.42%
controls:0.36%
cases:0.65%
controls:0.09%
—
—
cases:1.31%
controls:0.09%
cases:3.89%
controls:0.55%
cases:10.61%
controls:1.81%
51
145
1032
10669
37
39
1046
10775
7
10
1076
10804
—
14
10
1055
10783
39
57
964
10340
82
155
691
8418
Emergency Room and Inpatient Visit
ERIP [262]
1.4e+00
1.8e+00
2.7e+00
—
3.0e+00
1.6e+00
1.5e+00
cases:10.34%
controls:2.71%
cases:8.40%
controls:1.53%
cases:3.60%
controls:0.26%
—
—
cases:3.46%
controls:0.19%
cases:8.77%
controls:1.83%
cases:21.47%
controls:6.01%
112
293
971
10521
91
165
992
10649
39
28
1044
10786
—
37
20
1032
10773
88
190
915
10207
166
515
607
8058
acetylsalicylic acid; oral, parenteral, rectal
N02BA01 [21604305]
1.2e+00
1.6e+00
2.7e+00
—
2.8e+00
2.0e+00
1.6e+00
cases:5.45%
controls:1.66%
cases:3.23%
controls:0.65%
cases:1.48%
controls:0.10%
—
—
cases:1.59%
controls:0.10%
cases:4.69%
controls:0.67%
cases:8.02%
controls:1.75%
59
180
1024
10634
35
70
1048
10744
16
11
1067
10803
—
17
11
1052
10782
47
70
956
10327
62
150
711
8423
Tremor, unspecified
R25.1 [45539327]
4.0e+00
4.6e+00
1.0e+50
1.0e+50
—
—
3.2e+00
cases:3.32%
controls:0.06%
cases:6.28%
controls:0.06%
cases:1.48%
controls:0.00%
cases:0.92%
controls:0.00%
—
—
—
—
cases:2.85%
controls:0.12%
36
7
1047
10807
68
7
1015
10807
16
0
1067
10814
10
0
1073
10814
—
—
22
10
751
8563
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
1.2e+00
1.9e+00
2.7e+00
—
2.6e+00
1.8e+00
1.7e+00
cases:2.68%
controls:0.83%
cases:2.31%
controls:0.37%
cases:0.83%
controls:0.06%
—
—
cases:0.84%
controls:0.06%
cases:3.09%
controls:0.51%
cases:8.28%
controls:1.68%
29
90
1054
10724
25
40
1058
10774
9
6
1074
10808
—
9
7
1060
10786
31
53
972
10344
64
144
709
8429
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
1.3e+00
1.8e+00
2.7e+00
—
2.5e+00
1.8e+00
1.6e+00
cases:2.95%
controls:0.81%
cases:2.31%
controls:0.38%
cases:0.83%
controls:0.06%
—
—
cases:0.94%
controls:0.07%
cases:3.09%
controls:0.54%
cases:8.41%
controls:1.74%
32
88
1051
10726
25
41
1058
10773
9
6
1074
10808
—
10
8
1059
10785
31
56
972
10341
65
149
708
8424
Depressive episode, unspecified
F32.9 [45571760]
4.2e+00
—
1.0e+50
1.0e+50
—
3.6e+00
3.7e+00
cases:5.17%
controls:0.08%
—
—
cases:0.55%
controls:0.00%
cases:0.55%
controls:0.00%
—
—
cases:2.49%
controls:0.07%
cases:4.27%
controls:0.10%
56
9
1027
10805
—
6
0
1077
10814
6
0
1077
10814
—
25
7
978
10390
33
9
740
8564
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
1.4e+00
1.7e+00
2.5e+00
—
2.2e+00
1.7e+00
1.7e+00
cases:4.34%
controls:1.16%
cases:2.95%
controls:0.53%
cases:1.02%
controls:0.08%
—
—
cases:1.12%
controls:0.12%
cases:3.99%
controls:0.72%
cases:11.64%
controls:2.31%
47
125
1036
10689
32
57
1051
10757
11
9
1072
10805
—
12
13
1057
10780
40
75
963
10322
90
198
683
8375
vortioxetine; oral
N06AX26 [44819158]
3.1e+00
2.5e+00
—
—
—
2.8e+00
2.9e+00
cases:1.85%
controls:0.08%
cases:1.02%
controls:0.08%
—
—
—
—
—
—
cases:1.60%
controls:0.10%
cases:3.36%
controls:0.20%
20
9
1063
10805
11
9
1072
10805
—
—
—
16
10
987
10387
26
17
747
8556
alprazolam; oral
N05BA12 [21604577]
1.7e+00
1.8e+00
2.2e+00
—
2.1e+00
1.7e+00
1.7e+00
cases:4.06%
controls:0.75%
cases:2.49%
controls:0.43%
cases:1.39%
controls:0.15%
—
—
cases:0.94%
controls:0.11%
cases:2.19%
controls:0.40%
cases:3.36%
controls:0.63%
44
81
1039
10733
27
47
1056
10767
15
16
1068
10798
—
10
12
1059
10781
22
42
981
10355
26
54
747
8519
paroxetine; oral
N06AB05 [21604713]
2.7e+00
2.8e+00
—
—
—
2.8e+00
2.9e+00
cases:2.12%
controls:0.14%
cases:1.57%
controls:0.09%
—
—
—
—
—
—
cases:1.10%
controls:0.07%
cases:1.81%
controls:0.10%
23
15
1060
10799
17
10
1066
10804
—
—
—
11
7
992
10390
14
9
759
8564
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
1.4e+00
1.7e+00
2.0e+00
—
2.4e+00
2.0e+00
1.7e+00
cases:8.96%
controls:2.38%
cases:6.00%
controls:1.17%
cases:1.11%
controls:0.15%
—
—
cases:1.78%
controls:0.17%
cases:6.88%
controls:0.97%
cases:16.95%
controls:3.72%
97
257
986
10557
65
127
1018
10687
12
16
1071
10798
—
19
18
1050
10775
69
101
934
10296
131
319
642
8254
Guidance concerning treatment of rash and skin
SPAT1156 [2001700257]
1.1e+00
1.5e+00
2.5e+00
—
2.3e+00
1.9e+00
1.7e+00
cases:3.79%
controls:1.26%
cases:1.94%
controls:0.44%
cases:1.39%
controls:0.11%
—
—
cases:1.03%
controls:0.10%
cases:3.09%
controls:0.48%
cases:7.12%
controls:1.42%
41
136
1042
10678
21
48
1062
10766
15
12
1068
10802
—
11
11
1058
10782
31
50
972
10347
55
122
718
8451
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
7.1e-01
1.1e+00
1.9e+00
2.8e+00
2.3e+00
1.3e+00
8.6e-01
cases:11.91%
controls:6.25%
cases:9.14%
controls:3.25%
cases:2.68%
controls:0.40%
cases:0.74%
controls:0.05%
cases:3.84%
controls:0.40%
cases:11.37%
controls:3.40%
cases:21.73%
controls:10.47%
129
676
954
10138
99
351
984
10463
29
43
1054
10771
8
5
1075
10809
41
43
1028
10750
114
353
889
10044
168
898
605
7675
Voluntary or Charitable Agency
251V00000X [38004202]
1.8e+00
2.8e+00
—
—
—
3.3e+00
3.0e+00
cases:0.74%
controls:0.12%
cases:1.02%
controls:0.06%
—
—
—
—
—
—
cases:1.60%
controls:0.06%
cases:4.01%
controls:0.20%
8
13
1075
10801
11
7
1072
10807
—
—
—
16
6
987
10391
31
17
742
8556
macrogol; oral
A06AD15 [21600575]
2.7e+00
2.6e+00
—
—
—
3.0e+00
2.6e+00
cases:5.36%
controls:0.38%
cases:2.77%
controls:0.21%
—
—
—
—
—
—
cases:5.38%
controls:0.28%
cases:11.25%
controls:0.93%
58
41
1025
10773
30
23
1053
10791
—
—
—
54
29
949
10368
87
80
686
8493
mirabegron; oral
G04BD12 [43534790]
1.6e+00
1.7e+00
1.9e+00
—
2.0e+00
1.7e+00
1.9e+00
cases:5.45%
controls:1.15%
cases:4.43%
controls:0.81%
cases:1.85%
controls:0.28%
—
—
cases:1.59%
controls:0.21%
cases:5.58%
controls:1.02%
cases:9.96%
controls:1.66%
59
124
1024
10690
48
88
1035
10726
20
30
1063
10784
—
17
23
1052
10770
56
106
947
10291
77
142
696
8431
Emergency Room Visit
ER [9203]
1.3e+00
1.6e+00
2.6e+00
—
2.5e+00
1.6e+00
1.3e+00
cases:53.46%
controls:23.64%
cases:31.21%
controls:8.70%
cases:13.11%
controls:1.06%
—
—
cases:9.17%
controls:0.85%
cases:31.70%
controls:8.82%
cases:56.02%
controls:24.92%
579
2556
504
8258
338
941
745
9873
142
115
941
10699
—
98
92
971
10701
318
917
685
9480
433
2136
340
6437
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
6.4e-01
1.1e+00
1.6e+00
3.5e+00
2.0e+00
1.1e+00
1.0e+00
cases:20.31%
controls:11.90%
cases:14.96%
controls:5.71%
cases:3.88%
controls:0.84%
cases:1.75%
controls:0.06%
cases:5.71%
controls:0.83%
cases:16.75%
controls:6.22%
cases:35.83%
controls:16.72%
220
1287
863
9527
162
617
921
10197
42
91
1041
10723
19
6
1064
10808
61
90
1008
10703
168
647
835
9750
277
1433
496
7140
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
4.6e-01
1.0e+00
1.6e+00
4.1e+00
1.8e+00
1.1e+00
8.0e-01
cases:30.29%
controls:21.58%
cases:29.27%
controls:13.26%
cases:11.82%
controls:2.56%
cases:9.70%
controls:0.18%
cases:14.97%
controls:2.82%
cases:31.31%
controls:13.58%
cases:50.97%
controls:31.80%
328
2334
755
8480
317
1434
766
9380
128
277
955
10537
105
20
978
10794
160
304
909
10489
314
1412
689
8985
394
2726
379
5847
Guidance concerning hydration
SPAT1172 [2001700273]
2.4e+00
2.7e+00
—
—
—
2.9e+00
2.8e+00
cases:0.74%
controls:0.06%
cases:0.92%
controls:0.06%
—
—
—
—
—
—
cases:1.79%
controls:0.10%
cases:1.81%
controls:0.12%
8
7
1075
10807
10
7
1073
10807
—
—
—
18
10
985
10387
14
10
759
8563
Incontinence urine
U04 [2002001139]
2.5e+00
2.4e+00
—
—
—
3.4e+00
2.5e+00
cases:2.95%
controls:0.25%
cases:1.11%
controls:0.10%
—
—
—
—
—
—
cases:1.69%
controls:0.06%
cases:3.88%
controls:0.33%
32
27
1051
10787
12
11
1071
10803
—
—
—
17
6
986
10391
30
28
743
8545
Provision of support and information to patient’s family members
SPAT1245 [2001700346]
2.7e+00
2.9e+00
—
—
—
2.7e+00
2.4e+00
cases:1.11%
controls:0.07%
cases:1.02%
controls:0.06%
—
—
—
—
—
—
cases:1.30%
controls:0.09%
cases:2.72%
controls:0.24%
12
8
1071
10806
11
6
1072
10808
—
—
—
13
9
990
10388
21
21
752
8552
Feeling depressed
P03 [2002000800]
2.9e+00
3.5e+00
—
—
—
2.0e+00
2.2e+00
cases:2.68%
controls:0.16%
cases:1.57%
controls:0.05%
—
—
—
—
—
—
cases:0.70%
controls:0.10%
cases:2.85%
controls:0.31%
29
17
1054
10797
17
5
1066
10809
—
—
—
7
10
996
10387
22
27
751
8546
pH of Urine
2756-5 [3015736]
6.9e-01
1.2e+00
1.9e+00
2.5e+00
2.1e+00
1.4e+00
9.0e-01
cases:10.80%
controls:5.71%
cases:9.05%
controls:2.98%
cases:2.68%
controls:0.43%
cases:0.55%
controls:0.05%
cases:3.18%
controls:0.39%
cases:11.57%
controls:3.26%
cases:21.99%
controls:10.29%
117
617
966
10197
98
322
985
10492
29
46
1054
10768
6
5
1077
10809
34
42
1035
10751
116
339
887
10058
170
882
603
7691
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
1.6e+00
2.0e+00
—
—
3.5e+00
1.7e+00
1.7e+00
cases:9.88%
controls:2.26%
cases:4.89%
controls:0.69%
—
—
—
—
cases:1.78%
controls:0.06%
cases:4.59%
controls:0.88%
cases:12.03%
controls:2.41%
107
244
976
10570
53
75
1030
10739
—
—
19
6
1050
10787
46
91
957
10306
93
207
680
8366
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
9.2e-01
1.5e+00
2.1e+00
1.0e+50
3.0e+00
1.4e+00
1.5e+00
cases:4.16%
controls:1.70%
cases:3.60%
controls:0.85%
cases:0.92%
controls:0.11%
cases:0.65%
controls:0.00%
cases:2.99%
controls:0.16%
cases:2.89%
controls:0.71%
cases:9.06%
controls:2.18%
45
184
1038
10630
39
92
1044
10722
10
12
1073
10802
7
0
1076
10814
32
17
1037
10776
29
74
974
10323
70
187
703
8386
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
6.8e-01
1.1e+00
1.7e+00
2.6e+00
2.2e+00
1.3e+00
8.6e-01
cases:13.76%
controls:7.44%
cases:11.91%
controls:4.12%
cases:3.14%
controls:0.60%
cases:0.83%
controls:0.06%
cases:4.40%
controls:0.53%
cases:14.46%
controls:4.51%
cases:26.65%
controls:13.33%
149
805
934
10009
129
446
954
10368
34
65
1049
10749
9
7
1074
10807
47
57
1022
10736
145
469
858
9928
206
1143
567
7430
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
9.9e-01
1.6e+00
1.8e+00
—
2.7e+00
1.8e+00
1.4e+00
cases:8.59%
controls:3.38%
cases:5.72%
controls:1.22%
cases:1.29%
controls:0.21%
—
—
cases:2.34%
controls:0.16%
cases:6.48%
controls:1.13%
cases:13.07%
controls:3.51%
93
365
990
10449
62
132
1021
10682
14
23
1069
10791
—
25
17
1044
10776
65
118
938
10279
101
301
672
8272
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
6.9e-01
1.1e+00
1.7e+00
2.6e+00
2.2e+00
1.3e+00
8.4e-01
cases:13.57%
controls:7.32%
cases:11.73%
controls:4.07%
cases:3.14%
controls:0.60%
cases:0.83%
controls:0.06%
cases:4.40%
controls:0.53%
cases:14.26%
controls:4.49%
cases:26.00%
controls:13.22%
147
792
936
10022
127
440
956
10374
34
65
1049
10749
9
7
1074
10807
47
57
1022
10736
143
467
860
9930
201
1133
572
7440
chlordiazepoxide; oral, parenteral
N05BA02 [21604567]
2.5e+00
2.4e+00
—
—
—
2.3e+00
3.0e+00
cases:1.11%
controls:0.09%
cases:0.74%
controls:0.06%
—
—
—
—
—
—
cases:0.60%
controls:0.06%
cases:1.16%
controls:0.06%
12
10
1071
10804
8
7
1075
10807
—
—
—
6
6
997
10391
9
5
764
8568
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
6.6e-01
1.1e+00
1.7e+00
2.6e+00
2.1e+00
1.3e+00
8.6e-01
cases:13.67%
controls:7.59%
cases:11.82%
controls:4.17%
cases:3.14%
controls:0.61%
cases:0.83%
controls:0.06%
cases:4.40%
controls:0.54%
cases:14.16%
controls:4.51%
cases:26.65%
controls:13.34%
148
821
935
9993
128
451
955
10363
34
66
1049
10748
9
7
1074
10807
47
58
1022
10735
142
469
861
9928
206
1144
567
7429
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
6.0e-01
1.1e+00
1.6e+00
3.3e+00
1.9e+00
8.6e-01
7.7e-01
cases:30.56%
controls:19.40%
cases:27.52%
controls:11.26%
cases:6.19%
controls:1.30%
cases:1.29%
controls:0.05%
cases:8.79%
controls:1.36%
cases:24.03%
controls:11.77%
cases:47.22%
controls:29.23%
331
2098
752
8716
298
1218
785
9596
67
141
1016
10673
14
5
1069
10809
94
147
975
10646
241
1224
762
9173
365
2506
408
6067
Geriatric Medicine
38 [38004478]
2.5e+00
2.8e+00
—
1.0e+50
2.1e+00
2.7e+00
2.2e+00
cases:2.59%
controls:0.22%
cases:2.31%
controls:0.14%
—
—
cases:2.03%
controls:0.00%
cases:0.47%
controls:0.06%
cases:2.59%
controls:0.17%
cases:4.27%
controls:0.50%
28
24
1055
10790
25
15
1058
10799
—
22
0
1061
10814
5
6
1064
10787
26
18
977
10379
33
43
740
8530
Bacteria identified in Blood by Culture
600-7 [3023368]
9.8e-01
1.3e+00
2.5e+00
—
2.5e+00
1.3e+00
1.6e+00
cases:7.66%
controls:3.02%
cases:4.52%
controls:1.29%
cases:1.94%
controls:0.17%
—
—
cases:3.37%
controls:0.28%
cases:5.98%
controls:1.65%
cases:19.15%
controls:4.56%
83
327
1000
10487
49
139
1034
10675
21
18
1062
10796
—
36
30
1033
10763
60
172
943
10225
148
391
625
8182
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
1.3e+00
1.8e+00
1.9e+00
—
2.7e+00
1.4e+00
1.1e+00
cases:6.93%
controls:2.04%
cases:7.20%
controls:1.21%
cases:1.20%
controls:0.18%
—
—
cases:2.71%
controls:0.19%
cases:5.68%
controls:1.53%
cases:14.23%
controls:5.31%
75
221
1008
10593
78
131
1005
10683
13
19
1070
10795
—
29
20
1040
10773
57
159
946
10238
110
455
663
8118
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
2.1e+00
2.6e+00
—
1.0e+50
—
3.2e+00
2.1e+00
cases:1.75%
controls:0.21%
cases:1.02%
controls:0.07%
—
—
cases:0.74%
controls:0.00%
—
—
cases:1.20%
controls:0.05%
cases:3.49%
controls:0.43%
19
23
1064
10791
11
8
1072
10806
—
8
0
1075
10814
—
12
5
991
10392
27
37
746
8536
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
2.4e+00
3.2e+00
—
1.0e+50
—
3.0e+00
1.6e+00
cases:2.86%
controls:0.27%
cases:1.75%
controls:0.07%
—
—
cases:0.65%
controls:0.00%
—
—
cases:1.10%
controls:0.06%
cases:1.42%
controls:0.30%
31
29
1052
10785
19
8
1064
10806
—
7
0
1076
10814
—
11
6
992
10391
11
26
762
8547
doxepin; oral, parenteral
N06AA12 [21604699]
2.4e+00
2.6e+00
—
—
—
2.3e+00
2.8e+00
cases:2.68%
controls:0.26%
cases:1.66%
controls:0.13%
—
—
—
—
—
—
cases:1.30%
controls:0.13%
cases:2.98%
controls:0.19%
29
28
1054
10786
18
14
1065
10800
—
—
—
13
13
990
10384
23
16
750
8557
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
9.7e-01
1.6e+00
2.5e+00
1.0e+50
2.5e+00
1.0e+00
1.5e+00
cases:2.95%
controls:1.15%
cases:2.31%
controls:0.49%
cases:0.65%
controls:0.06%
cases:0.92%
controls:0.00%
cases:0.56%
controls:0.05%
cases:1.50%
controls:0.54%
cases:7.24%
controls:1.67%
32
124
1051
10690
25
53
1058
10761
7
6
1076
10808
10
0
1073
10814
6
5
1063
10788
15
56
988
10341
56
143
717
8430
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
9.7e-01
1.6e+00
2.5e+00
1.0e+50
2.5e+00
1.0e+00
1.5e+00
cases:2.95%
controls:1.15%
cases:2.31%
controls:0.49%
cases:0.65%
controls:0.06%
cases:0.92%
controls:0.00%
cases:0.56%
controls:0.05%
cases:1.50%
controls:0.54%
cases:7.24%
controls:1.67%
32
124
1051
10690
25
53
1058
10761
7
6
1076
10808
10
0
1073
10814
6
5
1063
10788
15
56
988
10341
56
143
717
8430
Anxiety disorder, unspecified
F41.9 [45542849]
3.1e+00
—
—
—
1.0e+50
3.4e+00
3.5e+00
cases:2.86%
controls:0.14%
—
—
—
—
—
—
cases:0.75%
controls:0.00%
cases:1.40%
controls:0.05%
cases:3.10%
controls:0.09%
31
15
1052
10799
—
—
—
8
0
1061
10793
14
5
989
10392
24
8
749
8565
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
4.0e-01
8.2e-01
1.5e+00
4.2e+00
1.7e+00
8.0e-01
5.5e-01
cases:36.10%
controls:27.41%
cases:38.04%
controls:21.23%
cases:14.50%
controls:3.78%
cases:9.79%
controls:0.16%
cases:17.68%
controls:3.78%
cases:38.58%
controls:22.03%
cases:56.14%
controls:42.56%
391
2964
692
7850
412
2296
671
8518
157
409
926
10405
106
17
977
10797
189
408
880
10385
387
2290
616
8107
434
3649
339
4924
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]
1.3e+00
1.6e+00
2.2e+00
—
2.6e+00
1.4e+00
9.8e-01
cases:9.60%
controls:2.89%
cases:4.16%
controls:0.89%
cases:1.11%
controls:0.13%
—
—
cases:1.31%
controls:0.10%
cases:4.69%
controls:1.22%
cases:10.87%
controls:4.37%
104
313
979
10501
45
96
1038
10718
12
14
1071
10800
—
14
11
1055
10782
47
127
956
10270
84
375
689
8198
Hypo-osmolality and hyponatraemia
E87.1 [45542779]
2.6e+00
2.4e+00
—
1.0e+50
1.0e+50
2.9e+00
2.0e+00
cases:1.85%
controls:0.14%
cases:1.02%
controls:0.09%
—
—
cases:0.65%
controls:0.00%
cases:0.56%
controls:0.00%
cases:0.90%
controls:0.05%
cases:2.20%
controls:0.31%
20
15
1063
10799
11
10
1072
10804
—
7
0
1076
10814
6
0
1063
10793
9
5
994
10392
17
27
756
8546
Eosinophils [#/volume] in Blood
26449-9 [3013115]
7.5e-01
8.8e-01
1.2e+00
3.2e+00
1.9e+00
9.4e-01
9.9e-01
cases:14.77%
controls:7.60%
cases:10.90%
controls:4.85%
cases:3.23%
controls:0.96%
cases:1.39%
controls:0.06%
cases:5.24%
controls:0.84%
cases:11.57%
controls:4.84%
cases:25.23%
controls:11.16%
160
822
923
9992
118
524
965
10290
35
104
1048
10710
15
6
1068
10808
56
91
1013
10702
116
503
887
9894
195
957
578
7616
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
4.0e-01
8.1e-01
1.4e+00
4.2e+00
1.7e+00
7.7e-01
5.3e-01
cases:36.20%
controls:27.64%
cases:38.32%
controls:21.59%
cases:14.50%
controls:3.90%
cases:9.88%
controls:0.16%
cases:17.77%
controls:3.88%
cases:38.48%
controls:22.43%
cases:56.14%
controls:42.88%
392
2989
691
7825
415
2335
668
8479
157
422
926
10392
107
17
976
10797
190
419
879
10374
386
2332
617
8065
434
3676
339
4897
INR in Blood by Coagulation assay
34714-6 [3032080]
6.9e-01
9.9e-01
1.0e+00
4.1e+00
1.2e+00
9.4e-01
8.4e-01
cases:13.85%
controls:7.46%
cases:10.80%
controls:4.30%
cases:4.16%
controls:1.51%
cases:2.77%
controls:0.05%
cases:4.96%
controls:1.50%
cases:11.07%
controls:4.63%
cases:21.47%
controls:10.60%
150
807
933
10007
117
465
966
10349
45
163
1038
10651
30
5
1053
10809
53
162
1016
10631
111
481
892
9916
166
909
607
7664
Basophils [#/volume] in Blood
26444-0 [3006315]
7.3e-01
8.6e-01
1.2e+00
3.2e+00
1.8e+00
9.2e-01
1.0e+00
cases:13.94%
controls:7.21%
cases:10.34%
controls:4.65%
cases:3.14%
controls:0.92%
cases:1.29%
controls:0.06%
cases:4.96%
controls:0.83%
cases:11.07%
controls:4.72%
cases:25.10%
controls:10.79%
151
780
932
10034
112
503
971
10311
34
100
1049
10714
14
6
1069
10808
53
90
1016
10703
111
491
892
9906
194
925
579
7648
Monocytes [#/volume] in Blood
26484-6 [3001604]
7.3e-01
8.6e-01
1.2e+00
3.2e+00
1.8e+00
9.2e-01
1.0e+00
cases:13.85%
controls:7.21%
cases:10.34%
controls:4.65%
cases:3.14%
controls:0.92%
cases:1.29%
controls:0.06%
cases:4.96%
controls:0.83%
cases:11.07%
controls:4.70%
cases:24.97%
controls:10.73%
150
780
933
10034
112
503
971
10311
34
100
1049
10714
14
6
1069
10808
53
90
1016
10703
111
489
892
9908
193
920
580
7653
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
1.6e+00
1.6e+00
1.6e+00
—
1.5e+00
1.7e+00
1.8e+00
cases:3.88%
controls:0.80%
cases:2.68%
controls:0.55%
cases:0.92%
controls:0.19%
—
—
cases:1.03%
controls:0.23%
cases:3.19%
controls:0.61%
cases:7.63%
controls:1.40%
42
86
1041
10728
29
59
1054
10755
10
21
1073
10793
—
11
25
1058
10768
32
63
971
10334
59
120
714
8453
Feeling anxious/nervous/tense
P01 [2002000798]
2.8e+00
2.8e+00
—
—
—
1.8e+00
2.3e+00
cases:2.31%
controls:0.15%
cases:1.20%
controls:0.07%
—
—
—
—
—
—
cases:0.70%
controls:0.12%
cases:2.85%
controls:0.28%
25
16
1058
10798
13
8
1070
10806
—
—
—
7
12
996
10385
22
24
751
8549
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
2.9e+00
—
—
—
—
3.3e+00
3.5e+00
cases:1.85%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.30%
controls:0.05%
cases:3.62%
controls:0.12%
20
11
1063
10803
—
—
—
—
13
5
990
10392
28
10
745
8563
Cells panel - Urine sediment
58434-2 [40761535]
1.1e+00
1.6e+00
2.1e+00
—
2.0e+00
1.6e+00
1.4e+00
cases:3.88%
controls:1.38%
cases:2.68%
controls:0.55%
cases:0.65%
controls:0.08%
—
—
cases:0.65%
controls:0.09%
cases:2.69%
controls:0.54%
cases:5.69%
controls:1.53%
42
149
1041
10665
29
59
1054
10755
7
9
1076
10805
—
7
10
1062
10783
27
56
976
10341
44
131
729
8442
bupropion; oral
N06AX12 [21604741]
3.1e+00
—
—
—
—
3.8e+00
2.7e+00
cases:2.31%
controls:0.10%
—
—
—
—
—
—
—
—
cases:2.19%
controls:0.05%
cases:1.81%
controls:0.13%
25
11
1058
10803
—
—
—
—
22
5
981
10392
14
11
759
8562
Pharmacy visit
OMOP4822462 [581458]
1.1e+00
1.7e+00
1.4e+00
1.8e+00
1.1e+00
1.5e+00
9.7e-01
cases:97.41%
controls:92.45%
cases:96.49%
controls:82.88%
cases:76.36%
controls:44.90%
cases:13.11%
controls:2.45%
cases:71.38%
controls:44.96%
cases:96.11%
controls:84.38%
cases:97.93%
controls:94.73%
1055
9998
28
816
1045
8963
38
1851
827
4856
256
5958
142
265
941
10549
763
4852
306
5941
964
8773
39
1624
757
8121
16
452
Constipation
D12 [2002000311]
2.4e+00
2.5e+00
—
—
—
2.1e+00
2.7e+00
cases:1.20%
controls:0.11%
cases:0.65%
controls:0.06%
—
—
—
—
—
—
cases:0.60%
controls:0.08%
cases:2.59%
controls:0.17%
13
12
1070
10802
7
6
1076
10808
—
—
—
6
8
997
10389
20
15
753
8558
Bacteria identified in Urine by Culture
630-4 [3026008]
1.0e+00
1.5e+00
2.1e+00
—
2.3e+00
1.4e+00
1.4e+00
cases:10.25%
controls:3.93%
cases:7.85%
controls:1.92%
cases:2.49%
controls:0.32%
—
—
cases:2.90%
controls:0.31%
cases:8.18%
controls:2.17%
cases:21.99%
controls:6.49%
111
425
972
10389
85
208
998
10606
27
35
1056
10779
—
31
33
1038
10760
82
226
921
10171
170
556
603
8017
Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]
1.5e+00
1.5e+00
2.1e+00
1.0e+50
1.8e+00
1.6e+00
1.1e+00
cases:4.06%
controls:0.98%
cases:2.40%
controls:0.53%
cases:0.74%
controls:0.09%
cases:0.74%
controls:0.00%
cases:0.75%
controls:0.12%
cases:2.59%
controls:0.55%
cases:5.43%
controls:1.81%
44
106
1039
10708
26
57
1057
10757
8
10
1075
10804
8
0
1075
10814
8
13
1061
10780
26
57
977
10340
42
155
731
8418
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
7.1e-01
8.1e-01
1.2e+00
3.2e+00
1.8e+00
8.9e-01
9.7e-01
cases:14.22%
controls:7.54%
cases:10.43%
controls:4.92%
cases:3.23%
controls:0.96%
cases:1.29%
controls:0.06%
cases:5.05%
controls:0.88%
cases:11.27%
controls:4.96%
cases:25.10%
controls:11.29%
154
815
929
9999
113
532
970
10282
35
104
1048
10710
14
6
1069
10808
54
95
1015
10698
113
516
890
9881
194
968
579
7605
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
1.0e+00
1.5e+00
2.5e+00
—
2.0e+00
1.4e+00
1.1e+00
cases:12.83%
controls:5.06%
cases:9.42%
controls:2.30%
cases:3.42%
controls:0.30%
—
—
cases:2.53%
controls:0.33%
cases:9.67%
controls:2.50%
cases:20.70%
controls:8.03%
139
547
944
10267
102
249
981
10565
37
32
1046
10782
—
27
36
1042
10757
97
260
906
10137
160
688
613
7885
Treatment of a patient needing special arrangements
WYA30 [2001310874]
2.1e+00
2.2e+00
—
—
—
2.5e+00
2.7e+00
cases:2.86%
controls:0.35%
cases:1.02%
controls:0.11%
—
—
—
—
—
—
cases:1.99%
controls:0.17%
cases:6.08%
controls:0.43%
31
38
1052
10776
11
12
1072
10802
—
—
—
20
18
983
10379
47
37
726
8536
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1.0e+00
1.5e+00
1.9e+00
—
2.3e+00
1.4e+00
1.4e+00
cases:15.42%
controls:6.09%
cases:13.11%
controls:3.36%
cases:3.51%
controls:0.55%
—
—
cases:6.45%
controls:0.67%
cases:12.76%
controls:3.42%
cases:27.17%
controls:8.67%
167
659
916
10155
142
363
941
10451
38
60
1045
10754
—
69
72
1000
10721
128
356
875
10041
210
743
563
7830
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
1.0e+00
1.5e+00
1.9e+00
—
2.4e+00
1.4e+00
1.2e+00
cases:16.44%
controls:6.75%
cases:15.51%
controls:3.89%
cases:4.52%
controls:0.68%
—
—
cases:8.14%
controls:0.78%
cases:14.66%
controls:3.97%
cases:28.07%
controls:10.60%
178
730
905
10084
168
421
915
10393
49
73
1034
10741
—
87
84
982
10709
147
413
856
9984
217
909
556
7664
Social worker
Z2446 [2001311559]
2.1e+00
2.5e+00
—
—
1.0e+50
2.6e+00
2.3e+00
cases:2.40%
controls:0.30%
cases:1.39%
controls:0.12%
—
—
—
—
cases:0.47%
controls:0.00%
cases:1.69%
controls:0.13%
cases:3.23%
controls:0.34%
26
32
1057
10782
15
13
1068
10801
—
—
5
0
1064
10793
17
13
986
10384
25
29
748
8544
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
1.3e+00
1.7e+00
—
—
3.2e+00
1.8e+00
1.5e+00
cases:2.77%
controls:0.76%
cases:1.66%
controls:0.30%
—
—
—
—
cases:1.31%
controls:0.06%
cases:1.69%
controls:0.30%
cases:4.01%
controls:0.97%
30
82
1053
10732
18
32
1065
10782
—
—
14
6
1055
10787
17
31
986
10366
31
83
742
8490
Assessment of need for aid
SPAT1229 [2001700330]
2.1e+00
2.2e+00
—
—
—
2.7e+00
2.4e+00
cases:2.68%
controls:0.32%
cases:1.11%
controls:0.13%
—
—
—
—
—
—
cases:2.29%
controls:0.15%
cases:5.43%
controls:0.54%
29
35
1054
10779
12
14
1071
10800
—
—
—
23
16
980
10381
42
46
731
8527
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
6.7e-01
1.4e+00
2.9e+00
1.0e+50
2.5e+00
1.4e+00
1.2e+00
cases:1.39%
controls:0.71%
cases:1.57%
controls:0.41%
cases:1.02%
controls:0.06%
cases:0.55%
controls:0.00%
cases:0.75%
controls:0.06%
cases:1.89%
controls:0.46%
cases:5.43%
controls:1.71%
15
77
1068
10737
17
44
1066
10770
11
6
1072
10808
6
0
1077
10814
8
7
1061
10786
19
48
984
10349
42
147
731
8426
pregabalin; oral
N02BF02 [955152]
1.3e+00
1.4e+00
1.6e+00
—
1.6e+00
1.7e+00
1.6e+00
cases:6.74%
controls:1.88%
cases:3.79%
controls:0.92%
cases:1.57%
controls:0.32%
—
—
cases:1.12%
controls:0.22%
cases:4.39%
controls:0.84%
cases:9.57%
controls:2.02%
73
203
1010
10611
41
99
1042
10715
17
35
1066
10779
—
12
24
1057
10769
44
87
959
10310
74
173
699
8400
Counselling and guidance related to physical exercise
SPAT1305 [2001700406]
1.2e+00
1.9e+00
2.5e+00
—
—
2.1e+00
1.6e+00
cases:2.59%
controls:0.79%
cases:1.66%
controls:0.25%
cases:0.55%
controls:0.05%
—
—
—
—
cases:2.29%
controls:0.29%
cases:4.14%
controls:0.85%
28
85
1055
10729
18
27
1065
10787
6
5
1077
10809
—
—
23
30
980
10367
32
73
741
8500
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
7.4e-01
8.9e-01
1.2e+00
2.9e+00
1.6e+00
9.7e-01
9.8e-01
cases:17.27%
controls:9.09%
cases:13.57%
controls:6.05%
cases:5.17%
controls:1.54%
cases:1.75%
controls:0.10%
cases:6.74%
controls:1.42%
cases:14.46%
controls:6.01%
cases:27.81%
controls:12.66%
187
983
896
9831
147
654
936
10160
56
167
1027
10647
19
11
1064
10803
72
153
997
10640
145
625
858
9772
215
1085
558
7488
Monocytes/Leukocytes in Blood
26485-3 [3019069]
7.1e-01
7.5e-01
1.2e+00
3.2e+00
1.7e+00
8.1e-01
8.9e-01
cases:13.20%
controls:6.99%
cases:8.86%
controls:4.37%
cases:3.05%
controls:0.91%
cases:1.29%
controls:0.06%
cases:4.49%
controls:0.82%
cases:9.37%
controls:4.40%
cases:21.22%
controls:9.94%
143
756
940
10058
96
473
987
10341
33
98
1050
10716
14
6
1069
10808
48
89
1021
10704
94
457
909
9940
164
852
609
7721
magnesium hydroxide; oral
G04BX01 [21602658]
1.8e+00
2.9e+00
—
—
1.0e+50
2.3e+00
2.2e+00
cases:1.29%
controls:0.22%
cases:1.02%
controls:0.06%
—
—
—
—
cases:0.47%
controls:0.00%
cases:1.00%
controls:0.10%
cases:2.59%
controls:0.28%
14
24
1069
10790
11
6
1072
10808
—
—
5
0
1064
10793
10
10
993
10387
20
24
753
8549
magnesium hydroxide; oral
A02AA04 [21600052]
1.8e+00
2.9e+00
—
—
1.0e+50
2.3e+00
2.2e+00
cases:1.29%
controls:0.22%
cases:1.02%
controls:0.06%
—
—
—
—
cases:0.47%
controls:0.00%
cases:1.00%
controls:0.10%
cases:2.59%
controls:0.28%
14
24
1069
10790
11
6
1072
10808
—
—
5
0
1064
10793
10
10
993
10387
20
24
753
8549
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
1.1e+00
1.6e+00
2.0e+00
—
2.4e+00
1.1e+00
1.0e+00
cases:15.79%
controls:5.79%
cases:12.56%
controls:2.90%
cases:2.22%
controls:0.30%
—
—
cases:3.27%
controls:0.30%
cases:9.07%
controls:3.19%
cases:23.80%
controls:10.12%
171
626
912
10188
136
314
947
10500
24
32
1059
10782
—
35
32
1034
10761
91
332
912
10065
184
868
589
7705
Basophils/Leukocytes in Blood
30180-4 [3022096]
6.7e-01
7.6e-01
1.2e+00
3.2e+00
1.7e+00
8.4e-01
8.7e-01
cases:12.83%
controls:6.98%
cases:8.96%
controls:4.40%
cases:3.05%
controls:0.90%
cases:1.29%
controls:0.06%
cases:4.49%
controls:0.83%
cases:9.57%
controls:4.38%
cases:20.83%
controls:9.95%
139
755
944
10059
97
476
986
10338
33
97
1050
10717
14
6
1069
10808
48
90
1021
10703
96
455
907
9942
161
853
612
7720
Memory disturbance
P20 [2002000816]
2.6e+00
2.7e+00
—
—
—
2.1e+00
1.8e+00
cases:6.56%
controls:0.53%
cases:4.71%
controls:0.32%
—
—
—
—
—
—
cases:3.29%
controls:0.40%
cases:7.24%
controls:1.25%
71
57
1012
10757
51
35
1032
10779
—
—
—
33
42
970
10355
56
107
717
8466
Dysphagia
R13 [45573013]
1.9e+00
3.0e+00
—
—
—
2.7e+00
1.7e+00
cases:2.12%
controls:0.33%
cases:1.29%
controls:0.06%
—
—
—
—
—
—
cases:1.30%
controls:0.09%
cases:2.46%
controls:0.48%
23
36
1060
10778
14
7
1069
10807
—
—
—
13
9
990
10388
19
41
754
8532
Base excess in Arterial blood by calculation
1925-7 [3003396]
9.8e-01
1.5e+00
2.6e+00
1.0e+50
2.7e+00
9.6e-01
1.5e+00
cases:2.95%
controls:1.13%
cases:2.31%
controls:0.51%
cases:0.74%
controls:0.06%
cases:1.11%
controls:0.00%
cases:0.65%
controls:0.05%
cases:1.50%
controls:0.58%
cases:7.24%
controls:1.74%
32
122
1051
10692
25
55
1058
10759
8
6
1075
10808
12
0
1071
10814
7
5
1062
10788
15
60
988
10337
56
149
717
8424
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
7.0e-01
7.4e-01
1.2e+00
3.2e+00
1.7e+00
8.0e-01
8.7e-01
cases:13.11%
controls:7.00%
cases:8.77%
controls:4.39%
cases:3.05%
controls:0.91%
cases:1.29%
controls:0.06%
cases:4.49%
controls:0.82%
cases:9.27%
controls:4.39%
cases:20.83%
controls:9.90%
142
757
941
10057
95
475
988
10339
33
98
1050
10716
14
6
1069
10808
48
89
1021
10704
93
456
910
9941
161
849
612
7724
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
9.9e-01
1.5e+00
2.6e+00
1.0e+50
1.6e+00
1.6e+00
9.9e-01
cases:7.11%
controls:2.76%
cases:5.26%
controls:1.26%
cases:1.75%
controls:0.14%
cases:0.46%
controls:0.00%
cases:0.84%
controls:0.18%
cases:4.89%
controls:0.98%
cases:7.24%
controls:2.82%
77
299
1006
10515
57
136
1026
10678
19
15
1064
10799
5
0
1078
10814
9
19
1060
10774
49
102
954
10295
56
242
717
8331
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
9.6e-01
1.5e+00
1.8e+00
—
2.4e+00
1.5e+00
1.0e+00
cases:10.25%
controls:4.18%
cases:8.59%
controls:2.06%
cases:2.12%
controls:0.36%
—
—
cases:3.37%
controls:0.31%
cases:10.07%
controls:2.41%
cases:16.95%
controls:6.94%
111
452
972
10362
93
223
990
10591
23
39
1060
10775
—
36
33
1033
10760
101
251
902
10146
131
595
642
7978
Emergency Medicine
93 [38004510]
9.1e-01
1.4e+00
2.4e+00
—
2.1e+00
1.3e+00
9.9e-01
cases:19.67%
controls:9.01%
cases:17.17%
controls:4.65%
cases:6.93%
controls:0.66%
—
—
cases:4.77%
controls:0.62%
cases:16.95%
controls:5.19%
cases:32.21%
controls:14.98%
213
974
870
9840
186
503
897
10311
75
71
1008
10743
—
51
67
1018
10726
170
540
833
9857
249
1284
524
7289
Specific gravity of Urine by Refractometry
5810-7 [3019150]
9.2e-01
1.4e+00
2.1e+00
—
2.3e+00
1.5e+00
1.0e+00
cases:8.40%
controls:3.53%
cases:7.02%
controls:1.86%
cases:2.03%
controls:0.26%
—
—
cases:2.34%
controls:0.25%
cases:8.67%
controls:2.06%
cases:16.43%
controls:6.71%
91
382
992
10432
76
201
1007
10613
22
28
1061
10786
—
25
27
1044
10766
87
214
916
10183
127
575
646
7998
Normoblasts [#/volume] in Blood
715-3 [3021589]
5.8e-01
7.3e-01
1.2e+00
3.6e+00
1.8e+00
5.5e-01
6.9e-01
cases:11.54%
controls:6.82%
cases:11.27%
controls:5.75%
cases:3.88%
controls:1.15%
cases:2.22%
controls:0.06%
cases:6.55%
controls:1.18%
cases:10.07%
controls:6.04%
cases:19.28%
controls:10.70%
125
737
958
10077
122
622
961
10192
42
124
1041
10690
24
7
1059
10807
70
127
999
10666
101
628
902
9769
149
917
624
7656
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
6.7e-01
7.6e-01
1.2e+00
3.2e+00
1.6e+00
7.9e-01
8.7e-01
cases:13.02%
controls:7.09%
cases:9.14%
controls:4.48%
cases:2.95%
controls:0.89%
cases:1.29%
controls:0.06%
cases:4.21%
controls:0.84%
cases:9.47%
controls:4.54%
cases:21.22%
controls:10.18%
141
767
942
10047
99
484
984
10330
32
96
1051
10718
14
6
1069
10808
45
91
1024
10702
95
472
908
9925
164
873
609
7700
pH of Arterial blood
2744-1 [3019977]
9.3e-01
1.6e+00
2.5e+00
1.0e+50
2.7e+00
8.7e-01
1.5e+00
cases:2.86%
controls:1.15%
cases:2.40%
controls:0.51%
cases:0.65%
controls:0.06%
cases:1.02%
controls:0.00%
cases:0.65%
controls:0.05%
cases:1.30%
controls:0.55%
cases:7.12%
controls:1.73%
31
124
1052
10690
26
55
1057
10759
7
6
1076
10808
11
0
1072
10814
7
5
1062
10788
13
57
990
10340
55
148
718
8425
pH of Serum or Plasma
2753-2 [3018418]
1.0e+00
1.4e+00
1.7e+00
—
2.3e+00
1.4e+00
1.2e+00
cases:9.79%
controls:3.68%
cases:8.40%
controls:2.15%
cases:2.03%
controls:0.39%
—
—
cases:4.12%
controls:0.44%
cases:8.37%
controls:2.13%
cases:17.08%
controls:5.86%
106
398
977
10416
91
233
992
10581
22
42
1061
10772
—
44
47
1025
10746
84
221
919
10176
132
502
641
8071
Insertion of urinary catheter
SPAT1167 [2001700268]
2.5e+00
2.0e+00
—
—
—
2.3e+00
2.2e+00
cases:1.11%
controls:0.09%
cases:0.55%
controls:0.07%
—
—
—
—
—
—
cases:0.90%
controls:0.09%
cases:2.07%
controls:0.24%
12
10
1071
10804
6
8
1077
10806
—
—
—
9
9
994
10388
16
21
757
8552
CBC panel - Blood by Automated count
58410-2 [40761511]
3.0e-01
7.1e-01
1.4e+00
3.7e+00
1.6e+00
7.3e-01
4.8e-01
cases:31.76%
controls:25.59%
cases:29.18%
controls:16.87%
cases:10.62%
controls:2.84%
cases:5.91%
controls:0.15%
cases:12.72%
controls:2.77%
cases:29.31%
controls:16.60%
cases:48.64%
controls:37.02%
344
2767
739
8047
316
1824
767
8990
115
307
968
10507
64
16
1019
10798
136
299
933
10494
294
1726
709
8671
376
3174
397
5399
Assessment of need for rehabilitation and/or rehabilitation plan
SPAT1220 [2001700321]
1.4e+00
2.2e+00
—
—
—
2.9e+00
2.5e+00
cases:2.40%
controls:0.59%
cases:1.57%
controls:0.18%
—
—
—
—
—
—
cases:1.99%
controls:0.12%
cases:4.14%
controls:0.35%
26
64
1057
10750
17
20
1066
10794
—
—
—
20
12
983
10385
32
30
741
8543
Supplier / Service Provider
OMOP5117446 [33004]
-2.3e-01
-3.8e-01
—
—
2.5e+00
2.7e+00
3.7e+00
cases:18.10%
controls:21.81%
cases:4.25%
controls:6.09%
—
—
—
—
cases:0.56%
controls:0.05%
cases:4.29%
controls:0.30%
cases:18.37%
controls:0.56%
196
2359
887
8455
46
659
1037
10155
—
—
6
5
1063
10788
43
31
960
10366
142
48
631
8525
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
6.4e-01
7.4e-01
1.2e+00
2.9e+00
1.7e+00
8.0e-01
8.8e-01
cases:12.83%
controls:7.19%
cases:9.05%
controls:4.53%
cases:3.05%
controls:0.92%
cases:1.20%
controls:0.06%
cases:4.40%
controls:0.87%
cases:9.67%
controls:4.61%
cases:21.99%
controls:10.49%
139
778
944
10036
98
490
985
10324
33
99
1050
10715
13
7
1070
10807
47
94
1022
10699
97
479
906
9918
170
899
603
7674
Assessment of need for services (elderly/care support)
SPAT1217 [2001700318]
2.2e+00
2.3e+00
—
—
—
2.3e+00
2.0e+00
cases:2.12%
controls:0.23%
cases:1.48%
controls:0.15%
—
—
—
—
—
—
cases:2.39%
controls:0.24%
cases:4.40%
controls:0.63%
23
25
1060
10789
16
16
1067
10798
—
—
—
24
25
979
10372
34
54
739
8519
clopidogrel; oral
B01AC04 [21600989]
9.7e-01
1.6e+00
1.7e+00
—
1.7e+00
1.9e+00
9.9e-01
cases:4.89%
controls:1.91%
cases:3.97%
controls:0.87%
cases:1.57%
controls:0.30%
—
—
cases:1.31%
controls:0.23%
cases:5.08%
controls:0.79%
cases:5.17%
controls:1.99%
53
207
1030
10607
43
94
1040
10720
17
32
1066
10782
—
14
25
1055
10768
51
82
952
10315
40
171
733
8402
Open wound of scalp
S01.0 [45592468]
2.3e+00
2.7e+00
—
—
—
2.1e+00
1.7e+00
cases:2.59%
controls:0.28%
cases:1.20%
controls:0.08%
—
—
—
—
—
—
cases:0.90%
controls:0.11%
cases:3.23%
controls:0.59%
28
30
1055
10784
13
9
1070
10805
—
—
—
9
11
994
10386
25
51
748
8522
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
3.2e-01
6.8e-01
1.3e+00
3.8e+00
1.5e+00
6.7e-01
3.9e-01
cases:36.84%
controls:29.79%
cases:39.70%
controls:24.93%
cases:16.07%
controls:4.81%
cases:9.79%
controls:0.23%
cases:19.46%
controls:4.91%
cases:40.08%
controls:25.56%
cases:56.27%
controls:46.46%
399
3222
684
7592
430
2696
653
8118
174
520
909
10294
106
25
977
10789
208
530
861
10263
402
2657
601
7740
435
3983
338
4590
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
8.6e-01
1.2e+00
2.1e+00
—
2.2e+00
1.2e+00
1.1e+00
cases:18.28%
controls:8.61%
cases:12.00%
controls:4.00%
cases:3.97%
controls:0.48%
—
—
cases:4.21%
controls:0.47%
cases:12.36%
controls:3.99%
cases:30.40%
controls:12.92%
198
931
885
9883
130
433
953
10381
43
52
1040
10762
—
45
51
1024
10742
124
415
879
9982
235
1108
538
7465
Other specified urinary incontinence
N39.4 [45577525]
2.2e+00
2.4e+00
—
—
—
2.0e+00
2.1e+00
cases:4.16%
controls:0.48%
cases:2.49%
controls:0.22%
—
—
—
—
—
—
cases:1.99%
controls:0.29%
cases:5.95%
controls:0.75%
45
52
1038
10762
27
24
1056
10790
—
—
—
20
30
983
10367
46
64
727
8509
Pneumonia, unspecified
J18.9 [45601123]
1.1e+00
1.1e+00
2.1e+00
—
1.7e+00
1.4e+00
1.4e+00
cases:7.66%
controls:2.73%
cases:3.32%
controls:1.13%
cases:1.29%
controls:0.17%
—
—
cases:1.31%
controls:0.25%
cases:5.28%
controls:1.42%
cases:16.56%
controls:4.46%
83
295
1000
10519
36
122
1047
10692
14
18
1069
10796
—
14
27
1055
10766
53
148
950
10249
128
382
645
8191
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
1.1e+00
1.5e+00
—
—
2.9e+00
2.0e+00
1.2e+00
cases:2.86%
controls:1.01%
cases:2.03%
controls:0.47%
—
—
—
—
cases:1.50%
controls:0.08%
cases:3.19%
controls:0.43%
cases:4.66%
controls:1.40%
31
109
1052
10705
22
51
1061
10763
—
—
16
9
1053
10784
32
45
971
10352
36
120
737
8453
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
8.1e-01
1.2e+00
2.6e+00
1.0e+50
1.9e+00
1.1e+00
1.2e+00
cases:2.77%
controls:1.26%
cases:2.40%
controls:0.76%
cases:1.29%
controls:0.10%
cases:0.46%
controls:0.00%
cases:0.65%
controls:0.10%
cases:2.19%
controls:0.77%
cases:7.50%
controls:2.34%
30
136
1053
10678
26
82
1057
10732
14
11
1069
10803
5
0
1078
10814
7
11
1062
10782
22
80
981
10317
58
201
715
8372
Osmolality of Urine
2695-5 [3026782]
8.3e-01
1.0e+00
2.0e+00
—
2.4e+00
1.2e+00
1.2e+00
cases:6.74%
controls:3.07%
cases:3.69%
controls:1.33%
cases:1.20%
controls:0.17%
—
—
cases:1.68%
controls:0.15%
cases:3.99%
controls:1.25%
cases:11.64%
controls:3.90%
73
332
1010
10482
40
144
1043
10670
13
18
1070
10796
—
18
16
1051
10777
40
130
963
10267
90
334
683
8239
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1.1e+00
1.2e+00
1.9e+00
—
2.1e+00
1.2e+00
1.1e+00
cases:10.06%
controls:3.64%
cases:5.26%
controls:1.62%
cases:1.39%
controls:0.21%
—
—
cases:1.96%
controls:0.24%
cases:5.88%
controls:1.84%
cases:16.56%
controls:5.91%
109
394
974
10420
57
175
1026
10639
15
23
1068
10791
—
21
26
1048
10767
59
191
944
10206
128
507
645
8066
Base excess in Venous blood by calculation
1927-3 [3002032]
6.7e-01
1.2e+00
2.6e+00
1.0e+50
2.4e+00
1.2e+00
1.3e+00
cases:1.75%
controls:0.91%
cases:1.75%
controls:0.54%
cases:1.29%
controls:0.10%
cases:0.55%
controls:0.00%
cases:0.94%
controls:0.08%
cases:1.99%
controls:0.61%
cases:6.60%
controls:1.95%
19
98
1064
10716
19
58
1064
10756
14
11
1069
10803
6
0
1077
10814
10
9
1059
10784
20
63
983
10334
51
167
722
8406
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
2.2e-01
6.4e-01
1.3e+00
3.9e+00
1.5e+00
6.5e-01
3.4e-01
cases:36.84%
controls:31.87%
cases:40.63%
controls:26.43%
cases:16.99%
controls:5.11%
cases:9.88%
controls:0.23%
cases:20.58%
controls:5.22%
cases:41.18%
controls:26.85%
cases:57.18%
controls:48.85%
399
3446
684
7368
440
2858
643
7956
184
553
899
10261
107
25
976
10789
220
563
849
10230
413
2792
590
7605
442
4188
331
4385
MCH [Entitic mass]
28539-5 [3035941]
2.2e-01
6.5e-01
1.3e+00
3.9e+00
1.5e+00
6.5e-01
3.3e-01
cases:36.84%
controls:31.79%
cases:40.72%
controls:26.39%
cases:16.99%
controls:5.12%
cases:9.88%
controls:0.23%
cases:20.39%
controls:5.21%
cases:41.28%
controls:26.83%
cases:57.05%
controls:48.82%
399
3438
684
7376
441
2854
642
7960
184
554
899
10260
107
25
976
10789
218
562
851
10231
414
2789
589
7608
441
4185
332
4388
Leukocytes [#/volume] in Blood
26464-8 [3010813]
2.3e-01
6.5e-01
1.3e+00
3.9e+00
1.5e+00
6.4e-01
3.3e-01
cases:37.03%
controls:31.89%
cases:40.72%
controls:26.43%
cases:16.99%
controls:5.14%
cases:9.88%
controls:0.23%
cases:20.49%
controls:5.23%
cases:41.18%
controls:26.88%
cases:57.05%
controls:48.92%
401
3449
682
7365
441
2858
642
7956
184
556
899
10258
107
25
976
10789
219
564
850
10229
413
2795
590
7602
441
4194
332
4379
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
7.1e-01
1.2e+00
2.6e+00
1.0e+50
2.4e+00
1.2e+00
1.2e+00
cases:1.85%
controls:0.92%
cases:1.75%
controls:0.55%
cases:1.29%
controls:0.10%
cases:0.55%
controls:0.00%
cases:0.94%
controls:0.08%
cases:1.99%
controls:0.60%
cases:6.34%
controls:2.02%
20
99
1063
10715
19
59
1064
10755
14
11
1069
10803
6
0
1077
10814
10
9
1059
10784
20
62
983
10335
49
173
724
8400
Other function in accordance with physical therapy nomenclature
SPAT1295 [2001700396]
1.6e+00
2.5e+00
—
—
—
2.5e+00
2.0e+00
cases:1.39%
controls:0.30%
cases:1.11%
controls:0.09%
—
—
—
—
—
—
cases:1.10%
controls:0.09%
cases:2.46%
controls:0.35%
15
32
1068
10782
12
10
1071
10804
—
—
—
11
9
992
10388
19
30
754
8543
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
7.4e-01
1.2e+00
1.9e+00
1.0e+50
2.1e+00
1.3e+00
1.2e+00
cases:6.00%
controls:2.96%
cases:4.52%
controls:1.37%
cases:1.02%
controls:0.15%
cases:0.65%
controls:0.00%
cases:1.87%
controls:0.23%
cases:4.99%
controls:1.39%
cases:12.81%
controls:4.11%
65
320
1018
10494
49
148
1034
10666
11
16
1072
10798
7
0
1076
10814
20
25
1049
10768
50
145
953
10252
99
352
674
8221
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
9.8e-01
9.6e-01
2.9e+00
1.0e+50
2.7e+00
1.0e+00
9.7e-01
cases:3.60%
controls:1.39%
cases:1.20%
controls:0.46%
cases:0.83%
controls:0.05%
cases:1.39%
controls:0.00%
cases:0.65%
controls:0.05%
cases:1.50%
controls:0.53%
cases:4.79%
controls:1.87%
39
150
1044
10664
13
50
1070
10764
9
5
1074
10809
15
0
1068
10814
7
5
1062
10788
15
55
988
10342
37
160
736
8413
Platelets [#/volume] in Blood
26515-7 [3007461]
2.2e-01
6.5e-01
1.3e+00
3.8e+00
1.5e+00
6.5e-01
3.3e-01
cases:36.75%
controls:31.76%
cases:40.63%
controls:26.35%
cases:16.99%
controls:5.12%
cases:9.88%
controls:0.24%
cases:20.39%
controls:5.21%
cases:41.28%
controls:26.79%
cases:57.05%
controls:48.77%
398
3434
685
7380
440
2850
643
7964
184
554
899
10260
107
26
976
10788
218
562
851
10231
414
2785
589
7612
441
4181
332
4392
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
2.2e-01
6.5e-01
1.3e+00
3.8e+00
1.5e+00
6.5e-01
3.3e-01
cases:36.84%
controls:31.87%
cases:40.81%
controls:26.44%
cases:16.99%
controls:5.12%
cases:9.88%
controls:0.24%
cases:20.39%
controls:5.21%
cases:41.28%
controls:26.84%
cases:57.05%
controls:48.86%
399
3446
684
7368
442
2859
641
7955
184
554
899
10260
107
26
976
10788
218
562
851
10231
414
2791
589
7606
441
4189
332
4384
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
2.2e-01
6.5e-01
1.3e+00
3.8e+00
1.5e+00
6.5e-01
3.3e-01
cases:36.84%
controls:31.85%
cases:40.72%
controls:26.39%
cases:16.99%
controls:5.11%
cases:9.88%
controls:0.24%
cases:20.39%
controls:5.21%
cases:41.28%
controls:26.84%
cases:56.92%
controls:48.83%
399
3444
684
7370
441
2854
642
7960
184
553
899
10261
107
26
976
10788
218
562
851
10231
414
2791
589
7606
440
4186
333
4387
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
2.2e-01
6.4e-01
1.3e+00
3.8e+00
1.5e+00
6.5e-01
3.3e-01
cases:36.93%
controls:31.89%
cases:40.72%
controls:26.51%
cases:16.99%
controls:5.15%
cases:9.88%
controls:0.24%
cases:20.39%
controls:5.21%
cases:41.28%
controls:26.91%
cases:57.05%
controls:48.90%
400
3449
683
7365
441
2867
642
7947
184
557
899
10257
107
26
976
10788
218
562
851
10231
414
2798
589
7599
441
4192
332
4381
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
1.2e+00
1.0e+00
1.8e+00
—
2.4e+00
1.1e+00
1.1e+00
cases:4.52%
controls:1.46%
cases:2.59%
controls:0.96%
cases:1.02%
controls:0.18%
—
—
cases:2.25%
controls:0.21%
cases:2.69%
controls:0.92%
cases:7.24%
controls:2.46%
49
158
1034
10656
28
104
1055
10710
11
19
1072
10795
—
24
23
1045
10770
27
96
976
10301
56
211
717
8362
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6.9e-01
8.8e-01
9.6e-01
2.7e+00
1.5e+00
8.0e-01
9.8e-01
cases:25.12%
controls:14.37%
cases:19.67%
controls:9.18%
cases:4.71%
controls:1.85%
cases:1.85%
controls:0.13%
cases:7.86%
controls:1.83%
cases:19.04%
controls:9.52%
cases:40.62%
controls:20.45%
272
1554
811
9260
213
993
870
9821
51
200
1032
10614
20
14
1063
10800
84
197
985
10596
191
990
812
9407
314
1753
459
6820
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
8.2e-01
1.1e+00
2.0e+00
—
2.1e+00
1.2e+00
1.2e+00
cases:11.36%
controls:5.34%
cases:7.39%
controls:2.51%
cases:2.40%
controls:0.33%
—
—
cases:2.81%
controls:0.34%
cases:9.07%
controls:2.79%
cases:20.83%
controls:7.68%
123
578
960
10236
80
271
1003
10543
26
36
1057
10778
—
30
37
1039
10756
91
290
912
10107
161
658
612
7915
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
1.2e+00
1.5e+00
1.5e+00
—
1.6e+00
1.3e+00
1.2e+00
cases:12.37%
controls:4.10%
cases:9.23%
controls:2.20%
cases:1.66%
controls:0.38%
—
—
cases:2.34%
controls:0.50%
cases:7.78%
controls:2.22%
cases:19.40%
controls:6.58%
134
443
949
10371
100
238
983
10576
18
41
1065
10773
—
25
54
1044
10739
78
231
925
10166
150
564
623
8009
pH of Specimen
17433-4 [3019225]
6.7e-01
1.2e+00
1.6e+00
1.0e+50
2.3e+00
1.0e+00
1.4e+00
cases:3.14%
controls:1.63%
cases:2.77%
controls:0.82%
cases:0.74%
controls:0.15%
cases:0.46%
controls:0.00%
cases:1.68%
controls:0.17%
cases:2.39%
controls:0.87%
cases:5.69%
controls:1.49%
34
176
1049
10638
30
89
1053
10725
8
16
1075
10798
5
0
1078
10814
18
18
1051
10775
24
90
979
10307
44
128
729
8445
Outpatient Hospital
22 [8756]
9.1e-01
1.0e+00
1.6e+00
—
2.2e+00
1.3e+00
1.1e+00
cases:37.67%
controls:19.62%
cases:15.97%
controls:6.25%
cases:4.06%
controls:0.85%
—
—
cases:6.55%
controls:0.76%
cases:19.84%
controls:6.03%
cases:37.90%
controls:16.52%
408
2122
675
8692
173
676
910
10138
44
92
1039
10722
—
70
82
999
10711
199
627
804
9770
293
1416
480
7157
Physiotherapist
Z3226 [2001311560]
1.2e+00
1.7e+00
—
—
2.2e+00
1.8e+00
1.2e+00
cases:5.17%
controls:1.62%
cases:2.12%
controls:0.41%
—
—
—
—
cases:0.75%
controls:0.08%
cases:2.99%
controls:0.49%
cases:5.30%
controls:1.62%
56
175
1027
10639
23
44
1060
10770
—
—
8
9
1061
10784
30
51
973
10346
41
139
732
8434
Cystitis, unspecified
N30.9 [45606488]
1.4e+00
2.5e+00
—
—
—
2.5e+00
1.6e+00
cases:1.48%
controls:0.36%
cases:0.92%
controls:0.07%
—
—
—
—
—
—
cases:1.30%
controls:0.11%
cases:2.20%
controls:0.45%
16
39
1067
10775
10
8
1073
10806
—
—
—
13
11
990
10386
17
39
756
8534
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
6.1e-01
6.9e-01
7.8e-01
2.8e+00
1.4e+00
8.2e-01
9.8e-01
cases:13.39%
controls:7.78%
cases:8.68%
controls:4.57%
cases:2.31%
controls:1.07%
cases:1.39%
controls:0.08%
cases:3.84%
controls:1.02%
cases:9.77%
controls:4.55%
cases:24.97%
controls:11.12%
145
841
938
9973
94
494
989
10320
25
116
1058
10698
15
9
1068
10805
41
110
1028
10683
98
473
905
9924
193
953
580
7620
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
2.9e-01
5.8e-01
1.1e+00
3.8e+00
1.4e+00
5.1e-01
3.3e-01
cases:24.56%
controls:19.52%
cases:25.67%
controls:16.15%
cases:9.23%
controls:3.26%
cases:6.83%
controls:0.17%
cases:12.82%
controls:3.35%
cases:24.83%
controls:16.56%
cases:38.29%
controls:30.90%
266
2111
817
8703
278
1747
805
9067
100
352
983
10462
74
18
1009
10796
137
362
932
10431
249
1722
754
8675
296
2649
477
5924
pH of Venous blood
2746-6 [3012544]
7.0e-01
1.1e+00
2.5e+00
1.0e+50
2.2e+00
1.1e+00
1.2e+00
cases:1.85%
controls:0.92%
cases:1.66%
controls:0.56%
cases:1.20%
controls:0.10%
cases:0.55%
controls:0.00%
cases:0.75%
controls:0.08%
cases:1.79%
controls:0.63%
cases:6.47%
controls:1.99%
20
100
1063
10714
18
61
1065
10753
13
11
1070
10803
6
0
1077
10814
8
9
1061
10784
18
66
985
10331
50
171
723
8402
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
1.0e+00
1.0e+00
1.9e+00
—
1.9e+00
1.1e+00
1.1e+00
cases:3.05%
controls:1.13%
cases:2.03%
controls:0.74%
cases:0.83%
controls:0.13%
—
—
cases:1.22%
controls:0.18%
cases:2.09%
controls:0.74%
cases:4.92%
controls:1.64%
33
122
1050
10692
22
80
1061
10734
9
14
1074
10800
—
13
19
1056
10774
21
77
982
10320
38
141
735
8432
Inpatient Visit
IP [9201]
7.4e-01
1.1e+00
1.8e+00
1.0e+50
2.0e+00
1.5e+00
8.3e-01
cases:10.16%
controls:5.11%
cases:5.45%
controls:1.79%
cases:1.11%
controls:0.18%
cases:2.86%
controls:0.00%
cases:1.78%
controls:0.24%
cases:7.38%
controls:1.77%
cases:12.94%
controls:6.08%
110
553
973
10261
59
194
1024
10620
12
20
1071
10794
31
0
1052
10814
19
26
1050
10767
74
184
929
10213
100
521
673
8052
Other obesity
E66.8 [45533036]
1.8e+00
2.3e+00
—
—
—
2.1e+00
1.8e+00
cases:1.39%
controls:0.24%
cases:0.83%
controls:0.08%
—
—
—
—
—
—
cases:0.60%
controls:0.08%
cases:1.16%
controls:0.19%
15
26
1068
10788
9
9
1074
10805
—
—
—
6
8
997
10389
9
16
764
8557
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
9.0e-01
1.2e+00
1.7e+00
—
1.9e+00
1.3e+00
8.7e-01
cases:7.48%
controls:3.18%
cases:6.28%
controls:1.95%
cases:1.48%
controls:0.27%
—
—
cases:1.68%
controls:0.25%
cases:7.08%
controls:1.98%
cases:13.45%
controls:6.10%
81
344
1002
10470
68
211
1015
10603
16
29
1067
10785
—
18
27
1051
10766
71
206
932
10191
104
523
669
8050
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1.1e+00
1.3e+00
1.4e+00
—
1.8e+00
1.2e+00
1.2e+00
cases:15.33%
controls:5.86%
cases:11.45%
controls:3.39%
cases:2.22%
controls:0.57%
—
—
cases:4.02%
controls:0.68%
cases:10.37%
controls:3.41%
cases:25.49%
controls:9.25%
166
634
917
10180
124
367
959
10447
24
62
1059
10752
—
43
73
1026
10720
104
355
899
10042
197
793
576
7780
Constipation
K59.0 [45557663]
2.3e+00
1.9e+00
—
—
—
1.9e+00
1.8e+00
cases:3.05%
controls:0.31%
cases:0.65%
controls:0.09%
—
—
—
—
—
—
cases:0.90%
controls:0.13%
cases:2.20%
controls:0.38%
33
33
1050
10781
7
10
1076
10804
—
—
—
9
14
994
10383
17
33
756
8540
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
2.1e-01
5.1e-01
1.2e+00
4.0e+00
1.5e+00
4.6e-01
3.1e-01
cases:24.75%
controls:21.00%
cases:26.32%
controls:17.62%
cases:10.34%
controls:3.41%
cases:6.74%
controls:0.14%
cases:13.47%
controls:3.37%
cases:26.02%
controls:18.10%
cases:40.10%
controls:33.01%
268
2271
815
8543
285
1905
798
8909
112
369
971
10445
73
15
1010
10799
144
364
925
10429
261
1882
742
8515
310
2830
463
5743
potassium chloride; oral
A12BA01 [21600877]
7.2e-01
1.2e+00
1.7e+00
—
1.4e+00
1.5e+00
1.4e+00
cases:3.05%
controls:1.51%
cases:3.42%
controls:1.04%
cases:1.20%
controls:0.22%
—
—
cases:1.03%
controls:0.26%
cases:4.49%
controls:1.06%
cases:8.54%
controls:2.27%
33
163
1050
10651
37
112
1046
10702
13
24
1070
10790
—
11
28
1058
10765
45
110
958
10287
66
195
707
8378
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
6.3e-01
8.3e-01
1.9e+00
—
2.4e+00
1.2e+00
9.5e-01
cases:8.59%
controls:4.74%
cases:4.80%
controls:2.15%
cases:1.94%
controls:0.30%
—
—
cases:2.53%
controls:0.24%
cases:6.68%
controls:2.11%
cases:15.91%
controls:6.81%
93
513
990
10301
52
233
1031
10581
21
32
1062
10782
—
27
26
1042
10767
67
219
936
10178
123
584
650
7989
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
7.0e-01
1.2e+00
1.7e+00
—
2.2e+00
1.3e+00
8.2e-01
cases:17.54%
controls:9.59%
cases:12.65%
controls:4.36%
cases:3.05%
controls:0.55%
—
—
cases:4.58%
controls:0.54%
cases:13.56%
controls:4.27%
cases:26.78%
controls:13.85%
190
1037
893
9777
137
471
946
10343
33
59
1050
10755
—
49
58
1020
10735
136
444
867
9953
207
1187
566
7386
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
7.9e-01
1.2e+00
1.7e+00
—
2.2e+00
1.0e+00
8.7e-01
cases:25.39%
controls:13.42%
cases:20.87%
controls:7.12%
cases:4.25%
controls:0.81%
—
—
cases:6.64%
controls:0.76%
cases:18.44%
controls:7.50%
cases:37.90%
controls:20.32%
275
1451
808
9363
226
770
857
10044
46
88
1037
10726
—
71
82
998
10711
185
780
818
9617
293
1742
480
6831
Clinic/Center
261Q00000X [38004207]
1.5e+00
2.0e+00
—
—
—
2.2e+00
2.1e+00
cases:1.85%
controls:0.43%
cases:0.92%
controls:0.12%
—
—
—
—
—
—
cases:1.00%
controls:0.12%
cases:2.85%
controls:0.35%
20
46
1063
10768
10
13
1073
10801
—
—
—
10
12
993
10385
22
30
751
8543
fluoxetine; oral
N06AB03 [21604711]
2.2e+00
2.0e+00
—
—
—
1.7e+00
1.9e+00
cases:3.05%
controls:0.33%
cases:1.29%
controls:0.18%
—
—
—
—
—
—
cases:1.00%
controls:0.18%
cases:1.68%
controls:0.26%
33
36
1050
10778
14
20
1069
10794
—
—
—
10
19
993
10378
13
22
760
8551
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
7.4e-01
1.0e+00
2.3e+00
1.0e+50
2.5e+00
1.6e+00
1.5e+00
cases:1.48%
controls:0.71%
cases:1.02%
controls:0.37%
cases:0.55%
controls:0.06%
cases:0.55%
controls:0.00%
cases:0.65%
controls:0.06%
cases:1.79%
controls:0.38%
cases:5.69%
controls:1.39%
16
77
1067
10737
11
40
1072
10774
6
6
1077
10808
6
0
1077
10814
7
6
1062
10787
18
40
985
10357
44
119
729
8454
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
7.4e-01
1.1e+00
1.9e+00
—
1.9e+00
1.1e+00
1.1e+00
cases:9.14%
controls:4.57%
cases:6.74%
controls:2.38%
cases:1.85%
controls:0.29%
—
—
cases:2.53%
controls:0.37%
cases:7.48%
controls:2.67%
cases:18.50%
controls:7.30%
99
494
984
10320
73
257
1010
10557
20
31
1063
10783
—
27
40
1042
10753
75
278
928
10119
143
626
630
7947
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
7.6e-01
1.3e+00
—
—
2.4e+00
2.0e+00
1.3e+00
cases:2.86%
controls:1.36%
cases:1.85%
controls:0.52%
—
—
—
—
cases:0.84%
controls:0.07%
cases:3.39%
controls:0.46%
cases:5.56%
controls:1.61%
31
147
1052
10667
20
56
1063
10758
—
—
9
8
1060
10785
34
48
969
10349
43
138
730
8435
Orthostatic hypotension
I95.1 [45605872]
2.2e+00
2.9e+00
—
1.0e+50
—
—
2.6e+00
cases:1.20%
controls:0.13%
cases:1.20%
controls:0.06%
—
—
cases:0.83%
controls:0.00%
—
—
—
—
cases:3.10%
controls:0.23%
13
14
1070
10800
13
7
1070
10807
—
9
0
1074
10814
—
—
24
20
749
8553
Case Management Agency
251B00000X [38004193]
6.4e-01
6.1e-01
9.1e-01
3.7e+00
9.3e-01
5.8e-01
3.8e-01
cases:72.11%
controls:57.72%
cases:65.19%
controls:50.36%
cases:35.92%
controls:18.41%
cases:25.21%
controls:0.80%
cases:35.83%
controls:18.12%
cases:67.50%
controls:53.73%
cases:80.98%
controls:74.35%
781
6242
302
4572
706
5446
377
5368
389
1991
694
8823
273
87
810
10727
383
1956
686
8837
677
5586
326
4811
626
6374
147
2199
dipyridamole; oral, parenteral
B01AC07 [21600992]
1.8e+00
1.9e+00
—
—
2.5e+00
1.6e+00
1.1e+00
cases:1.57%
controls:0.26%
cases:1.02%
controls:0.16%
—
—
—
—
cases:0.56%
controls:0.05%
cases:1.00%
controls:0.21%
cases:0.91%
controls:0.31%
17
28
1066
10786
11
17
1072
10797
—
—
6
5
1063
10788
10
22
993
10375
7
27
766
8546
Acute cystitis
N30.0 [45601724]
1.3e+00
1.2e+00
2.6e+00
—
2.1e+00
1.4e+00
1.3e+00
cases:3.05%
controls:0.85%
cases:1.29%
controls:0.41%
cases:0.83%
controls:0.06%
—
—
cases:0.47%
controls:0.06%
cases:2.29%
controls:0.55%
cases:7.12%
controls:2.13%
33
92
1050
10722
14
44
1069
10770
9
7
1074
10807
—
5
6
1064
10787
23
57
980
10340
55
183
718
8390
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
6.5e-01
1.0e+00
1.9e+00
—
1.9e+00
1.2e+00
1.1e+00
cases:7.48%
controls:4.04%
cases:5.36%
controls:2.00%
cases:1.66%
controls:0.25%
—
—
cases:2.15%
controls:0.32%
cases:6.48%
controls:2.13%
cases:15.27%
controls:5.84%
81
437
1002
10377
58
216
1025
10598
18
27
1065
10787
—
23
35
1046
10758
65
221
938
10176
118
501
655
8072
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
1.0e-01
5.5e-01
1.3e+00
3.8e+00
1.3e+00
5.5e-01
2.6e-01
cases:25.39%
controls:23.53%
cases:27.70%
controls:18.10%
cases:11.45%
controls:3.45%
cases:6.28%
controls:0.16%
cases:11.69%
controls:3.53%
cases:27.42%
controls:17.86%
cases:42.17%
controls:35.94%
275
2545
808
8269
300
1957
783
8857
124
373
959
10441
68
17
1015
10797
125
381
944
10412
275
1857
728
8540
326
3081
447
5492
Sleep disturbance
P06 [2002000803]
2.0e+00
1.9e+00
—
—
—
1.7e+00
2.1e+00
cases:2.12%
controls:0.31%
cases:0.83%
controls:0.12%
—
—
—
—
—
—
cases:0.90%
controls:0.16%
cases:3.10%
controls:0.41%
23
33
1060
10781
9
13
1074
10801
—
—
—
9
17
994
10380
24
35
749
8538
Remote contact by phone
ZYC01 [2001311579]
1.7e+00
2.0e+00
—
—
—
2.5e+00
1.5e+00
cases:1.02%
controls:0.19%
cases:1.20%
controls:0.17%
—
—
—
—
—
—
cases:1.60%
controls:0.13%
cases:2.46%
controls:0.55%
11
21
1072
10793
13
18
1070
10796
—
—
—
16
14
987
10383
19
47
754
8526
Microorganisms panel - Urine sediment
58435-9 [40761536]
9.1e-01
1.5e+00
—
—
2.5e+00
1.4e+00
1.3e+00
cases:3.23%
controls:1.33%
cases:2.03%
controls:0.44%
—
—
—
—
cases:1.22%
controls:0.10%
cases:2.09%
controls:0.52%
cases:4.40%
controls:1.25%
35
144
1048
10670
22
48
1061
10766
—
—
13
11
1056
10782
21
54
982
10343
34
107
739
8466
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
8.3e-01
1.1e+00
2.0e+00
—
1.7e+00
1.0e+00
1.1e+00
cases:5.45%
controls:2.44%
cases:3.23%
controls:1.12%
cases:1.48%
controls:0.21%
—
—
cases:0.94%
controls:0.18%
cases:3.49%
controls:1.30%
cases:10.09%
controls:3.67%
59
264
1024
10550
35
121
1048
10693
16
23
1067
10791
—
10
19
1059
10774
35
135
968
10262
78
315
695
8258
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
1.4e+00
2.0e+00
—
—
—
2.4e+00
1.8e+00
cases:1.66%
controls:0.43%
cases:1.11%
controls:0.15%
—
—
—
—
—
—
cases:1.20%
controls:0.11%
cases:2.85%
controls:0.48%
18
47
1065
10767
12
16
1071
10798
—
—
—
12
11
991
10386
22
41
751
8532
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
3.8e+00
—
1.0e+50
—
—
—
3.8e+00
cases:3.88%
controls:0.09%
—
—
cases:0.74%
controls:0.00%
—
—
—
—
—
—
cases:6.47%
controls:0.15%
42
10
1041
10804
—
8
0
1075
10814
—
—
—
50
13
723
8560
disulfiram; oral
N07BB01 [21604821]
3.8e+00
—
1.0e+50
—
—
—
3.8e+00
cases:3.14%
controls:0.07%
—
—
cases:0.46%
controls:0.00%
—
—
—
—
—
—
cases:2.98%
controls:0.07%
34
8
1049
10806
—
5
0
1078
10814
—
—
—
23
6
750
8567
Bacteria [Presence] in Urine
87829-8 [36304419]
7.6e-01
9.0e-01
1.7e+00
—
1.8e+00
1.2e+00
1.2e+00
cases:7.66%
controls:3.74%
cases:4.52%
controls:1.89%
cases:1.20%
controls:0.22%
—
—
cases:1.78%
controls:0.30%
cases:6.38%
controls:1.99%
cases:15.27%
controls:5.34%
83
404
1000
10410
49
204
1034
10610
13
24
1070
10790
—
19
32
1050
10761
64
207
939
10190
118
458
655
8115
haloperidol; oral, parenteral
N05AD01 [21604516]
—
—
—
—
—
3.9e+00
3.6e+00
—
—
—
—
—
—
—
—
—
—
cases:2.29%
controls:0.05%
cases:3.88%
controls:0.10%
—
—
—
—
—
23
5
980
10392
30
9
743
8564
Leukocytes [#/volume] in Urine
30405-5 [3018095]
7.4e-01
1.1e+00
1.8e+00
—
1.9e+00
1.0e+00
1.1e+00
cases:9.97%
controls:5.00%
cases:7.94%
controls:2.89%
cases:2.22%
controls:0.39%
—
—
cases:2.90%
controls:0.44%
cases:7.98%
controls:3.09%
cases:20.70%
controls:8.28%
108
541
975
10273
86
312
997
10502
24
42
1059
10772
—
31
48
1038
10745
80
321
923
10076
160
710
613
7863
Abdominal X-ray examination without contrast
JN3AA [2001305553]
2.4e+00
2.3e+00
—
—
—
2.6e+00
2.4e+00
cases:1.20%
controls:0.11%
cases:0.46%
controls:0.05%
—
—
—
—
—
—
cases:0.90%
controls:0.07%
cases:1.94%
controls:0.19%
13
12
1070
10802
5
5
1078
10809
—
—
—
9
7
994
10390
15
16
758
8557
amitriptyline; oral, parenteral
N06AA09 [21604696]
1.2e+00
1.6e+00
1.5e+00
—
1.3e+00
1.5e+00
1.5e+00
cases:5.26%
controls:1.60%
cases:3.79%
controls:0.78%
cases:0.83%
controls:0.18%
—
—
cases:0.94%
controls:0.27%
cases:3.99%
controls:0.88%
cases:7.12%
controls:1.76%
57
173
1026
10641
41
84
1042
10730
9
20
1074
10794
—
10
29
1059
10764
40
92
963
10305
55
151
718
8422
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
1.0e+00
1.2e+00
2.3e+00
1.0e+50
—
1.6e+00
1.1e+00
cases:3.79%
controls:1.36%
cases:1.57%
controls:0.50%
cases:0.74%
controls:0.07%
cases:0.46%
controls:0.00%
—
—
cases:2.09%
controls:0.42%
cases:5.56%
controls:1.83%
41
147
1042
10667
17
54
1066
10760
8
8
1075
10806
5
0
1078
10814
—
21
44
982
10353
43
157
730
8416
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 [586526]
1.6e+00
2.3e+00
—
—
—
1.8e+00
1.6e+00
cases:1.39%
controls:0.30%
cases:1.20%
controls:0.12%
—
—
—
—
—
—
cases:1.10%
controls:0.18%
cases:3.75%
controls:0.80%
15
32
1068
10782
13
13
1070
10801
—
—
—
11
19
992
10378
29
69
744
8504
Lumbar spine MRI examination with high intensity magnet
NA3BG [2001307034]
1.4e+00
2.1e+00
-1.0e+50
—
—
2.1e+00
1.6e+00
cases:2.22%
controls:0.55%
cases:1.20%
controls:0.15%
cases:0.00%
controls:0.05%
—
—
—
—
cases:0.70%
controls:0.09%
cases:2.33%
controls:0.48%
24
59
1059
10755
13
16
1070
10798
0
5
1083
10809
—
—
7
9
996
10388
18
41
755
8532
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
3.2e-01
6.9e-01
9.5e-01
2.9e+00
1.3e+00
6.3e-01
3.7e-01
cases:35.09%
controls:28.09%
cases:34.35%
controls:20.86%
cases:9.23%
controls:3.77%
cases:3.05%
controls:0.18%
cases:12.35%
controls:3.60%
cases:34.50%
controls:21.99%
cases:53.56%
controls:44.24%
380
3038
703
7776
372
2256
711
8558
100
408
983
10406
33
19
1050
10795
132
389
937
10404
346
2286
657
8111
414
3793
359
4780
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
7.6e-01
8.0e-01
1.6e+00
—
2.0e+00
1.1e+00
7.9e-01
cases:5.63%
controls:2.72%
cases:3.69%
controls:1.69%
cases:1.29%
controls:0.26%
—
—
cases:1.68%
controls:0.22%
cases:5.18%
controls:1.70%
cases:9.06%
controls:4.30%
61
294
1022
10520
40
183
1043
10631
14
28
1069
10786
—
18
24
1051
10769
52
177
951
10220
70
369
703
8204
zopiclone; oral
N05CF01 [21604654]
1.4e+00
1.2e+00
1.2e+00
—
1.2e+00
1.1e+00
1.1e+00
cases:20.59%
controls:6.15%
cases:13.02%
controls:4.33%
cases:3.42%
controls:1.08%
—
—
cases:3.37%
controls:1.06%
cases:12.26%
controls:4.25%
cases:17.85%
controls:6.85%
223
665
860
10149
141
468
942
10346
37
117
1046
10697
—
36
114
1033
10679
123
442
880
9955
138
587
635
7986
Unspecified fall
W19 [45756257]
1.6e+00
1.8e+00
—
—
—
2.4e+00
1.4e+00
cases:2.40%
controls:0.49%
cases:1.02%
controls:0.18%
—
—
—
—
—
—
cases:1.79%
controls:0.17%
cases:2.72%
controls:0.70%
26
53
1057
10761
11
19
1072
10795
—
—
—
18
18
985
10379
21
60
752
8513
Hypothyroidism, unspecified
E03.9 [45537945]
1.1e+00
1.2e+00
—
1.0e+50
2.1e+00
1.4e+00
1.2e+00
cases:3.88%
controls:1.35%
cases:2.03%
controls:0.62%
—
—
cases:1.11%
controls:0.00%
cases:0.94%
controls:0.11%
cases:2.79%
controls:0.67%
cases:6.08%
controls:1.87%
42
146
1041
10668
22
67
1061
10747
—
12
0
1071
10814
10
12
1059
10781
28
70
975
10327
47
160
726
8413
Pain general/multiple sites
A01 [2002000142]
1.4e+00
1.9e+00
—
—
—
1.7e+00
2.0e+00
cases:1.48%
controls:0.37%
cases:0.83%
controls:0.12%
—
—
—
—
—
—
cases:1.30%
controls:0.23%
cases:3.88%
controls:0.55%
16
40
1067
10774
9
13
1074
10801
—
—
—
13
24
990
10373
30
47
743
8526
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
1.3e+00
1.6e+00
1.2e+00
—
1.6e+00
1.4e+00
1.1e+00
cases:6.65%
controls:1.94%
cases:5.36%
controls:1.09%
cases:0.83%
controls:0.24%
—
—
cases:1.12%
controls:0.22%
cases:4.29%
controls:1.13%
cases:10.87%
controls:3.76%
72
210
1011
10604
58
118
1025
10696
9
26
1074
10788
—
12
24
1057
10769
43
117
960
10280
84
322
689
8251
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
1.0e+00
8.9e-01
1.2e+00
—
1.7e+00
1.3e+00
9.2e-01
cases:11.27%
controls:4.41%
cases:6.37%
controls:2.72%
cases:1.39%
controls:0.41%
—
—
cases:2.43%
controls:0.45%
cases:8.87%
controls:2.64%
cases:16.17%
controls:7.12%
122
477
961
10337
69
294
1014
10520
15
44
1068
10770
—
26
49
1043
10744
89
274
914
10123
125
610
648
7963
Other function in accordance with SHToL (Finnish classification of nursing interventions)
SPAT1292 [2001700393]
8.8e-01
1.5e+00
—
—
2.0e+00
1.7e+00
9.5e-01
cases:1.85%
controls:0.78%
cases:1.48%
controls:0.33%
—
—
—
—
cases:0.56%
controls:0.07%
cases:1.99%
controls:0.38%
cases:3.36%
controls:1.33%
20
84
1063
10730
16
36
1067
10778
—
—
6
8
1063
10785
20
40
983
10357
26
114
747
8459
solifenacin; oral
G04BD08 [21602641]
1.9e+00
2.2e+00
—
—
—
1.4e+00
1.5e+00
cases:3.88%
controls:0.62%
cases:2.12%
controls:0.23%
—
—
—
—
—
—
cases:1.30%
controls:0.33%
cases:2.98%
controls:0.68%
42
67
1041
10747
23
25
1060
10789
—
—
—
13
34
990
10363
23
58
750
8515
Fracture of neck of femur
S72.0 [45593656]
1.0e+00
2.5e+00
—
—
—
2.8e+00
1.6e+00
cases:0.74%
controls:0.27%
cases:0.92%
controls:0.07%
—
—
—
—
—
—
cases:1.30%
controls:0.08%
cases:2.20%
controls:0.45%
8
29
1075
10785
10
8
1073
10806
—
—
—
13
8
990
10389
17
39
756
8534
Other and unspecified convulsions
R56.8 [45602033]
3.2e+00
—
—
—
1.0e+50
—
3.8e+00
cases:2.22%
controls:0.09%
—
—
—
—
—
—
cases:0.65%
controls:0.00%
—
—
cases:2.46%
controls:0.06%
24
10
1059
10804
—
—
—
7
0
1062
10793
—
19
5
754
8568
Localized oedema
R60.0 [45597193]
1.5e+00
1.8e+00
—
—
—
2.1e+00
1.5e+00
cases:3.42%
controls:0.76%
cases:1.85%
controls:0.31%
—
—
—
—
—
—
cases:2.29%
controls:0.28%
cases:5.17%
controls:1.22%
37
82
1046
10732
20
34
1063
10780
—
—
—
23
29
980
10368
40
105
733
8468
amitriptyline and psycholeptics
N06CA01 [21604789]
2.0e+00
1.9e+00
—
—
—
1.5e+00
1.5e+00
cases:2.77%
controls:0.40%
cases:1.39%
controls:0.20%
—
—
—
—
—
—
cases:1.20%
controls:0.28%
cases:1.81%
controls:0.40%
30
43
1053
10771
15
22
1068
10792
—
—
—
12
29
991
10368
14
34
759
8539
Urinary tract infection, site not specified
N39.0 [45548665]
1.4e+00
1.6e+00
—
—
—
2.2e+00
1.7e+00
cases:4.34%
controls:1.12%
cases:1.94%
controls:0.39%
—
—
—
—
—
—
cases:2.99%
controls:0.35%
cases:9.70%
controls:1.96%
47
121
1036
10693
21
42
1062
10772
—
—
—
30
36
973
10361
75
168
698
8405
Headache
R51.80 [2000503603]
1.5e+00
1.9e+00
—
—
—
2.0e+00
1.4e+00
cases:2.49%
controls:0.55%
cases:0.92%
controls:0.14%
—
—
—
—
—
—
cases:1.50%
controls:0.20%
cases:3.36%
controls:0.84%
27
59
1056
10755
10
15
1073
10799
—
—
—
15
21
988
10376
26
72
747
8501
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
8.9e-01
1.4e+00
—
—
1.8e+00
1.5e+00
1.3e+00
cases:2.49%
controls:1.04%
cases:2.40%
controls:0.61%
—
—
—
—
cases:0.75%
controls:0.13%
cases:2.39%
controls:0.56%
cases:5.30%
controls:1.45%
27
112
1056
10702
26
66
1057
10748
—
—
8
14
1061
10779
24
58
979
10339
41
124
732
8449
Oxygen saturation in Arterial blood
2708-6 [3016502]
1.1e+00
1.6e+00
2.8e+00
1.0e+50
—
8.2e-01
1.4e+00
cases:2.86%
controls:0.98%
cases:2.12%
controls:0.45%
cases:0.74%
controls:0.05%
cases:0.92%
controls:0.00%
—
—
cases:1.20%
controls:0.53%
cases:6.08%
controls:1.54%
31
106
1052
10708
23
49
1060
10765
8
5
1075
10809
10
0
1073
10814
—
12
55
991
10342
47
132
726
8441
Concussion
S06.0 [45582805]
3.7e+00
—
—
—
—
—
3.2e+00
cases:2.49%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:2.98%
controls:0.13%
27
7
1056
10807
—
—
—
—
—
23
11
750
8562
Telehealth
OMOP5556618 [722455]
7.9e-01
1.0e+00
1.5e+00
—
1.7e+00
1.0e+00
7.9e-01
cases:33.24%
controls:18.50%
cases:17.54%
controls:7.11%
cases:5.08%
controls:1.15%
—
—
cases:5.80%
controls:1.10%
cases:18.15%
controls:7.48%
cases:34.67%
controls:19.42%
360
2001
723
8813
190
769
893
10045
55
124
1028
10690
—
62
119
1007
10674
182
778
821
9619
268
1665
505
6908
folic acid
V04CX02 [715877]
8.5e-01
1.2e+00
1.9e+00
—
—
1.6e+00
1.4e+00
cases:1.94%
controls:0.84%
cases:2.12%
controls:0.64%
cases:0.65%
controls:0.10%
—
—
—
—
cases:3.09%
controls:0.66%
cases:4.79%
controls:1.28%
21
91
1062
10723
23
69
1060
10745
7
11
1076
10803
—
—
31
69
972
10328
37
110
736
8463
folic acid; oral, parenteral
B03BB01 [21601129]
8.5e-01
1.2e+00
1.9e+00
—
—
1.6e+00
1.4e+00
cases:1.94%
controls:0.84%
cases:2.12%
controls:0.64%
cases:0.65%
controls:0.10%
—
—
—
—
cases:3.09%
controls:0.66%
cases:4.79%
controls:1.28%
21
91
1062
10723
23
69
1060
10745
7
11
1076
10803
—
—
31
69
972
10328
37
110
736
8463
Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]
1.3e+00
1.5e+00
2.6e+00
—
—
1.1e+00
1.4e+00
cases:3.51%
controls:1.01%
cases:2.03%
controls:0.45%
cases:0.65%
controls:0.05%
—
—
—
—
cases:1.20%
controls:0.40%
cases:5.95%
controls:1.54%
38
109
1045
10705
22
49
1061
10765
7
5
1076
10809
—
—
12
42
991
10355
46
132
727
8441
Hospital outpatient
ZY010 [2001311599]
3.8e+00
—
1.0e+50
—
1.0e+50
—
2.9e+00
cases:2.49%
controls:0.06%
—
—
cases:0.92%
controls:0.00%
—
—
cases:1.12%
controls:0.00%
—
—
cases:3.23%
controls:0.17%
27
6
1056
10808
—
10
0
1073
10814
—
12
0
1057
10793
—
25
15
748
8558
Retention of urine
R33 [45587507]
1.1e+00
2.4e+00
—
1.0e+50
—
2.0e+00
1.3e+00
cases:2.49%
controls:0.82%
cases:2.22%
controls:0.21%
—
—
cases:0.55%
controls:0.00%
—
—
cases:2.39%
controls:0.34%
cases:4.79%
controls:1.35%
27
89
1056
10725
24
23
1059
10791
—
6
0
1077
10814
—
24
35
979
10362
37
116
736
8457
Constipation caused by slow bowel passage (SCT)
K59.00 [2000502924]
2.2e+00
—
—
—
—
2.3e+00
2.3e+00
cases:0.55%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.50%
controls:0.05%
cases:0.78%
controls:0.08%
6
7
1077
10807
—
—
—
—
5
5
998
10392
6
7
767
8566
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
1.8e+00
1.8e+00
—
—
—
1.7e+00
1.5e+00
cases:5.08%
controls:0.88%
cases:2.22%
controls:0.39%
—
—
—
—
—
—
cases:1.69%
controls:0.32%
cases:5.82%
controls:1.40%
55
95
1028
10719
24
42
1059
10772
—
—
—
17
33
986
10364
45
120
728
8453
Essential tremor
G25.0 [45533132]
3.3e+00
—
—
1.0e+50
1.0e+50
—
3.3e+00
cases:1.29%
controls:0.05%
—
—
—
—
cases:1.48%
controls:0.00%
cases:0.56%
controls:0.00%
—
—
cases:2.59%
controls:0.09%
14
5
1069
10809
—
—
16
0
1067
10814
6
0
1063
10793
—
20
8
753
8565
Gas panel - Venous blood
24339-4 [3000991]
9.1e-01
1.1e+00
2.0e+00
—
—
1.3e+00
1.4e+00
cases:1.75%
controls:0.71%
cases:1.29%
controls:0.45%
cases:0.55%
controls:0.07%
—
—
—
—
cases:1.69%
controls:0.46%
cases:4.92%
controls:1.28%
19
77
1064
10737
14
49
1069
10765
6
8
1077
10806
—
—
17
48
986
10349
38
110
735
8463
Catheterisation of bladder
TKC20 [2001306020]
1.5e+00
2.2e+00
—
—
—
1.6e+00
1.3e+00
cases:2.12%
controls:0.48%
cases:1.29%
controls:0.14%
—
—
—
—
—
—
cases:1.00%
controls:0.20%
cases:2.46%
controls:0.66%
23
52
1060
10762
14
15
1069
10799
—
—
—
10
21
993
10376
19
57
754
8516
Fitting and adjustment of unspecified device
Z46.9 [45537644]
1.8e+00
2.5e+00
—
—
—
2.0e+00
2.2e+00
cases:0.55%
controls:0.09%
cases:0.65%
controls:0.06%
—
—
—
—
—
—
cases:0.80%
controls:0.11%
cases:1.81%
controls:0.21%
6
10
1077
10804
7
6
1076
10808
—
—
—
8
11
995
10386
14
18
759
8555
X-ray examination of the lungs in one projection
GD1PA [2001303645]
1.1e+00
2.0e+00
—
1.0e+50
—
1.9e+00
1.6e+00
cases:1.66%
controls:0.56%
cases:1.48%
controls:0.19%
—
—
cases:0.55%
controls:0.00%
—
—
cases:1.30%
controls:0.19%
cases:5.30%
controls:1.14%
18
61
1065
10753
16
21
1067
10793
—
6
0
1077
10814
—
13
20
990
10377
41
98
732
8475
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
4.4e-01
7.6e-01
1.7e+00
—
2.4e+00
1.1e+00
7.1e-01
cases:6.37%
controls:4.19%
cases:4.34%
controls:2.07%
cases:1.48%
controls:0.27%
—
—
cases:2.53%
controls:0.24%
cases:6.08%
controls:2.20%
cases:12.68%
controls:6.64%
69
453
1014
10361
47
224
1036
10590
16
29
1067
10785
—
27
26
1042
10767
61
229
942
10168
98
569
675
8004
Laboratory Visit
OMOP4822461 [32036]
1.8e-01
4.3e-01
1.1e+00
3.3e+00
1.3e+00
5.0e-01
2.1e-01
cases:39.61%
controls:35.34%
cases:42.84%
controls:32.68%
cases:24.10%
controls:9.54%
cases:12.19%
controls:0.53%
cases:27.60%
controls:9.23%
cases:45.96%
controls:34.13%
cases:58.60%
controls:53.38%
429
3822
654
6992
464
3534
619
7280
261
1032
822
9782
132
57
951
10757
295
996
774
9797
461
3549
542
6848
453
4576
320
3997
Syncope and collapse
R55 [45568141]
1.7e+00
1.4e+00
—
—
—
2.1e+00
1.4e+00
cases:4.34%
controls:0.84%
cases:1.48%
controls:0.36%
—
—
—
—
—
—
cases:1.99%
controls:0.25%
cases:4.92%
controls:1.26%
47
91
1036
10723
16
39
1067
10775
—
—
—
20
26
983
10371
38
108
735
8465
Bacterial infection, unspecified
A49.9 [45590816]
1.5e+00
1.6e+00
—
1.0e+50
—
2.0e+00
1.5e+00
cases:2.31%
controls:0.55%
cases:1.20%
controls:0.24%
—
—
cases:0.46%
controls:0.00%
—
—
cases:2.29%
controls:0.31%
cases:5.69%
controls:1.35%
25
59
1058
10755
13
26
1070
10788
—
5
0
1078
10814
—
23
32
980
10365
44
116
729
8457
Sampling
SPAT1263 [2001700364]
6.2e-01
1.1e+00
1.4e+00
—
1.2e+00
1.3e+00
9.7e-01
cases:11.17%
controls:6.36%
cases:6.46%
controls:2.25%
cases:1.85%
controls:0.44%
—
—
cases:1.68%
controls:0.53%
cases:7.58%
controls:2.27%
cases:17.72%
controls:7.57%
121
688
962
10126
70
243
1013
10571
20
48
1063
10766
—
18
57
1051
10736
76
236
927
10161
137
649
636
7924
nitrofurantoin; oral
J01XE01 [21603058]
1.0e+00
1.2e+00
—
—
2.2e+00
1.1e+00
9.9e-01
cases:4.71%
controls:1.73%
cases:1.94%
controls:0.61%
—
—
—
—
cases:0.75%
controls:0.08%
cases:1.89%
controls:0.64%
cases:6.08%
controls:2.34%
51
187
1032
10627
21
66
1062
10748
—
—
8
9
1061
10784
19
67
984
10330
47
201
726
8372
Thorax X-ray examination
GD1AA [2001303617]
9.4e-01
9.9e-01
1.5e+00
—
1.2e+00
9.7e-01
8.8e-01
cases:14.68%
controls:6.27%
cases:6.83%
controls:2.64%
cases:1.57%
controls:0.37%
—
—
cases:1.12%
controls:0.33%
cases:7.08%
controls:2.81%
cases:16.17%
controls:7.42%
159
678
924
10136
74
286
1009
10528
17
40
1066
10774
—
12
36
1057
10757
71
292
932
10105
125
636
648
7937
pantoprazole; oral, parenteral
A02BC02 [21600097]
6.0e-01
8.3e-01
8.5e-01
1.8e+00
8.6e-01
8.1e-01
7.4e-01
cases:22.53%
controls:13.74%
cases:16.16%
controls:7.77%
cases:3.51%
controls:1.53%
cases:0.65%
controls:0.11%
cases:3.74%
controls:1.61%
cases:16.65%
controls:8.18%
cases:29.11%
controls:16.39%
244
1486
839
9328
175
840
908
9974
38
165
1045
10649
7
12
1076
10802
40
174
1029
10619
167
850
836
9547
225
1405
548
7168
Physical Medicine And Rehabilitation
25 [38004468]
1.0e+00
1.2e+00
1.5e+00
—
1.7e+00
1.4e+00
1.1e+00
cases:9.60%
controls:3.59%
cases:4.43%
controls:1.34%
cases:0.83%
controls:0.19%
—
—
cases:1.22%
controls:0.22%
cases:5.18%
controls:1.35%
cases:9.96%
controls:3.71%
104
388
979
10426
48
145
1035
10669
9
21
1074
10793
—
13
24
1056
10769
52
140
951
10257
77
318
696
8255
omeprazole; oral, parenteral
A02BC01 [21600096]
5.9e-01
8.2e-01
1.9e+00
—
1.3e+00
1.1e+00
7.5e-01
cases:6.19%
controls:3.53%
cases:3.69%
controls:1.66%
cases:1.57%
controls:0.25%
—
—
cases:1.40%
controls:0.37%
cases:4.59%
controls:1.64%
cases:6.86%
controls:3.36%
67
382
1016
10432
40
179
1043
10635
17
27
1066
10787
—
15
40
1054
10753
46
171
957
10226
53
288
720
8285
tolterodine; oral
G04BD07 [21602640]
1.7e+00
1.7e+00
—
—
1.6e+00
1.7e+00
1.4e+00
cases:2.22%
controls:0.43%
cases:1.11%
controls:0.21%
—
—
—
—
cases:0.47%
controls:0.09%
cases:1.10%
controls:0.20%
cases:1.42%
controls:0.36%
24
46
1059
10768
12
23
1071
10791
—
—
5
10
1064
10783
11
21
992
10376
11
31
762
8542
Mixed anxiety and depressive disorder
F41.2 [45566845]
3.2e+00
—
—
—
—
—
3.2e+00
cases:1.57%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:2.72%
controls:0.12%
17
7
1066
10807
—
—
—
—
—
21
10
752
8563
Constipation, unspecified
K59.09 [2000502926]
2.1e+00
2.4e+00
—
—
—
1.7e+00
1.9e+00
cases:1.85%
controls:0.24%
cases:0.83%
controls:0.07%
—
—
—
—
—
—
cases:0.70%
controls:0.13%
cases:3.23%
controls:0.51%
20
26
1063
10788
9
8
1074
10806
—
—
—
7
14
996
10383
25
44
748
8529
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]
1.4e+00
1.7e+00
—
1.0e+50
—
1.9e+00
1.3e+00
cases:3.88%
controls:0.98%
cases:2.12%
controls:0.40%
—
—
cases:0.74%
controls:0.00%
—
—
cases:2.59%
controls:0.39%
cases:5.05%
controls:1.38%
42
106
1041
10708
23
43
1060
10771
—
8
0
1075
10814
—
26
41
977
10356
39
118
734
8455
Acute tubulo-interstitial nephritis
N10 [45543856]
1.3e+00
1.6e+00
—
—
—
1.5e+00
1.9e+00
cases:3.60%
controls:0.96%
cases:1.94%
controls:0.40%
—
—
—
—
—
—
cases:1.79%
controls:0.39%
cases:8.41%
controls:1.41%
39
104
1044
10710
21
43
1062
10771
—
—
—
18
41
985
10356
65
121
708
8452
Sodium [Moles/volume] in Urine
2955-3 [3003181]
2.0e+00
2.4e+00
—
—
—
—
1.9e+00
cases:0.83%
controls:0.11%
cases:0.83%
controls:0.07%
—
—
—
—
—
—
—
—
cases:1.42%
controls:0.22%
9
12
1074
10802
9
8
1074
10806
—
—
—
—
11
19
762
8554
Depressive disorder
P76 [2002000870]
3.4e+00
—
1.0e+50
—
—
—
2.9e+00
cases:1.94%
controls:0.06%
—
—
cases:0.65%
controls:0.00%
—
—
—
—
—
—
cases:2.20%
controls:0.13%
21
7
1062
10807
—
7
0
1076
10814
—
—
—
17
11
756
8562
Differential panel, method unspecified - Blood
69738-3 [42870588]
6.4e-01
8.2e-01
1.1e+00
—
1.9e+00
8.3e-01
1.0e+00
cases:8.59%
controls:4.73%
cases:6.00%
controls:2.75%
cases:1.94%
controls:0.67%
—
—
cases:3.65%
controls:0.58%
cases:6.28%
controls:2.83%
cases:15.52%
controls:6.08%
93
511
990
10303
65
297
1018
10517
21
72
1062
10742
—
39
63
1030
10730
63
294
940
10103
120
521
653
8052
Procedure duration 10 to 19 minutes
ZXE02 [2001311396]
1.7e+00
1.9e+00
—
—
—
—
2.7e+00
cases:2.03%
controls:0.37%
cases:1.11%
controls:0.17%
—
—
—
—
—
—
—
—
cases:2.59%
controls:0.19%
22
40
1061
10774
12
18
1071
10796
—
—
—
—
20
16
753
8557
Disorientation, unspecified
R41.0 [45558469]
3.5e+00
—
—
—
1.0e+50
—
2.8e+00
cases:1.48%
controls:0.05%
—
—
—
—
—
—
cases:0.56%
controls:0.00%
—
—
cases:2.07%
controls:0.13%
16
5
1067
10809
—
—
—
6
0
1063
10793
—
16
11
757
8562
Memory test
SPAT1053 [2001700154]
1.4e+00
2.2e+00
1.0e+50
—
—
1.5e+00
1.2e+00
cases:5.63%
controls:1.41%
cases:3.14%
controls:0.37%
cases:0.46%
controls:0.00%
—
—
—
—
cases:2.39%
controls:0.56%
cases:5.69%
controls:1.87%
61
152
1022
10662
34
40
1049
10774
5
0
1078
10814
—
—
24
58
979
10339
44
160
729
8413
No disease
A97 [2002000230]
6.9e-01
1.1e+00
1.8e+00
—
2.2e+00
1.2e+00
9.0e-01
cases:3.51%
controls:1.78%
cases:1.94%
controls:0.63%
cases:0.55%
controls:0.09%
—
—
cases:0.75%
controls:0.08%
cases:2.69%
controls:0.80%
cases:7.37%
controls:3.15%
38
193
1045
10621
21
68
1062
10746
6
10
1077
10804
—
8
9
1061
10784
27
83
976
10314
57
270
716
8303
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
1.1e+00
2.1e+00
—
1.0e+50
—
1.3e+00
1.7e+00
cases:2.03%
controls:0.68%
cases:1.94%
controls:0.25%
—
—
cases:0.65%
controls:0.00%
—
—
cases:1.20%
controls:0.33%
cases:4.79%
controls:0.94%
22
74
1061
10740
21
27
1062
10787
—
7
0
1076
10814
—
12
34
991
10363
37
81
736
8492
Mild cognitive disorder
F06.7 [45605450]
—
3.2e+00
—
1.0e+50
—
1.0e+50
2.9e+00
—
—
cases:1.11%
controls:0.05%
—
—
cases:0.55%
controls:0.00%
—
—
cases:0.80%
controls:0.00%
cases:1.29%
controls:0.07%
—
12
5
1071
10809
—
6
0
1077
10814
—
8
0
995
10397
10
6
763
8567
trimethoprim; oral, parenteral
J01EA01 [21602931]
7.3e-01
1.3e+00
1.9e+00
—
1.2e+00
1.0e+00
1.2e+00
cases:9.14%
controls:4.62%
cases:5.08%
controls:1.50%
cases:1.48%
controls:0.23%
—
—
cases:0.65%
controls:0.20%
cases:4.69%
controls:1.71%
cases:16.30%
controls:5.58%
99
500
984
10314
55
162
1028
10652
16
25
1067
10789
—
7
22
1062
10771
47
178
956
10219
126
478
647
8095
Orthostatic test
SPAT1101 [2001700202]
2.0e+00
2.5e+00
—
—
—
1.6e+00
1.6e+00
cases:1.85%
controls:0.26%
cases:1.02%
controls:0.08%
—
—
—
—
—
—
cases:0.60%
controls:0.12%
cases:1.68%
controls:0.35%
20
28
1063
10786
11
9
1072
10805
—
—
—
6
12
997
10385
13
30
760
8543
gabapentin; oral
N02BF01 [955005]
1.5e+00
1.7e+00
1.5e+00
—
1.7e+00
1.5e+00
1.3e+00
cases:4.89%
controls:1.15%
cases:3.05%
controls:0.55%
cases:0.74%
controls:0.17%
—
—
cases:0.47%
controls:0.08%
cases:2.89%
controls:0.66%
cases:6.60%
controls:1.82%
53
124
1030
10690
33
60
1050
10754
8
18
1075
10796
—
5
9
1064
10784
29
69
974
10328
51
156
722
8417
Pain in limb
M79.6 [45587063]
9.0e-01
1.2e+00
1.8e+00
—
1.3e+00
1.2e+00
8.5e-01
cases:9.33%
controls:4.02%
cases:5.17%
controls:1.54%
cases:0.92%
controls:0.15%
—
—
cases:0.56%
controls:0.15%
cases:4.49%
controls:1.37%
cases:12.55%
controls:5.80%
101
435
982
10379
56
167
1027
10647
10
16
1073
10798
—
6
16
1063
10777
45
142
958
10255
97
497
676
8076
pH of Blood
11558-4 [3010421]
9.8e-01
2.1e+00
—
—
—
2.1e+00
1.9e+00
cases:0.74%
controls:0.28%
cases:0.65%
controls:0.08%
—
—
—
—
—
—
cases:1.10%
controls:0.13%
cases:2.33%
controls:0.36%
8
30
1075
10784
7
9
1076
10805
—
—
—
11
14
992
10383
18
31
755
8542
Nausea and vomiting
R11 [45539317]
1.7e+00
1.1e+00
—
—
—
2.3e+00
1.9e+00
cases:1.66%
controls:0.30%
cases:0.55%
controls:0.19%
—
—
—
—
—
—
cases:1.00%
controls:0.10%
cases:3.75%
controls:0.61%
18
32
1065
10782
6
21
1077
10793
—
—
—
10
10
993
10387
29
52
744
8521
Tension-type headache
G44.2 [45581495]
1.8e+00
1.7e+00
—
—
—
2.3e+00
1.9e+00
cases:1.75%
controls:0.29%
cases:0.55%
controls:0.10%
—
—
—
—
—
—
cases:1.10%
controls:0.12%
cases:2.33%
controls:0.37%
19
31
1064
10783
6
11
1077
10803
—
—
—
11
12
992
10385
18
32
755
8541
Chest pain, unspecified
R07.4 [45558450]
9.8e-01
1.4e+00
1.9e+00
—
—
8.8e-01
7.1e-01
cases:7.76%
controls:3.07%
cases:3.60%
controls:0.88%
cases:0.74%
controls:0.11%
—
—
—
—
cases:2.39%
controls:1.01%
cases:6.99%
controls:3.56%
84
332
999
10482
39
95
1044
10719
8
12
1075
10802
—
—
24
105
979
10292
54
305
719
8268
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
8.0e-01
1.2e+00
—
—
1.9e+00
1.1e+00
9.5e-01
cases:6.74%
controls:3.14%
cases:5.26%
controls:1.61%
—
—
—
—
cases:1.12%
controls:0.18%
cases:4.69%
controls:1.66%
cases:12.42%
controls:5.20%
73
340
1010
10474
57
174
1026
10640
—
—
12
19
1057
10774
47
173
956
10224
96
446
677
8127
EKG study
11524-6 [3013512]
4.3e-01
7.6e-01
1.7e+00
1.0e+50
1.5e+00
9.2e-01
5.5e-01
cases:9.33%
controls:6.30%
cases:6.74%
controls:3.27%
cases:1.75%
controls:0.32%
cases:0.83%
controls:0.00%
cases:2.34%
controls:0.52%
cases:8.08%
controls:3.40%
cases:15.39%
controls:9.51%
101
681
982
10133
73
354
1010
10460
19
35
1064
10779
9
0
1074
10814
25
56
1044
10737
81
353
922
10044
119
815
654
7758
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
6.7e-01
1.3e+00
—
—
2.2e+00
1.0e+00
6.8e-01
cases:3.23%
controls:1.67%
cases:3.51%
controls:0.99%
—
—
—
—
cases:1.22%
controls:0.14%
cases:2.69%
controls:0.96%
cases:5.95%
controls:3.10%
35
181
1048
10633
38
107
1045
10707
—
—
13
15
1056
10778
27
100
976
10297
46
266
727
8307
cyanocobalamin; nasal, oral, parenteral
B03BA01 [21601121]
1.3e+00
2.3e+00
—
—
—
2.1e+00
1.4e+00
cases:1.02%
controls:0.29%
cases:1.39%
controls:0.14%
—
—
—
—
—
—
cases:1.10%
controls:0.13%
cases:1.81%
controls:0.45%
11
31
1072
10783
15
15
1068
10799
—
—
—
11
14
992
10383
14
39
759
8534
Spinal stenosis
M48.0 [45557888]
1.4e+00
1.5e+00
—
—
1.4e+00
1.6e+00
1.3e+00
cases:4.99%
controls:1.25%
cases:2.03%
controls:0.48%
—
—
—
—
cases:0.47%
controls:0.11%
cases:2.59%
controls:0.56%
cases:5.69%
controls:1.55%
54
135
1029
10679
22
52
1061
10762
—
—
5
12
1064
10781
26
58
977
10339
44
133
729
8440
Psychosocial counselling and guidance
SPAT1307 [2001700408]
3.1e+00
—
—
—
—
—
2.7e+00
cases:1.57%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:1.55%
controls:0.10%
17
8
1066
10806
—
—
—
—
—
12
9
761
8564
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
6.7e-01
8.7e-01
1.2e+00
—
1.0e+00
1.1e+00
9.6e-01
cases:41.74%
controls:26.88%
cases:28.53%
controls:14.32%
cases:7.66%
controls:2.45%
—
—
cases:6.64%
controls:2.55%
cases:33.30%
controls:14.59%
cases:56.79%
controls:33.55%
452
2907
631
7907
309
1549
774
9265
83
265
1000
10549
—
71
275
998
10518
334
1517
669
8880
439
2876
334
5697
Vertigo/dizziness
N17 [2002000728]
1.5e+00
1.7e+00
—
—
—
1.4e+00
1.1e+00
cases:3.69%
controls:0.88%
cases:2.22%
controls:0.40%
—
—
—
—
—
—
cases:1.20%
controls:0.30%
cases:3.88%
controls:1.28%
40
95
1043
10719
24
43
1059
10771
—
—
—
12
31
991
10366
30
110
743
8463
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5.1e-01
5.9e-01
1.6e+00
—
1.9e+00
8.3e-01
9.1e-01
cases:5.72%
controls:3.51%
cases:2.86%
controls:1.61%
cases:1.39%
controls:0.29%
—
—
cases:1.59%
controls:0.25%
cases:3.39%
controls:1.51%
cases:10.09%
controls:4.34%
62
380
1021
10434
31
174
1052
10640
15
31
1068
10783
—
17
27
1052
10766
34
157
969
10240
78
372
695
8201
Gas panel - Central venous blood
97535-9 [1616796]
2.0e+00
2.0e+00
—
—
—
2.1e+00
1.6e+00
cases:1.20%
controls:0.17%
cases:0.46%
controls:0.06%
—
—
—
—
—
—
cases:0.60%
controls:0.08%
cases:1.42%
controls:0.29%
13
18
1070
10796
5
7
1078
10807
—
—
—
6
8
997
10389
11
25
762
8548
Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]
1.6e+00
—
—
—
—
3.0e+00
2.6e+00
cases:0.65%
controls:0.13%
—
—
—
—
—
—
—
—
cases:1.00%
controls:0.05%
cases:1.94%
controls:0.15%
7
14
1076
10800
—
—
—
—
10
5
993
10392
15
13
758
8560
Treatment of chronic ulcer or burn
SPAT1148 [2001700249]
1.5e+00
1.6e+00
—
—
—
1.6e+00
9.2e-01
cases:4.62%
controls:1.10%
cases:2.12%
controls:0.43%
—
—
—
—
—
—
cases:2.39%
controls:0.50%
cases:4.40%
controls:1.81%
50
119
1033
10695
23
46
1060
10768
—
—
—
24
52
979
10345
34
155
739
8418
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
6.6e-01
8.7e-01
9.4e-01
—
1.5e+00
8.8e-01
7.3e-01
cases:22.53%
controls:13.03%
cases:15.05%
controls:6.90%
cases:2.31%
controls:0.92%
—
—
cases:3.84%
controls:0.89%
cases:14.46%
controls:6.54%
cases:31.82%
controls:18.34%
244
1409
839
9405
163
746
920
10068
25
99
1058
10715
—
41
96
1028
10697
145
680
858
9717
246
1572
527
7001
Fever, unspecified
R50.9 [45582716]
1.1e+00
1.3e+00
—
—
—
1.6e+00
1.6e+00
cases:3.23%
controls:1.05%
cases:1.48%
controls:0.43%
—
—
—
—
—
—
cases:1.89%
controls:0.40%
cases:5.82%
controls:1.25%
35
114
1048
10700
16
46
1067
10768
—
—
—
19
42
984
10355
45
107
728
8466
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
7.5e-01
1.2e+00
—
—
2.7e+00
8.6e-01
8.5e-01
cases:2.77%
controls:1.33%
cases:1.20%
controls:0.36%
—
—
—
—
cases:0.84%
controls:0.06%
cases:1.20%
controls:0.51%
cases:4.14%
controls:1.81%
30
144
1053
10670
13
39
1070
10775
—
—
9
6
1060
10787
12
53
991
10344
32
155
741
8418
nortriptyline; oral, parenteral
N06AA10 [21604697]
2.0e+00
1.6e+00
—
—
—
2.1e+00
1.5e+00
cases:1.48%
controls:0.20%
cases:0.46%
controls:0.09%
—
—
—
—
—
—
cases:0.60%
controls:0.08%
cases:1.42%
controls:0.33%
16
22
1067
10792
5
10
1078
10804
—
—
—
6
8
997
10389
11
28
762
8545

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
548
1807
5.10
155.94
4.8
1.8
477.03
188.35
u/l
1.76
524
1675
90
32
30.57
135.25
1.3
1.3
4.30
22.17
e6/l
0.50
69
23
89
33
29.28
131.86
1.4
1.4
78.52
34.48
e6/l
0.46
73
25
394
1135
4.88
129.09
2.1
1.6
1234.48
1130.73
nmol/l
1.15
307
849
109
0
+∞
115.73
11.6
0.0
718.78
—
nmol/l
—
101
0
74
38
20.82
96.35
1.2
1.4
—
—
—
0
0
89
0
+∞
94.15
2.7
0.0
129.28
—
nmol/l
—
81
0
528
2319
3.48
88.83
5.0
2.9
—
—
—
0
0
503
2259
3.28
79.55
5.4
4.1
—
—
—
0
0
49
15
34.16
76.55
2.5
1.3
—
—
—
0
0
120
186
7.13
75.43
2.6
2.8
744.03
337.44
ug/l
1.06
111
179
456
2102
3.01
66.28
2.2
1.6
18.61
19.90
nmol/l
1.04
394
1698
680
3900
2.99
65.70
8.7
7.0
1.22
1.21
mmol/l
4.03
606
3346
632
3496
2.93
65.14
7.9
6.3
1.22
1.21
mmol/l
2.41
596
3241
611
3459
2.75
57.90
2.8
2.0
94.27
94.86
pmol/l
0.12
386
1734
621
3553
2.74
57.48
4.8
5.1
34.30
34.91
g/l
1.69
582
3322
784
5075
2.95
56.62
8.6
4.1
7516.43
2152.30
e6/l
0.53
14
66
344
1469
2.96
55.83
2.0
1.6
444.99
17377198.78
pmol/l
1.04
288
1197
74
96
8.20
54.11
2.0
2.7
29.81
34.93
umol/l
0.90
67
89
508
2718
2.63
52.46
3.4
4.1
2.35
2.36
mmol/l
0.87
460
2438
517
2807
2.61
51.56
6.4
3.4
29.11
69.28
ng/l
2.12
445
2099
298
1237
2.94
50.26
2.6
3.3
0.83
0.82
mmol/l
0.44
275
1166
141
369
4.24
48.95
3.6
4.0
5.28
5.07
kpa
1.99
136
355
447
2345
2.54
46.83
2.9
2.4
48.79
61.39
u/l
6.14
411
2147
698
4519
2.52
45.76
7.4
4.4
6.94
6.78
mmol/l
0.85
677
4272
134
359
4.12
44.96
3.7
4.0
7.42
7.41
ph
1.15
120
303
433
2347
2.40
41.02
4.7
4.2
7.41
7.40
ph
4.70
329
1651
534
3190
2.32
40.16
5.7
3.1
6.57
6.21
ph
9.22
286
1758
36
26
14.28
39.21
1.1
1.0
—
—
—
0
0
389
2046
2.40
39.06
2.5
2.2
2.85
2.88
mg/l
0.09
331
1747
536
3323
2.21
35.48
2.7
2.2
75.22
79.80
nmol/l
2.97
480
2950
337
1724
2.38
35.45
7.2
3.5
1.02
1.02
kg/l
0.59
240
1137
224
948
2.72
35.19
5.8
7.0
2.02
0.75
mmol/l
3.51
185
775
139
451
3.39
34.93
5.1
4.0
—
—
—
0
0
234
1023
2.64
34.39
4.4
5.2
1.00
1.04
mmol/l
1.13
214
944
150
515
3.22
34.36
2.1
2.4
406.96
403.92
nmol/l
0.06
134
479
85
199
4.55
33.82
3.4
3.9
25.92
24.77
mmol/l
1.59
85
199
220
949
2.65
33.12
5.9
7.1
7.42
7.41
ph
0.55
141
484
220
950
2.65
33.04
5.7
7.1
10.79
12.34
kpa
4.62
210
911
220
950
2.65
33.04
5.6
7.1
5.22
5.07
kpa
1.05
209
906
427
2479
2.19
32.64
3.6
3.0
31.08
36.78
u/l
1.10
401
2318
337
1783
2.29
32.31
3.7
2.5
5.69
5.83
e6/l
0.07
311
1612
223
985
2.59
31.89
1.9
2.1
29.68
29.99
s
0.26
217
959
611
4099
2.12
31.76
6.8
3.5
0.12
4.73
estimate
1.04
128
882
43
55
8.10
31.67
1.9
1.3
292.07
276.15
mosm/kgh2o
1.89
28
40
570
3738
2.10
31.32
17.4
16.7
1.31
1.33
inr
0.25
493
3098
38
9
43.63
31.05
1.1
1.0
252.87
226.22
ng/l
—
24
9
38
9
43.63
31.05
1.1
1.0
731.96
1016.00
ng/l
—
23
9
586
3896
2.09
30.88
10.3
6.0
0.60
0.60
e9/l
0.01
520
3249
739
5364
2.18
30.82
7.4
4.1
—
2.75
—
0
8
760
5588
2.20
30.51
6.6
3.7
15.19
15.00
pmol/l
1.14
697
5010
29
0
+∞
30.35
2.3
0.0
18.19
—
umol/l
—
29
0
585
3907
2.08
30.22
10.4
6.0
0.04
0.04
e9/l
2.64
518
3256
600
4046
2.08
30.17
6.8
3.5
0.00
0.00
estimate
-0.00
127
855
163
630
2.87
30.16
3.1
2.2
5.08
8.15
ug/l
2.02
132
573
199
853
2.63
30.13
5.9
7.4
94.33
95.58
%
2.01
193
824
596
4019
2.07
29.86
11.5
6.1
0.19
0.20
e9/l
0.34
527
3404
392
2267
2.14
29.66
7.3
3.5
0.00
0.01
estimate
0.78
110
768
590
3982
2.05
29.27
10.7
6.0
1.91
1.82
e9/l
0.48
528
3424
439
2662
2.09
29.20
4.8
3.2
45.65
139.04
e6/l
1.14
359
2028
52
91
5.95
28.71
2.8
1.3
—
—
—
0
0
186
789
2.64
28.68
5.0
3.5
2.78
1.64
mmol/l
3.91
161
663
605
4143
2.04
28.57
6.9
3.5
0.08
0.01
estimate
1.03
124
825
295
1566
2.21
27.40
3.8
2.8
501.33
540.43
mosm/kgh2o
2.48
252
1363
645
4561
2.02
27.34
20.3
10.0
4.36
4.14
e9/l
1.78
574
3878
299
1607
2.19
26.85
3.1
3.4
2.47
2.47
mmol/l
0.29
269
1435
66
152
4.56
26.75
1.7
1.2
0.22
0.29
mg/l
0.43
20
65
430
2662
2.02
26.37
3.3
3.1
1249.87
1603.31
ng/l
1.07
378
2349
29
28
10.61
26.32
3.8
3.0
—
—
—
0
0
185
818
2.52
26.03
4.8
3.4
7.39
7.38
ph
2.79
108
466
52
101
5.36
25.71
2.8
1.3
—
—
—
0
0
148
590
2.75
25.66
2.7
3.3
80.98
94.11
ng/l
0.96
121
516
605
4241
1.96
25.62
5.6
7.3
11.20
12.87
umol/l
1.10
575
4045
467
3002
1.97
25.49
5.7
3.7
132.11
151.71
e6/l
0.14
358
2122
52
104
5.20
24.88
2.8
1.3
—
—
—
0
0
52
104
5.20
24.88
2.8
1.3
—
—
—
0
0
531
3609
1.92
24.17
9.5
6.2
59.04
57.83
%
1.52
506
3440
35
17
21.23
23.99
1.2
1.6
—
—
—
0
0
360
2158
2.00
23.65
4.5
3.1
0.00
959.77
estimate
—
7
16
415
2619
1.95
23.42
8.1
6.3
—
—
—
0
0
529
3622
1.90
23.24
9.7
6.3
8.73
9.14
%
2.55
498
3381
797
6250
2.03
23.15
8.7
8.4
79.67
82.79
u/l
1.06
763
5892
375
2297
1.97
23.02
4.7
3.2
0.32
0.56
e6/l
2.75
301
1686
526
3615
1.88
22.65
9.6
6.3
2.55
2.85
%
2.03
496
3377
645
4732
1.89
22.61
5.2
2.7
49.43
54.10
u/l
0.51
596
4344
462
3054
1.89
22.39
7.4
3.4
0.00
0.04
estimate
2.67
101
683
534
3706
1.87
22.13
9.6
6.3
26.03
26.82
%
0.87
509
3496
524
3627
1.86
21.79
9.8
6.3
0.58
0.69
%
5.07
497
3385
158
706
2.45
21.52
5.2
7.6
1.44
1.28
mmol/l
0.56
152
692
50
110
4.72
21.42
1.4
1.2
56.68
60.78
mmol/l
0.25
38
87
171
807
2.33
20.55
2.0
1.6
—
—
—
0
0
99
362
2.91
20.05
2.2
1.9
1.25
1.97
ug/l
0.71
82
332
164
769
2.33
19.98
5.5
6.0
10.21
11.41
mmol/l
1.19
154
729
249
1381
2.04
19.85
2.4
2.5
11.06
12.40
umol/l
1.93
222
1307
197
1002
2.18
19.71
2.1
2.5
1.75
1.73
%
0.08
164
899
268
1533
1.99
19.56
4.9
3.5
125.78
684.26
ng/l
6.38
219
1290
151
690
2.38
19.49
6.0
8.8
—
—
—
0
0
237
1299
2.05
19.48
2.3
2.5
2.29
2.25
g/l
0.62
204
1215
24
7
35.01
18.95
1.8
1.1
—
—
—
0
0
76
249
3.21
18.60
3.8
4.1
—
—
—
0
0
71
226
3.29
18.22
5.4
4.8
1.33
1.46
mmol/l
0.45
66
200
45
104
4.47
18.16
3.0
1.3
—
—
—
0
0
137
622
2.38
17.89
4.2
2.8
—
—
—
0
0
455
3273
1.67
14.68
3.3
2.8
133.57
161.08
ug/l
2.06
410
3034
140
698
2.15
14.52
3.1
2.2
0.24
0.39
e6/l
1.14
133
666
210
1222
1.89
14.11
2.4
2.5
19.49
22.33
%
2.59
184
1152
251
1549
1.81
13.95
1.9
1.6
1.40
1.68
mg/l
0.59
206
1208
834
7076
1.77
13.82
8.8
4.4
1.87
2.09
mu/l
5.27
782
6323
116
547
2.25
13.78
6.7
9.1
1.55
1.24
%
2.46
116
542
87
361
2.53
13.75
3.0
3.4
4.16
4.44
pmol/l
1.93
72
326
142
728
2.09
13.67
2.3
2.1
0.00
0.02
estimate
0.50
25
139
13
0
+∞
13.57
1.1
0.0
43.04
—
nmol/l
—
13
0
135
692
2.09
12.98
3.9
2.8
169.87
242.38
ng/l
2.02
121
623
147
781
2.02
12.82
1.8
2.4
68.82
65.49
e9/l
0.47
115
589
136
703
2.07
12.78
2.2
2.7
64.60
65.76
g/l
0.94
113
650
163
905
1.94
12.52
8.7
3.1
5.04
4.84
e9/l
0.07
127
775
138
732
2.01
12.07
1.8
2.2
0.21
0.20
g/l
0.51
131
691
45
140
3.31
12.01
4.0
2.6
16.10
15.58
%
0.54
45
140
224
1393
1.77
11.95
1.4
1.2
1.33
1.27
u/ml
0.04
52
359
116
593
2.07
11.21
4.9
3.9
1.24
1.23
mmol/l
1.19
104
519
47
157
3.08
11.18
4.6
4.0
—
—
—
0
0
106
529
2.11
10.91
2.4
2.7
—
—
—
0
0
179
1079
1.79
10.53
2.0
1.8
—
—
—
0
0
23
31
7.55
10.21
2.2
2.3
804.28
297.96
mu/l
1.08
18
24
152
883
1.84
10.08
1.6
1.6
—
—
—
0
0
195
2941
0.59
10.04
3.5
3.2
—
—
—
0
0
150
872
1.84
9.92
1.4
1.3
—
—
—
0
0
15
9
16.88
9.89
1.1
1.3
153.07
150.56
nmol/l
—
15
9
244
1628
1.64
9.86
8.5
4.5
—
—
—
0
0
286
1994
1.59
9.62
4.1
3.9
85.08
85.81
%
0.19
277
1949
335
2448
1.53
9.07
10.2
6.5
—
—
—
0
0
145
866
1.78
8.74
1.8
2.6
9.61
11.09
umol/l
0.20
118
782
51
207
2.54
8.49
2.9
3.6
1.35
2.08
index
0.46
20
98
880
7889
1.61
8.49
31.4
14.4
28.96
28.69
mg/l
0.08
813
6279
21
49
4.35
8.42
2.0
3.6
0.80
0.55
mmol/l
0.09
21
49
215
1441
1.61
8.41
4.1
3.0
0.91
0.99
e6/l
0.20
129
796
67
310
2.24
8.35
1.4
1.2
—
—
—
0
0
73
352
2.15
8.22
2.2
2.1
0.00
0.01
estimate
0.50
18
113
83
421
2.05
8.20
1.4
1.7
1.60
1.54
g/l
0.22
68
357
123
721
1.80
7.88
5.3
4.3
7.35
7.35
ph
0.08
96
510
14
14
10.11
7.54
1.9
1.0
122.75
57.44
umol/l
—
8
9
122
727
1.76
7.39
2.1
2.4
27.25
36.30
u/l
2.86
103
611
196
1340
1.56
6.96
4.4
3.1
2.20
1.88
e6/l
0.31
110
695
86
474
1.88
6.72
1.2
1.2
—
—
—
0
0
91
511
1.85
6.71
5.4
9.2
24.70
24.21
mmol/l
0.54
85
502
284
2126
1.45
6.48
6.5
3.1
0.00
0.01
estimate
0.69
104
626
31
114
2.77
6.32
1.3
1.4
—
—
—
0
0
31
114
2.77
6.32
1.3
1.4
—
—
—
0
0
31
114
2.77
6.32
1.3
1.4
—
—
—
0
0
31
114
2.77
6.32
1.3
1.4
—
—
—
0
0
6
0
+∞
6.25
1.3
0.0
208.33
—
ug/l
—
6
0
184
1269
1.54
6.25
1.3
1.5
2.45
2.69
g/l
0.62
87
755
122
764
1.67
6.18
1.8
2.6
134.31
153.66
ug/g
0.20
92
611
63
324
2.00
6.04
2.6
4.1
38.55
53.87
mg/l
0.79
52
286
63
325
2.00
5.99
2.6
4.1
40.65
235.86
mg/l
0.64
52
283
67
354
1.95
5.96
2.1
1.7
—
—
—
0
0
99
592
1.74
5.94
7.9
3.4
—
—
—
0
0
370
2961
1.38
5.65
5.2
3.5
—
0.78
—
0
9
34
141
2.46
5.50
4.5
4.7
3.16
2.67
mmol/l
0.42
24
90
8
5
16.11
5.41
1.6
1.2
—
—
—
0
0
15
30
5.05
5.26
2.2
1.2
—
—
—
0
0
5
0
+∞
5.21
1.8
0.0
301.20
—
nmol/l
—
5
0
21
70
3.04
5.12
2.4
1.7
1.57
0.70
u/field
0.62
14
30
366
2961
1.36
5.11
3.6
3.3
6.44
7.35
mmol/l
3.37
299
2472
38
172
2.25
5.08
1.9
1.8
2.48
4.16
iu/l
1.86
15
64
58
310
1.92
5.02
1.2
1.7
—
—
—
0
0
38
174
2.23
4.95
2.8
2.8
55.18
62.29
%
1.17
38
174
136
930
1.53
4.78
1.3
1.3
—
—
—
0
0
53
284
1.91
4.58
2.6
3.8
1.39
9.24
ratio
1.38
31
173
10
15
6.72
4.47
1.3
1.3
—
—
—
0
0
432
3640
1.31
4.41
18.7
10.7
0.00
0.00
e9/l
1.80
353
2922
39
192
2.07
4.28
1.2
1.8
—
—
—
0
0
69
413
1.72
4.18
2.5
2.4
—
—
—
0
0
121
831
1.51
4.18
1.2
1.3
288.00
577.18
titre
1.87
15
177
357
2958
1.31
4.05
4.2
4.0
10.92
7.94
mg/mmol
0.48
223
1829
108
737
1.52
3.85
5.1
4.2
1.09
0.85
%
0.46
33
252
19
71
2.71
3.83
2.3
2.5
2776.77
3258.93
u/l
—
7
34
18
66
2.76
3.76
1.1
1.2
115.28
105.68
pmol/l
0.24
18
66
28
128
2.22
3.72
1.5
1.8
0.66
0.81
%
1.45
18
94
51
291
1.79
3.67
2.5
2.0
9.45
10.79
g/l
1.17
40
261
320
2649
1.29
3.58
2.5
2.6
—
—
—
0
0
346
2900
1.28
3.50
3.6
3.4
48.52
42.65
mg/l
0.19
227
1844
63
389
1.66
3.45
1.2
1.2
117.32
138.16
u/ml
0.17
26
140
26
523
0.48
3.43
1.2
1.3
—
—
—
0
0
281
3369
0.78
3.30
2.0
2.2
—
—
—
0
0
889
8385
1.33
3.26
38.4
17.3
139.71
139.72
mmol/l
0.02
880
8160
35
185
1.92
3.22
1.2
1.1
—
—
—
0
0
101
708
1.47
3.19
5.3
4.3
0.08
0.12
%
0.15
24
222
38
209
1.85
3.12
1.3
1.3
235.95
257.16
ug/g
0.26
20
125
889
8401
1.32
3.10
38.2
17.5
4.00
4.00
mmol/l
0.01
879
8156
168
2142
0.74
3.08
3.2
3.4
0.74
0.88
ug/l
1.35
121
1448
98
690
1.46
3.04
4.9
4.3
0.50
0.70
%
0.70
28
234
98
692
1.46
3.00
5.5
4.6
0.14
0.19
%
0.11
21
207
5
5
10.04
2.98
1.0
1.2
—
—
—
0
0
5
5
10.04
2.98
1.0
1.4
79.00
79.00
%
—
5
5
5
5
10.04
2.98
1.0
1.4
1046.80
362.00
mu/l
—
5
5
20
88
2.30
2.95
2.3
1.9
91.22
88.41
%
1.44
20
88
39
221
1.79
2.92
3.1
4.3
—
—
—
0
0
92
658
1.43
2.65
1.5
1.5
—
—
—
0
0
814
7669
1.24
2.51
8.9
6.1
40.52
39.42
mmol/mol
2.52
764
7044
32
180
1.80
2.49
2.1
2.3
8.38
87.25
ug/min
2.83
16
101
255
2137
1.25
2.49
4.8
2.9
0.00
0.01
0.49
11
72
57
839
0.66
2.42
1.3
1.4
—
—
—
0
0
11
39
2.84
2.34
2.4
1.7
507.67
519.04
min
—
6
28
17
78
2.20
2.31
1.1
1.5
25.06
30.45
ng/l
0.43
17
78
194
2340
0.79
2.28
1.3
1.3
—
—
—
0
0
42
264
1.61
2.23
1.1
1.3
—
—
—
0
0
26
143
1.84
2.20
1.3
1.1
—
—
—
0
0
25
136
1.86
2.19
1.2
1.2
—
—
—
0
0
82
600
1.40
2.13
4.2
2.5
6.33
5.94
ph
3.28
59
422
20
102
1.98
2.11
2.2
2.5
—
—
—
0
0
105
804
1.34
2.06
1.5
1.5
—
—
—
0
0
6
15
4.02
2.04
1.0
1.5
—
—
—
0
0
34
208
1.65
2.03
4.4
3.0
0.83
0.75
nmol/l
0.68
26
161
71
513
1.41
1.99
2.2
3.3
9.74
11.10
g/l
2.20
58
475
15
73
2.07
1.81
2.1
2.0
—
—
—
0
0
37
240
1.56
1.78
14.9
9.9
—
—
—
0
0
7
24
2.93
1.72
1.7
1.3
—
—
—
0
0
15
280
0.53
1.69
1.2
1.2
—
—
—
0
0
13
63
2.08
1.60
1.3
1.6
—
—
—
0
0
7
26
2.70
1.58
4.1
7.0
26.44
24.61
mmol/l
—
7
26
8
33
2.43
1.54
4.9
2.4
32.95
38.56
g/l
—
8
33
414
3778
1.15
1.51
2.8
2.8
—
—
estimate
—
0
0
6
21
2.87
1.50
1.2
1.0
1993.67
1377.00
miu/ml
—
6
21
27
171
1.59
1.47
1.1
1.2
20.76
34.90
u/l
0.63
20
148
12
227
0.52
1.44
1.8
1.8
—
—
—
0
0
13
66
1.98
1.43
1.2
1.2
2.33
1.54
nmol/l
0.54
13
59
6
22
2.74
1.43
1.2
1.5
—
—
—
0
0
821
7887
1.17
1.40
7.4
5.0
6.21
5.96
mmol/l
6.41
749
7086
859
8282
1.18
1.40
28.9
12.8
—
—
—
0
0
12
60
2.01
1.38
1.2
1.3
5.71
20.78
%
—
7
40
12
60
2.01
1.38
1.4
1.4
113677.17
22774.41
e6/l
—
6
44
102
1245
0.80
1.35
1.2
1.4
—
—
—
0
0
21
128
1.65
1.34
3.6
3.5
4.88
4.01
e9/l
0.89
21
128
12
61
1.98
1.33
1.1
1.1
6.86
3.10
u/ml
—
7
30
11
54
2.05
1.33
1.3
1.1
—
—
—
0
0
41
292
1.42
1.32
2.8
3.4
317.21
428.10
mg/l
0.24
19
136
19
115
1.66
1.25
1.7
2.4
0.69
1.14
g/24h
—
8
68
13
70
1.87
1.24
1.1
1.0
—
—
—
0
0
10
50
2.01
1.16
1.3
1.4
61.10
103.12
ng/l
—
10
50
24
158
1.53
1.15
3.5
3.4
55.87
57.31
%
0.19
24
158
22
145
1.53
1.06
1.1
1.0
—
—
—
0
0
10
179
0.55
1.05
1.1
1.1
—
—
—
0
0
14
82
1.72
1.05
1.5
1.1
—
—
—
0
0
5
22
2.28
1.03
1.0
1.0
172.40
210.32
iu/ml
—
5
22
7
34
2.07
1.03
1.4
1.5
—
—
—
0
0
19
122
1.57
1.03
2.6
2.7
—
—
—
0
0
50
386
1.31
1.03
2.2
3.1
—
—
—
0
0
9
47
1.92
1.02
1.2
2.2
—
—
—
0
0
19
123
1.55
1.00
1.4
1.3
—
—
—
0
0
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
0
29
0.00
0.98
0.0
1.1
—
14.42
—
0
23
7
36
1.95
0.97
2.3
1.1
—
—
—
0
0
10
55
1.83
0.92
1.4
1.1
—
—
—
0
0
8
43
1.87
0.87
1.9
1.9
8.29
7.87
mmol/l
—
8
43
8
46
1.74
0.82
1.1
1.2
—
—
—
0
0
48
382
1.27
0.82
1.3
1.2
95.71
205.44
u/ml
1.37
39
351
8
47
1.71
0.80
1.6
2.0
15.90
15.69
%
—
8
47
16
106
1.52
0.79
1.0
1.1
—
—
—
0
0
97
1117
0.86
0.76
2.3
5.1
5.37
32.53
ug/l
2.49
74
936
5
24
2.09
0.74
1.4
1.2
208.20
154.33
mmol/24h
—
5
24
23
171
1.35
0.66
1.1
1.2
—
—
—
0
0
890
8727
1.11
0.65
39.5
19.8
79.80
81.75
umol/l
0.82
881
8574
16
112
1.43
0.63
1.4
1.3
20.70
32.54
iu/l
0.93
11
95
23
174
1.33
0.60
1.8
1.5
9833.00
15506.03
e6/l
0.53
17
112
54
456
1.19
0.58
5.7
3.3
1.02
1.02
ratio
0.09
49
414
11
73
1.51
0.56
1.2
2.0
—
—
—
0
0
6
38
1.58
0.54
3.5
5.1
0.83
0.95
index
—
6
38
6
39
1.54
0.53
1.3
1.2
—
—
—
0
0
82
925
0.88
0.52
1.4
1.4
—
—
—
0
0
786
8019
0.93
0.51
5.7
4.7
1.34
1.47
mmol/l
14.83
713
7276
7
45
1.56
0.49
1.0
1.1
—
—
—
0
0
683
6659
1.07
0.49
40.4
18.6
13.93
13.76
%
2.95
677
6519
792
8072
0.93
0.48
5.8
4.9
4.22
4.62
mmol/l
24.89
721
7380
11
76
1.45
0.48
1.3
1.1
—
—
—
0
0
7
48
1.46
0.47
2.0
2.2
—
—
—
0
0
5
31
1.62
0.43
3.2
3.3
—
—
—
0
0
365
3501
1.06
0.42
4.7
6.1
2.37
3.91
ug/l
2.18
319
3164
6
95
0.63
0.42
1.2
1.1
—
—
—
0
0
6
95
0.63
0.42
1.5
1.2
—
—
—
0
0
15
195
0.77
0.42
1.3
1.3
—
—
—
0
0
5
33
1.52
0.41
3.2
3.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
52.62
—
0
15
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
3.6
—
37.20
—
0
15
0
15
0.00
0.41
0.0
7.2
—
7.87
—
0
15
0
16
0.00
0.41
0.0
1.1
—
27.75
—
0
16
11
79
1.40
0.40
4.8
4.3
10.83
11.18
index
—
6
38
5
35
1.43
0.39
1.0
3.6
1652.00
1263.46
u/ml
—
5
35
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
36
418
0.86
0.37
1.6
3.8
32.00
3578.89
u/ml
0.86
29
358
54
478
1.14
0.37
1.2
1.3
—
—
—
0
0
811
8228
0.94
0.35
6.6
5.6
2.36
2.70
mmol/l
25.49
741
7493
128
1194
1.08
0.34
1.3
1.2
59.57
44.60
iu/ml
0.16
35
377
15
118
1.27
0.33
1.0
1.1
—
—
—
0
0
63
697
0.90
0.33
1.4
1.6
—
—
—
0
0
6
87
0.69
0.33
2.2
2.3
366.50
809.17
mg
—
6
87
68
745
0.91
0.31
2.1
2.0
11.78
13.60
nmol/l
0.93
52
669
53
478
1.11
0.29
1.5
1.4
—
—
—
0
0
8
108
0.74
0.29
1.0
1.2
—
—
—
0
0
12
94
1.28
0.28
1.8
2.5
—
—
—
0
0
221
2118
1.05
0.28
3.0
2.9
360.40
357.74
umol/l
0.14
183
1842
47
424
1.11
0.26
1.5
2.0
1.15
1.37
g/l
0.42
40
380
15
123
1.22
0.25
1.1
1.2
284.60
251.66
u/ml
—
5
74
116
1096
1.07
0.24
1.3
1.2
10.37
20.22
u/ml
0.56
35
399
5
40
1.25
0.22
2.6
2.5
2460.00
1750.00
ml
—
5
35
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
34
377
0.90
0.21
1.1
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
328
3363
0.96
0.20
2.0
1.8
1.51
1.29
mmol/l
4.15
281
2780
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
51
1.18
0.19
2.3
1.6
77.50
84.20
umol/l
—
6
51
8
96
0.83
0.13
1.3
1.1
—
—
—
0
0
12
104
1.16
0.12
1.8
2.3
—
—
—
0
0
16
178
0.90
0.11
1.0
1.2
—
2832.00
—
0
5
27
250
1.08
0.11
9.0
3.7
—
—
—
0
0
758
7619
0.98
0.08
4.9
4.1
1.44
1.24
mmol/l
8.24
684
6846
6
70
0.86
0.07
1.7
1.9
—
—
—
0
0
6
75
0.80
0.07
3.3
2.1
—
—
—
0
0
17
184
0.92
0.07
1.3
1.2
—
1.79
—
0
10
17
184
0.92
0.07
3.1
3.1
20.35
31.73
mg/l
—
8
126
673
6695
1.01
0.06
47.0
19.2
330.06
331.92
g/l
5.26
667
6642
13
142
0.91
0.06
1.5
1.4
1468.60
1612.49
e6/l
—
5
92
11
99
1.11
0.06
1.0
1.1
—
—
—
0
0
11
121
0.91
0.06
1.8
1.5
—
—
—
0
0
13
121
1.08
0.03
1.2
1.4
—
—
—
0
0
893
8918
1.01
0.02
52.1
22.4
39.22
40.22
%
6.50
884
8753
11
117
0.94
0.01
1.9
1.5
—
—
—
0
0
892
8912
1.00
0.00
51.6
22.0
240.61
243.03
e9/l
0.55
881
8640
27
264
1.02
0.00
2.2
1.5
14.00
6.07
iu/ml
—
6
50
13
127
1.02
0.00
4.9
3.8
21.61
49.05
nmol/l
0.26
13
127
892
8918
1.00
0.00
51.6
21.9
4.34
4.47
e12/l
11.27
878
8606
12
123
0.98
0.00
1.4
1.3
—
—
—
0
0
892
8921
1.00
0.00
52.1
22.1
130.46
135.16
g/l
17.65
883
8766
865
8647
1.00
0.00
16.2
11.4
23.50
25.65
u/l
2.32
844
8306
892
8919
1.00
0.00
52.1
21.9
7.18
6.65
e9/l
7.25
878
8603
0
7
0.00
-0.00
0.0
1.1
—
360.57
—
0
7
892
8917
1.00
-0.00
51.4
21.9
91.69
91.48
fl
0.78
882
8754
892
8917
1.00
-0.00
51.4
21.8
30.32
30.42
pg
1.10
882
8756
5
53
0.94
-0.00
1.0
1.6
55.94
176.90
pmol/l
—
5
53
6
67
0.89
-0.00
1.0
1.1
—
—
—
0
0
5
58
0.86
-0.00
1.4
1.3
2483.00
1826.97
ml
—
5
58
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
7
74
0.95
-0.00
1.1
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
118.86
—
0
7
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
67
0.89
-0.00
3.0
3.1
3.92
20.50
mg/l
—
6
51
0
6
0.00
-0.00
0.0
1.0
—
0.12
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
50
1.00
-0.00
1.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
54
0.93
-0.00
2.2
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint PD2ND_EXMORE and mortality.

Females

Parameter HR [95% CI] p-value
PD2ND_EXMORE 2.661 [2.41, 2.94] < 0.001
Birth year 0.999 [0.99, 1.01] 0.791

During the follow-up period (1.1.1998 — 31.12.2019), 2267 out of 4093 females with PD2ND_EXMORE died.

Males

Parameter HR [95% CI] p-value
PD2ND_EXMORE 2.923 [2.58, 3.32] < 0.001
Birth year 0.988 [0.98, 1.0] 0.01

During the follow-up period (1.1.1998 — 31.12.2019), 2505 out of 4106 males with PD2ND_EXMORE died.

Mortality risk

Mortality risk for people of age

years, who have PD2ND_EXMORE.

N-year risk Females Males
1 0.243% 0.641%
5 1.816% 3.416%
10 4.328% 8.089%
15 8.267% 16.043%
20 14.327% 25.852%

Relationships between endpoints

↥

Index endpoint: PD2ND_EXMORE – Secondary parkinsonism, excluding more controls

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data